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Abstract
Breast fed infants are at a lower risk of SIDS compared to formula fed infants but
the actual protective mechanism of breast feeding in relation to SIDS is not known.
A model has been proposed which suggests that SIDS victims die from uncontrolled
inflammatory responses to bacterial toxins. Bacteria associated with SIDS include
Staphylococcus aureus and Clostridium perfringens. Both colonise mucosal surfaces
and produce superantigenic toxins which induce strong inflammatory responses.
The aim of the study was to investigate the protective effect of breast feeding at two
stages of the model: colonisation of mucosal surfaces by toxigenic bacteria;
inflammatory responses to toxin.
Experiments were carried out to investigate the effect of breast milk, infant formula
and synthetic Lewis antigens on binding ofA. aureus and C. perfringens to epithelial
cells. Two different methods were used: the conventional experimental or in vitro
approach; the second an in vivo approach developed to simulate interactions at
mucosal surfaces. With the in vivo method, breast milk enhanced bacterial binding
to cells whilst infant formula inhibited binding; however, for the in vitro method,
human milk and infant formula enhanced binding due to bacterial aggregation. For
both methods, the oligosaccharides Lewis3 and Lewisb found in both human milk
and infant formula inhibited bacterial binding in a dose dependent manner.
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IgA antibodies against the staphylococcal toxins TSST-1 and SEC and C.
perfringens enterotoxin A (CEA) were present in milk samples from 28 donors.
Most SIDS deaths occur during 2-4 months of age when infants have decreasing
levels of maternal antibodies to infectious agents. Most deaths occur during the
early hours of the morning. Adults are more susceptible to inflammatory responses
at night due to lower Cortisol levels associated with circadian rhythm patterns.
Infants develop these patterns between 7-22 weeks, at which time their night-time
Cortisol levels drop dramatically. Breast fed infants develop these patterns
significantly earlier than formula fed infants. Human buffy coats were used to
investigate pro-inflammatory cytokine production in response to TSST-1 and to
investigate the effect of Cortisol levels observed in infants before and after circadian
rhythm pattern development. Human buffy coats consistently produced TNF-a and
IL-6 but only Cortisol levels (>5 pg df1) found in infants during the day or at night
prior to the change significantly decreased TNF-a and IL-6 production.
The bacterial binding studies indicate protection associated with breast feeding in
relation to SIDS could be due partly to enhanced clearance of bacterial aggregates.
Human IgA antibodies in breast milk might neutralise bacterial toxins on mucosal
surfaces. If the switch to the circadian rhythm pattern occurs in an infant when
maternal antibodies are present or an infant is receiving IgA in breast milk, the
infant might be able to neutralise a challenge with the toxins; however, if the switch
occurs in an infant when antibody levels are low or an infant is formula fed, lower
3
night-time Cortisol levels might be insufficient to control inflammatory responses
induced by bacterial toxins alone or in combination with other infections.
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Abbreviations
ALTE apparent life threatening event
BI binding index
BSA bovine serum albumin
CEA Clostridium perfringens enterotoxin A
CI confidence interval
CMV cytomegalovirus
CSE cigarette smoke extract
D defatted breast milk
DEPC diethyl pyrocarbonate
DMEM Dulbeco's Modified Eagle's Medium
DPT diphtheria-pertussis-tetanus
EBV Epstein-Barr virus
ELISA enzyme linked immunosorbent assay
FCS foetal calf serum
FITC fluorescein isothiocyanate









OSAS obstructive sleep apnea syndrome
PBS phosphate buffered saline
PCR polymerase chain reaction
RSV respiratory syncytial virus
RT reverse transcriptase
RT-PCR reverse transcriptase polymerase chain reaction
SEC staphylococcal enterotoxin C
SEM standard error of the mean
SIDS sudden infant death syndrome
TNF-a tumour necrosis factor alpha
TSST-1 toxic shock syndrome toxin
v/v volume per volume
w/v weight per volume





1.1 Sudden and unexpected deaths in infants
Reports of sudden and unexpected deaths in infants can be found in the Old
Testament, in Roman records, and in 12th and 13th Century medical and legal
literature. These deaths were classified as overlaying. By the late 18th and 19lh
centuries, the suggested cause of death was fatal interference of heart and lung
function by an enlarged thymus [Limerick, 1992],
The first epidemiological patterns of a higher number of deaths occurring during the
winter months and early mornings (especially Sunday and Monday), were noted by
Wakley in the 19th Century [Limerick, 1992],
1.2 Sudden Infant Death Syndrome (SIDS) - definition and incidence ofSIDS
1.2.1 Definition ofSIDS
The current definition of Sudden Infant Death Syndrome (SIDS) was made by
Beckwith at the 1969 International Conference on the Causes of Sudden Deaths in
Infants [Limerick, 1992], The definition states that SIDS is "the sudden death of any
infant or young child which is unexpected by history and in which a thorough
post-mortem examination fails to demonstrate an adequate cause of death"
[Beckwith, 1970], Today, a thorough investigation of the scene of the death is
strongly recommended.
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In 1971, SIDS was accepted as a registrable cause of neonatal death by the Registrar
for Births, Deaths and Marriages in Scotland, the Procurators Fiscal and the
Coroner's Office [Busuttil et al., 1992],
The use of the term SIDS has increased the thoroughness of the post-mortem
examination and stimulated research. Epidemiological studies have been able to
identify infants at risk [Busuttil et al., 1992; Limerick, 1992], One difficulty with
SIDS research is the lack of appropriate controls. Ideal controls would be 1 - 6
month old healthy infants who die suddenly due to an accident, but fortunately,
these are few in number [Limerick, 1992], To overcome this problem, many studies
include infants who have died of other causes or live infants closely matched for
age, sex and socioeconomic background [Blackwell et al., 1995a],
1.2.2 Incidence ofSIDS
Although the incidence of SIDS has declined over recent years, it is still the leading
cause of postneonatal death in the developed world accounting for approximately
40% of postneonatal mortality [Bernshaw, 1991; Lindsay et al., 1994; Chantler,
1996], In 1995, the incidence of SIDS in Scotland was 0.7 deaths per 1,000 live
births [Brooke etal., 1997],
Ethnic origin influences the incidence of SIDS in a population [Mitchell et al.,
1993; Nelson, 1996], Among white infants in Britain, the incidence of SIDS was
reported to be 1.7 per 1,000 live births in the late 1980s. In contrast, Asian infants
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during this period had a much lower incidence of SIDS (half or less than half that of
white infants), and this is accompanied by lower mortality from respiratory causes
[Balarajan et al., 1989; Farooqi et al., 1995], Many indigenous groups, Australian
Aborigines, American Indians and Alaskan natives, have a much higher rate of
SIDS. In Australia, among Aboriginal infants the rate of SIDS was 6.1 per 1,000 live
births compared to the non-Aboriginal rate of 1.7 per 1,000 live births [Alessandri et
al., 1994], In New Zealand, Maoris had a SIDS rate of 7.4 per 1,000 live births
compared to the non-Maori rate of 3.6 per 1,000 live births. This difference between
the Maori and non-Maori groups might be due to the fact that the prevalence of risk
factors for SIDS including maternal smoking, prone sleeping position and bottle
feeding, is higher in the Maori population [Mitchell et al., 1993; Potter et al.,
1996],
1.3 A diagnosis ofexclusion
SIDS is a diagnosis of exclusion and is made once all alternative causes of death
have been ruled out. To diagnose SIDS, a full history, death-scene and thorough
post-mortem examination must be carried out. A SIDS death is thought to be due to
a final common pathway triggered by several disorders [Berry et al., 1989; Busuttil
et al., 1992; Limerick, 1992], Typical post-mortem findings in SIDS infants are
shown in Table 1.1. Hypostatic staining can be used to indicate an infant's sleeping
position. No single feature distinguishes SIDS infants from control infants although
several differences can be detected by epidemiological studies [Berry et al., 1989;
Berry, 1992],
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Table 1.1 Typical findings in SIDS infants [Berry et al., 1989]
External
Body apparently well developed and well nourished
Frothy, often blood-tinged fluid around the nose
Cyanosis of lips and nailbeds
Internal
'Large' thymus with petechiae
Petechiae beneath visceral pleura
Epicardial petechiae
Full expansion of lungs
Liquid heart blood
Empty bladder
Prominent lymph nodes and Peyer's patches
Microscopic
Pulmonary congestion and oedema
Mild inflammation of upper respiratory tract
Focal fibrinoid necrosis of vocal cords
Persistent haemopoiesis in the liver
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1.4 Developmental and environmental riskfactors associated with SIDS
One consistent finding in epidemiological studies is the age distribution of SIDS
deaths. SIDS can affect infants aged between one week and one year of life;
however, the peak incidence of SIDS occurs during the 2 - 4 month age range and
80% of SIDS deaths occur during the first 6 months of life [Morris et al., 1987;
Berry, 1992; Drucker el al., 1992; Lindsay et al., 1994; Blackwell et al., 1995a;
Chantler, 1996],
SIDS is associated with a number of developmental and environmental risk factors
which are similar to those associated with respiratory tract infections. These risk
factors include: the age range affected; winter peak of these deaths in many
countries; a mild respiratory or gastrointestinal tract infection prior to death; bottle
fed rather than breast fed; exposure to cigarette smoke; the prone sleeping position;
no immunisation or late immunisation [Blackwell et al., 1995a; Chantler, 1996],
SIDS is more likely to occur during the winter months and in families of lower
socioeconomic conditions (social class IV or V) [Berry et al., 1989; Lindsay et al.,
1994; Blair et al., 1996; Chantler, 1996], Low birthweight infants who are
premature (< 36 weeks) or who had intra-uterine growth retardation and are small
for gestational age or below the given 5th centile, are also at greater risk of dying
from SIDS [Berry et al., 1989; Brooke et al., 1997], Maternal risk factors associated
with SIDS include a young and / or unmarried mother, high parity, high birth order,
maternal smoking or opiate / barbiturate addiction and a short inter-pregnancy
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interval [Berry et al., 1989], SIDS is more likely to occur during the early hours of
the morning (midnight to 6.00 a.m.) and it has been suggested that sleep might be
involved in the mechanism of some SIDS deaths [Schechtman et al., 1995; Cornwell
et al., 1998],
Male infants have an increased risk of SIDS, 1.84-fold that of females (95% CI 1.22
to 2.77) [Brooke et al., 1997], One epidemiological study has found a very similar
prevalence of SIDS risk factors for both males and females and has suggested that
the increased risk associated with male infants is due to an inherent factor [Mitchell
etal., 1997],
1.5 Hypotheses developed to explain a SIDS death
A number of different hypotheses have been proposed to explain the mechanism of
a SIDS death and are listed in Table 1.2 [Berry et al., 1989], It is unlikely that one
single hypothesis can explain the mechanism of a SIDS death.
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1.5.1 S1DS and hypersensitivity to cows' milk
One early hypothesis stated that SIDS occurred in infants who were hypersensitive
to cows' milk. It was suggested that these infants had developed antibodies to cows'
milk proteins absorbed from the alimentary tract [Parish et al., 1960; Coombs et al.,
1982], If a sleeping hypersensitive infant regurgitated some stomach contents which
were aspirated in to the respiratory tract, death might result from an anaphylactic
type of reaction. Evidence for this hypothesis came from experiments involving
guinea pigs sensitised to cows' milk. The hypothesis was later disproved by a study
which measured total and specific anti-cows' milk IgE levels in infants who died
from SIDS and from infants who had had reported episodes of milk aspiration. If a
SIDS infant had died from anaphylaxis, there should be increased levels of IgE. The
study found that increased total and specific levels of IgE were only present in
infants with a history of milk aspiration [Boulloche et al., 1986], Breast fed infants
have also been found to die as suddenly and unexpectedly as those fed cows' milk
[Berry et al., 1989],
1.5.2 Metabolic disorders
A number of inborn errors of metabolism or metabolic deficiencies have been
associated with SIDS [Bonham et al., 1992; Burchell et al., 1992]. Some metabolic
disorders can mimic SIDS by their sudden onset and rapid deterioration [Bonham et
al., 1992], One example is infants who have problems maintaining glucose
homeostasis. These infants are subject to potentially fatal hypoglycaemic events and
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this problem is enhanced during times of stress such as minor infections [Burchell et
al., 1992],
1.5.3 Sleep apnoea
Sleep apnoea has been proposed as an alternative mechanism of a SIDS death.
Infants with sleep apnoea have abnormal respiratory control, airway obstruction and
failure of arousal which results in death. Near-miss SIDS or infants who have had an
apparently life threatening event (ALTE) have been followed to try to provide
evidence for this hypothesis [Berry et al., 1989],
Studies of adults with obstructive sleep apnea syndrome (OSAS) found that these
patients, compared to normal, healthy controls, had altered cytokine release patterns
associated with circadian rhythm. Maximum release of cytokines from leukocytes of
normal subjects in response to endotoxin occurred in the later evening or early hours
of the morning and corresponded to minimal levels of Cortisol. Leukocytes from
OSAS subjects showed maximal release of cytokines during the afternoons which
also corresponded to minimal Cortisol levels (Figures 1.1a and b) [Entzian et al.,
1996],
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Figure 1.1a) interferon-gamma (IFN-y) and b) Cortisol release in OSAS patients and









1.5.4 Virus infection and overheating
Infection and overheating are strongly associated with a SIDS death. A number of
epidemiological factors provide evidence that virus infection is associated with
SIDS; however, no definite association between SIDS and specific viruses have
been reported, and it appears unlikely that virus infection alone is sufficient to cause
death. Virus infection might contribute to overheating by induction of fever as a
result of pyrogenic cytokine release in response to a primary viral or secondary
bacterial infection [Fleming, 1992; Flowatson, 1992],
Infants who had a virus infection and were heavily wrapped were found to be at an
increased risk of sudden infant death [Gilbert et al., 1992], Physiological evidence
indicates that infants in the 2 - 3 month age range are more vulnerable to heat stress
than younger infants [Fleming et al., 1992],
1.5.5 The common bacterial toxin hypothesis
The common bacterial toxin hypothesis is based on a mathematical model which
was proposed to explain the mechanism of a SIDS death [Morris et al., 1987], The
model is consistent with epidemiological and experimental studies that viral
infections predispose to SIDS, there are minimal morphological changes at autopsy,
maximum incidence during sleep, and the hypothesis closely predicts the observed
SIDS age distribution.
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The model states that early in life, infants encounter bacteria which form the normal
flora of the respiratory tract. Infants are protected during this time by maternal IgG
until they develop their own immunity to these bacteria and their toxins. The normal
nasopharyngeal bacterial flora can, however, be disturbed by virus infection and this
results in infants carrying increased numbers of toxigenic bacteria. The hypothesis
states that if an infant with a viral infection is exposed to a toxigenic organism for
the first time, the organism might overgrow in the nasopharynx and produce toxins
which are absorbed across the respiratory mucosa. These toxins will stimulate strong
inflammatory responses, and in a vulnerable infant, a SIDS death might result before
immunity is developed. The hypothesis is based on the fact that the toxins are
produced by bacteria of the normal flora and infants commonly encounter them
during the first few weeks of life.
Nasopharyngeal bacterial flora and not gastrointestinal flora have been considered
in this model because although the gastrointestinal tract contains many toxigenic
bacteria, a strong association is observed between viral respiratory tract infections
and SIDS.
The hypothesis closely predicts the observed age incidence of SIDS. Around 3
months of age, a baby's maternal immunoglobulins have declined and its active
immunity will not be fully developed. The hypothesis also explains why premature
compared to full term infants have an increased risk of dying from SIDS since
premature infants have lower levels of maternal IgG in the first months of life.
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The higher incidence of SIDS observed between midnight and 6.00 a.m. can also be
explained. Gravity and mucociliary action normally clear nasopharyngeal secretions;
however, if viral infection impairs mucociliary clearance, secretions can pool
resulting in increased bacterial growth and toxin production during the later hours of
sleep.
1.6 Infectious agents and SIDS
1.6.1 Infections prior to death
Prior to death, many SIDS infants had mild symptoms of respiratory or
gastrointestinal infections [Lindsay et al., 1994], Infants are particularly susceptible
to infections during the 2-4 month age range because levels of passive antibodies
against bacteria and viruses are decreasing and infants are more reliant on their
inflammatoiy responses to deal with infectious agents to which they are exposed.
1.6.2 Evidence ofinflammatory responses in SIDS infants
There is evidence for mild infection and associated inflammatory responses in SIDS
infants. As a group, SIDS victims had evidence of increased inflammatory
stimulation in the upper airways and intestinal tract compared with infants who
died of other causes (e.g. violent deaths). Pro-inflammatory cytokines such as
interleukin-6 (IL-6), interleukin-1 (3 (IL-lp) and tumour necrosis factor-a (TNF-a)
have been detected in body fluids or tissues of SIDS victims. At autopsy, there is
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often evidence of mild inflammatory reactions and increased levels of some acute
phase proteins, increased production of immunoglobulins in the respiratory tract
and gut, and changes indicating T-cell activation [Forsyth et al., 1999; Vege et al.,
1999],
1.6.3 Toxigenic bacteria isolatedfrom SIDS infants
With the exception of an association between whooping cough and SIDS in some
Scandinavian countries, [Lindgren et al., 1997], there is no association between
outbreak of disease and SIDS therefore it seems unlikely that one infectious agent is
solely responsible for SIDS [Blackwell et al., 1995a], Bacteria which colonise
mucosal surfaces and produce soluble toxins that diffuse into the bloodstream have
formed the majority of the work involving the role of bacteria in SIDS [Blackwell
et al., 1995b],
There is evidence which indicates that the nasopharyngeal bacterial flora is
disturbed in some SIDS infants [McKendrick et al., 1992], Compared to healthy
infants, infants who died from SIDS have a significantly higher probability of
having a toxigenic bacterial species isolated from their nasopharyngeal flora.
Toxigenic bacteria isolated more often from SIDS cases compared to controls
include Staphylococcus aureus, Streptococcus pyogenes, Clostridium perfringens,
Clostridium difficile and toxigenic Escherichia coli [Telford et al., 1989;
Bettelheim el al., 1990; Murrell et al., 1993; Bettiol et al., 1994; Lindsay et al.,
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1994], It has also been suggested that enteric staphylococcal infection is involved in
some SIDS deaths [Trube-Becker, 1978], Bordetella pertussis has been implicated
by epidemiological studies as a possible cause of SIDS [Wennegren et al., 1987;
Nicoll et al., 1988; Lindgren et al., 1997]. The numbers of SIDS cases in
Scandinavia increased following discontinuation of the pertussis vaccine
[Wennegren et al., 1987], B. pertussis has not been isolated from any cases of SIDS
[Saadi et al., 1996a; Heinenger et al., 1996], but DNA from these bacteria was
identified in 9/51 (18%) of SIDS infants. The study was not carried out in parallel
with attempts to culture the bacteria [Heininger et al., 1996],
In a recent study, S. aureus was the species most frequently isolated from SIDS
infants. S. aureus was isolated from 56% of 253 healthy infants aged 3 months or
younger compared to 86.4% of SIDS infants in the same age range. A large number
of SIDS deaths now occur during the first 3 months of life, and three studies have
found that in the normal flora of the respiratory tract of infants, S. aureus was the
predominant isolate during the 0-3 month age range [Aniansson et al., 1992;
Blackwell et al., 1999; Harrison et al., 1999a], In infants with and without an upper
respiratory tract infection, S. aureus was found to be more common during the
autumn and winter months compared to the spring and summer months [Harrison et
al., 1999a], This parallels the winter peak of SIDS noted in many countries
[Blackwell et al., 1995a], Although male infants compared to female infants were
not more likely to be colonised by the respiratory pathogen S. aureus which has
been implicated in SIDS, male infants had significantly heavier growth [Harrison et
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al., 1999a], In this study, compared to female infants, male infants who slept prone
were found to have significantly higher counts of S. aureus regardless of the
presence or absence of an upper respiratory tract infection.
1.6.4 Bacterial toxins associated with S1DS
Several groups have proposed that bacterial toxins play a role in precipitating the
series of events leading to SIDS [Morris et al., 1987; Blackwell el al., 1992; Lindsay
et al., 1994; Blackwell et al., 1995a; Blackwell et al., 1995b], Three bacteria
commonly isolated from SIDS infants, S. aureus, S. pyogenes and C. perfringens,
produce superantigenic toxins which bind to MHC class II molecules and activate
VP-specific T cells [Johnson et al., 1996], These toxins have been implicated as
having a significant role in SIDS [Lindsay et al., 1994],
The 5. aureus toxins, toxic shock syndrome toxin-1 (TSST-1) and staphylococcal
enterotoxin C (SEC), have been identified in tissues of SIDS infants by
immunohistochemical methods [Newbould et al., 1989; Malam et al., 1992], By
ELISA and flow cytometry methods, pyrogenic staphylococcal toxins have been
identified in over half of the specimens from SIDS infants from Scotland, France
and Australia examined in a recent study [Zorgani et al., 1999],
C. perfringens and its enterotoxin A have been identified in body fluids of SIDS
infants [Murrell et al., 1987], and a significantly higher incidence of both were
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found in the faeces of formula fed infants compared to breast fed infants [Murrell et
al., 1993],
The common bacterial toxin hypothesis suggested that SIDS might be caused by a
number of different toxins which could act synergistically [Morris el al., 1987,
1999], The chick embryo model has been used to examine the lethality of toxins
produced by bacteria associated with SIDS. Synergy between Gram-positive and
Gram-negative bacteria (S. aureus and E. coli) has been demonstrated [Drucker et
al., 1992], A later study [Sayers et al., 1995a] showed that synergy can occur
between the toxins of nasopharyngeal staphylococci and enterobacteria and that this
combination of strains is more likely to occur in the nasopharynx of SIDS victims
than in healthy infants. The pyrogenic staphylococcal toxins have been
demonstrated to enhance the effect of endotoxin over 100,000 fold [Bohach et al.,
1990], While high levels of endotoxin have not been identified in SIDS infants [Piatt
el al., 1994; Crawley et al., 1999], in combination with pyrogenic toxins of
staphylococci or streptococci, these might have lethal effects.
Other animal models indicate virus infection can enhance inflammatory responses to
staphylococcal toxins [Jakeman et al., 1991; Sarawar et al., 1994; LeClaire et al.,
1995], This enhancement effect is due to priming of inflammatory responses (TNF
and nitric oxide) by IFN-y produced in response to the viral infection [Sarawar et al.,
1994; LeClaire et al., 1995], Influenza virus infection of human leukocytes resulted
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in increased production of TNF-a in response to endotoxin [Lundemose et al.,
1993],
1.7 Factors that contribute to susceptibility to SIDS
1.7.1 Exposure to cigarette smoke
Maternal smoking whether ante- or post-natal, is a risk factor for SIDS. In a recent
epidemiological study, the risk of SIDS increased with the number of parents who
smoked and with the number of cigarettes smoked. The risk of SIDS caused by
maternal smoking was increased if the mother shared a bed with the infant [Mitchell
et al., 1995; Brooke et al., 1997],
Smoking is associated with respiratory viral infections which enhance bacterial
binding, and buccal epithelial cells from smokers have been found to bind
significantly more bacteria compared to cells from non-smokers [Saadi et al., 1996a;
El Ahmer et al., 1999], The studies by El Ahmer et al, [1999] indicate a broad range
of bacteria exhibited this pattern including species implicated in SIDS (S. aureus
and B. pertussis) and species that cause respiratory tract infections (Haemophilus
influenzae, Streptococcuspneumoniae, Moraxella catarrhalis).
Buccal epithelial cells from non-smokers treated with a water soluble cigarette
smoke extract (CSE) demonstrated enhanced bacterial binding. The effect was
observed up to a 1 in 300 dilution of the extract. Passive exposure to cigarette
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smoke might result in adsorption of substances that enhance attachment of bacterial
species. Passive coating of an infant's mucosa by components of cigarette smoke
might increase the non-specific "stickiness" of these cells for bacteria.
A significant association has been found between isolation of specific bacterial
species from both mother and infant [Blackwell et al1999], The mother is
probably the source of an infant's normal flora and the significantly enhanced
binding of bacteria to buccal cells of adult smokers might result in the infant being
exposed to a greater number of bacteria.
Sayers et al. [1995b] showed that very low concentrations of nicotine can interact
with selected bacterial toxins and potentiate the lethal effect of both single toxins
and synergistic combinations. This might also explain why parental smoking
increases the risk of SIDS. Cigarette smoke components were found to induce
inflammatory responses on their own and could enhance inflammatory responses to
virus infection [Raza et al., 1999],
Low birthweight is also associated with an increased risk of SIDS and a recent study
has suggested that most of the SIDS risk associated with growth retardation might
be due to maternal smoking [Cooke, 1998],
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1.7.2 The prone sleepingposition
Infants sleeping prone were found to be at 3 times the risk of SIDS compared to
infants in other sleeping positions [Beal, 1995], The incidence of SIDS has declined
in response to campaigns to discourage prone sleeping [Beal, 1995; Court, 1995;
Molony et al., 1998],
Pyrogenic toxins of S. aureus have been identified in the tissues and body fluids of
SIDS infants [Newbould et al., 1989; Malam et al., 1992; Zorgani et al., 1999],
These toxins are induced only between 37 and 40°C, and the nasal temperature is
usually well below this range due to the passage of air. In the prone position, there
could be an accumulation of secretions or blocking of a nostril by bedding which
would create a microenvironment allowing increased bacterial growth and toxin
production. Infants sleeping prone also have a reduced ability to lose heat compared
to infants sleeping supine [Tuffnell et al., 1995],
The temperatures in the noses of young children were found to be significantly
higher than those of adults [Molony et al., 1996], In a recent study, the nasal
temperatures of children lying in the prone position were significantly higher than in
the standing position. The temperature in the prone position, but not in the upright
position, reached 37°C in 5 children who had no evidence of a respiratory tract
infection [Molony et al., 1998; Molony et al., 1999], If the prone position can raise
the upper airway surface temperature to the range in which pyrogenic toxins are
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produced, this might be one mechanism by which prone sleeping contributes to
SIDS in the absence of a respiratory tract infection [Molony et al., 1998],
The hypothesis that the prone sleeping position is associated with accumulation of
upper airways secretions and increased bacterial growth was investigated in adults.
In a study in which 10 adults with upper respiratory tract infections lay prone for
one hour and then supine for one hour, higher bacterial counts were obtained from
nasal swabs after the prone position. In the prone sleeping position, the clearance of
upper respiratory tract secretions is reduced leading to increased bacterial growth
and potentially to increased toxin production [Bell et al., 1996],
A recent study found that infants who had an upper respiratory tract infection and
slept prone had significantly higher numbers of bacteria in their secretions and a
similar nasopharyngeal flora to that observed in SIDS infants [Harrison et al.,
1999a], These observations are consistent with the common bacterial toxin
hypothesis [Morris et al., 1987, 1999] which suggests that if an infant with an upper
respiratory tract infection is placed in the prone sleeping position, increased
bacterial growth and toxin production might result in an infant being at an increased
risk of a SIDS death [Harrison et al., 1999a, 1999b],
1.7.3 Sleep and developmental changes in relation to SIDS
Most SIDS deaths occur between midnight and 6.00 am [Morris et al., 1987] when
babies are asleep, and it has been suggested that sleep might be a part of the
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pathophysiological mechanism of SIDS [Schechtman et al., 1995; Cornwell et al.,
1998], Studies on the physiology of sleep in infants have produced important clues
to relate developmental stage with the proposed role of inflammation in SIDS.
The 2-4 month age range has been consistently identified as the period in which the
majority of SIDS deaths occur. During this age range, infants develop adult-like
night-time temperature and hormone rhythm patterns. In normal infants, between 7
and 16 weeks, the body temperature falls at night to 36.4°C, similar to that of
sleeping adults. Breast fed infants undergo this change significantly earlier than
formula fed infants. Among infants of low birthweight or who experienced problems
at delivery, this change can occur as late as 22 weeks [Lodemore et al., 1992],
Infants who remain in the "immature" state share many risk factors with SIDS
infants, and Wailoo and colleagues have suggested that the "immature" state is a
risk factor for SIDS. In contrast, other work by this group found that Asian infants
stay in the "immature" stage significantly longer than white infants [Petersen et al.,
1994], but Asian infants have a lower incidence of SIDS [Balarajan el al., 1989],
The findings of Wailoo and colleagues can also be explained by relating them to
other physiological changes they found to occur in conjunction with the change in
body temperature rhythm. The week following the switch to an adult-like night-time
temperature pattern, there is a dramatic drop in night-time (but not day-time) levels
of the anti-inflammatory agent Cortisol. In adults, inflammatory responses are less
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well controlled at night due to the circadian rhythm pattern ofCortisol. Lowest levels
ofCortisol occur during the early hours of the morning [Entzian et al., 1996],
The period in which the drop in night-time Cortisol levels occurs is thought to be a
window of vulnerability for SIDS. If the change occurs when maternal antibodies
are present to neutralise viruses or toxins (or the infant has produced its own
antibodies), the infant can deal with infectious challenges. If this drop in night-time
Cortisol levels occurs in an infant who has little or no specific protection, the infant
is at increased risk of dying from SIDS due to an uncontrolled immune response
[Blackwell et al., 1995a, b]. Evidence that younger infants control inflammatory
responses more effectively, comes from studies carried out in relation to trials for
the change in immunisation schedules in Britain. This evidence was that younger
infants had fewer episodes of high temperature and fewer local inflammatory
reactions [Miller et al., 1997],
1.8 Factors that reduce susceptibility to SIDS
1.8.1 Immunisation with diphtheria-pertussis-tetanus vaccine
Infants who were not immunised or who were immunised late against diphtheria,
pertussis and tetanus (DPT) were found to be at a greater risk of SIDS. The NICHD
SIDS Co-operative Epidemiological Study found that there was a significantly lower
incidence of immunisation among SIDS infants compared to control infants
[Hoffman etal., 1987],
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In 1990, the DPT immunisation schedule in Britain was changed; immunisation was
initiated at 2 months rather than 3 months. The DPT vaccine can induce antibodies
which cross-react with staphylococcal pyrogenic enterotoxins [Essery et al., 1999],
The new immunisation schedule might prevent a few deaths due to asymptomatic
whooping cough but they might also induce production of antibodies which are
cross-reactive with adhesins or toxins of other species during a period in which
infants appear to be better able to handle their inflammatory responses.
1.8.2 Breast feeding andSIDS
The first association between SIDS and the complete absence of breast feeding was
noted by Carpenter in 1965 [cited in Klonoff-Cohen et al., 1995], The actual
protective mechanism of breast feeding in relation to SIDS is not known; however,
breast fed infants have a lower risk of SIDS and breast feeding promotes an infant's
general health and well-being.
Breast milk is specifically made for humans and because of its anti-infective,
nutritional and biological properties, has been characterised as the optimal food for
human growth and development [Uauy et al., 1995; Golding et al., 1997], Breast
milk is a dynamic body fluid and its composition varies both during the day and over
the course of lactation thus providing the infant with the specific nutrients it needs
at each age [Lawrence, 1994; Emmett et al., 1997], It is not presently understood
what the physiological basis of this variation is in relation to infant development
31
[Emmett et al., 1997], Breast feeding has also been found to protect against the
development of diseases such as insulin dependent diabetes mellitus later in life
[Lambert etal., 1995],
Breast milk is used as the standard by which infant formulas are improved [Jensen et
al., 1992]; however, although nutritionally complete, infant formula does not
contain protective immunological factors, and it is not possible to provide either the
type and quality of the individual nutrients or the day to day variations observed in
breast milk.
1.8.2.1 Evidence for a protective effect ofbreast feeding in relation to SIDS
Epidemiological studies, including the New Zealand Cot Death Study which was
carried out over a period of 3 years and examined data from 465 SIDS cases and
1,762 controls [Mitchell et al., 1991; Mitchell et al., 1992], indicated that exclusive
breast feeding, compared with partial breast / formula or exclusive formula feeding,
provided a protective effect against the risk of SIDS. Infants not exclusively breast
fed on discharge from hospital were twice as likely to die from SIDS compared to
infants who were exclusively breast fed [Ford et al., 1993], This figure was also
found in a case-control study conducted by the National Institute of Child Health
and Human Development SIDS Co-operative Epidemiological Study in the US
[Hoffman et al., 1988], This reduced risk persisted during the first 6 months of life
after controlling for confounding demographic, maternal and infant factors [Ford et
al., 1993],
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The reduced risk of SIDS in breast fed infants was evident during the first 6 months
of life. Higher levels were found for control infants compared to SIDS infants, and
compared to control infants, breast feeding stopped earlier in SIDS cases. During the
first week of life, 92% of control infants were breast fed compared with 86% of
SIDS cases. By 6 weeks, the numbers were 77% and 63% respectively and by 6
months, the numbers were 58% and 36% respectively. This study could not identify
a causal relationship between the reduced risk of SIDS and breast feeding, but it has
been suggested that the protective effect might be due to the breast milk itself, to the
environment which has led to a continuation of breast feeding, or to a combination
of both [Ford et al., 1993],
Contradictory reports came from a UK study which investigated the hypothesis that
bottle feeding is associated with SIDS. Compared with fully breast fed babies, the
crude odds ratio for SIDS among fully bottle fed babies was 3.1 and for mixed
breast and bottle fed infants 1.5. Ratios fell to 1.8 and 1.2 respectively after
adjustment for maternal smoking, parental employment, pre-term gestation and
sleeping position. The conclusion of the British study was that bottle feeding was
not a significant independent risk factor for SIDS and that most of the apparent
associations between bottle feeding and SIDS could be accounted for by maternal
smoking, pre-term gestation and parental employment status [Gilbert et al., 1995],
These results have, however, been criticised on the basis of design and small
numbers. Only larger studies tend to demonstrate an independent risk of bottle
33
feeding associated with SIDS. A second major design flaw of the study was biased
controls. To recruit control infants, health visitors were asked to identify two infants
living in the same neighbourhood; however, these controls would be more likely to
have the same feeding method compared to randomly selected controls. This could
account for the fact that bottle feeding was not found to be independently associated
with SIDS. One other factor which could account for this finding is that when the
limited format of an observational case-control study is used, adjustment for
socioeconomic status might remove the effect of breast feeding [Tappin, 1995], In
Britain, breast feeding tends to be confined to the upper and middle classes, whereas
in countries such as New Zealand, women of all socioeconomic groups breast feed
[Tappin, 1995], In a longitudinal study ofmothers and infants, smoking and formula
feeding were found to be significantly higher among lower socioeconomic groups
[Blackwell et al., 1999],
1.8.2.2 Generalprotective effects ofbreastfeeding
In comparison to bottle fed infants, breast fed infants are less susceptible to
gastrointestinal and respiratory tract infections [Buescher, 1994; Pisacane et al.,
1994], Breast feeding has been found to be protective against specific pathogens
including Salmonella, Shigella, Vibrio cholerae, Escherichia coli, polioviruses,
rotavirus and respiratory syncytial virus (RSV) [Goldman, 1993], This protection
might also be applicable to S. aureus and C. perfringens, toxigenic bacteria which
colonise the respiratory and gastrointestinal tracts respectively and have been
implicated in SIDS [Lindsay et al., 1994; Blackwell et al., 1995a], Secretory IgA
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from human colostrum has also been found to inhibit adherence of H. pylori to the
human gastric mucosa [Lonnerdal, 1996],
1.8.2.2.1 Immune factors in human milk
It has been suggested that breast milk confers general and specific protection upon
an infant. Antibody-producing cells specific for the mother's microbial flora are
secreted in breast milk. The infant acquires its mucosal flora from the mother. There
was a significant association between isolation of potential pathogens such as S.
aureus or H. influenzae from both mother and baby [Mackenzie el al., 1996;
Blackwell et al., 1999], The infant's respiratory defences might be stimulated by
immunoregulatory factors present in human milk [Cunningham et al., 1991],
Secretory IgA and cells of the immune system present in breast milk could enhance
this protective effect.
Breast milk contains a number of antimicrobial factors including lactoferrin,
lysozyme and secretory IgA. These factors are common to mucosal sites, are able to
survive in the gastrointestinal tract because of their resistance to digestive enzymes
and can protect without triggering inflammatory reactions [Goldman, 1993],
Breast milk also contains a number of anti-inflammatory agents including enzymes
that degrade mediators of inflammation. In studies with a rat subcutaneous air pouch
model of inflammation, colostrum was found to have significant anti-inflammatory
activity [Murphey et al., 1993], In a later study involving chemically induced colitis
in rats, human milk was found to have an anti-inflammatory effect compared to rats
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fed infant formula. This might have been due to the presence of the IL-1 receptor
antagonist in human milk [Grazioso et al., 1997], Human milk also contains the
anti-inflammatory cytokine 1L-10. This has been found to regulate mucosal defences
and limit inflammatory reactions in the upper part of the alimentary and respiratory
tracts [Garofalo et al., 1995],
Breast milk also contains growth factors including epithelial growth factor,
lactoferrin, Cortisol and immunomodulating agents [Goldman, 1993], The cytokines
IL-1 [3 and TNF-a have been identified in colostrum and human milk. These have
been suggested to activate T cells and enhance secretory component production
respectively [Rudloff et al., 1991; Saito et al., 1991; Goldman, 1993], Both IL-6
(which enhances IgA production in the breasts) and granulocyte-colony stimulating
factor are involved in the activation and maturation of the immune system, and these
might help to protect the breast fed infant against pathogenic organisms. The
presence of these cytokines could contribute to the lower infection rate in breast fed
infants [Wallace et al., 1997],
1.8.2.2.2 IgA
Secretory IgA is the main immunoglobulin in breast milk and is made up of an IgA
dimer linked to glycoprotein produced by epithelial cells. Many of the IgA
antibodies are specific for microorganisms in the respiratory system or
gastrointestinal tract. This specificity is due to immunogen-triggered migration of B
cells from Peyer's patches of the lower small intestine and from lymphoid centres in
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the bronchial tree to the lamina propria of the mammary gland [Goldman, 1993],
Compared to bottle fed infants, breast fed infants have enhanced immunity on their
mucosal surfaces during the early neonatal period as development of the secretory
IgA system does not occur until sometime after birth; however, it has been shown
that by 6 weeks, local antigens are the main source of stimulation for
immunoglobulin production in the respiratory mucosa [Stephens, 1986; Goldman,
1993],
1.8.2.2.3 Oligosaccharides in human milk
The initial event in development ofmost bacterial diseases is attachment to mucosal
surfaces [Beachey, 1981], Human milk contains a unique set of complex
oligosaccharides, and because of similarities with epithelial cell-surface
carbohydrates, both free oligosaccharides and glycoconjugates in human milk have
been suggested to act as receptor analogues for some bacterial adhesins [Kunz el al.,
1993], These might increase the resistance of breast fed infants to infection by
binding to bacterial adhesins thereby reducing the ability of respiratory and
gastrointestinal pathogens to colonise epithelial surfaces [Sabharwal et al., 1991;
Goldman, 1993; Kunz et al., 1993; Ashkenazi, 1996], Human milk oligosaccharides
have been found to inhibit binding of S. pneumoniae and H. influenzae to epithelial
cells [Andersson et ah, 1986] and to inhibit binding and block activity of the heat
stable enterotoxin ofE. coli [Crane et al., 1994],
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The concentration of oligosaccharides in human milk are highest early in lactation
[McVeagh, 1995], Oligosaccharides are present in colostrum at 2.1 g/100 ml and in
mature milk at 1.3 g/100 ml [Emmett et al., 1997], Breast milk contains over 130
different forms and the variety of oligosaccharides differs from woman to woman
[McVeagh, 1995],
The Lewis antigens can occur as free oligosaccharides in breast milk [Henry et al.,
1995], Oligosaccharides in milk are related to the mother's secretor status
[McVeagh, 1995], Milk from women who secrete their ABO blood group antigens
are characterised by the presence of 2-fucosyl-lactose (Fucal-2Gaipi-4Glc) and of
lacto-N-fucopentaose 1 (Fucal-2Gaipi-3GlcNAcpi-3Gaipi-4Glc) and of more
complex oligosaccharides, all possessing Fucal-2Gaipi-3GlcNAc residues. In milk
of non-secretors, the major fucosylated oligosaccharide is lacto-N-fucopentaose II
(Gaipi-3[Fucal-4]GlcNAcpi-3Gaipi-4Glc) which is the Lewis3 blood group
component (Figure 1.2) [Kunz et al., 1993],
The Lewis antigens are fucose containing oligosaccharides that can act as receptors
for several bacteria: H. pylori [Alkout et al., 1997]; S. aureus [Saadi el al., 1993,
1999]; B. pertussis [Saadi et al., 1996a], The Lewis antigens are not structural
components of cells but are rather acquired by cells from plasma or secretions.
Expression of the Lewis antigens depends on the Lewis (on the short arm of
chromosome 19) and secretor loci. The Lewis gene encodes for an a-l,3/4-fucosyl-
transferase which transfers fucose to the subterminal pGlcNAc unit of precursor
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chains. The secretor gene codes for an a-l,2-fucosyl-transferase that transfers fucose
to the terminal pGal unit of precursor chains [Henry el al., 1995],
Fucosyltransferases coded by genes at these loci compete and interact with each
other and with other transferases to determine an individual's Lewis and secretor
phenotype [Henry et al., 1995], If the secretor enzyme adds fucose first, the structure
can act as a substrate for the Lewis enzyme to form the Lewisb antigen; however, if
the Lewis enzyme adds fucose to the subterminal sugar first to form Lewis3, the
secretor gene is unable to use this as a substrate to form Lewisb Figure 1.3 outlines
the synthesis pathways of the Lewis3 and Lewisb antigens.
Figure 1.2 The structure of the Lewis antigens [Henry et al1995]
Lewis3 Gaip l-3GlcNAcp 1 -3Gaip 1 -4GlcP 1 -ICer
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Figure 1.3 The synthesis pathways of the Lewis3 and Lewisb antigens [Watkins,
1980]
























1.8.2.2.4 Effect ofbreastfeeding on neurological development
Infants fed different nutrient mixtures have been found to have important
biochemical and physiological differences. Low birth weight infants were found to
have significant differences in fundamental autonomic functions and this could be
related to dietary intake. Studies have also found that depending on the quality of
lipid in the diet, significant differences were found in the visual responses of
neonates fed human milk versus formula [Schulze, et al., 1995],
Breast milk has been suggested to contribute to optimal brain development [Uauy et
al., 1995], Long-chain polyunsaturated fatty acids such as arachidonic and
docosahexaenoic acid are essential for brain development [Lanting et al., 1994],
Brain growth is associated with increased incorporation of these fatty acids into the
phospholipid which is primarily located in the cerebral cortex [Farquharson et al.,
1992], During periods of rapid neuronal multiplication, the placenta supplies the
foetus with arachidonic and docosahexaenoic acids [Kohn et al., 1994; Lanting el
al., 1994]; however, after birth, young infants are unable to synthesis these fatty
acids from their CI 8 precursors quickly enough and, therefore, require an external
source [Emmett et al., 1997], These fatty acids are present in breast milk but not in
infant formula. Compared to breast fed infants, the plasma docosahexaenoic acid
levels are much lower in formula fed infants [Uauy et al., 1995], It has been
suggested that infant formula could be improved by the addition of long chain fatty
acids [Farquharson et al., 1992]
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One study investigated the phospholipid fatty acid composition of the cerebral
cortex from SIDS infants and split them into groups depending upon whether they
were fed breast milk or infant formula. Although small, this study found that breast
fed infants had significantly higher concentrations of docosahexaenoic acid in their
cerebral cortex than formula fed infants [Farquharson et al., 1992],
1.8.2.2.5 Disadvantages ofbreast feeding
Breast feeding has some disadvantages. Breast milk might contain any maternal
medication or drugs ingested (e.g. caffeine, nicotine, alcohol), and viruses including
Epstein-Barr virus (EBV), cytomegalovirus (CMV) and HIV, can be passed from
mother to infant [Golding et al., 1997],
It has been found that the protective effect of breast feeding against SIDS is negated
among infants exposed to maternal tobacco smoke [Klonoff-Cohen et al., 1995],
Compared to passive smokers, breast milk from mothers who smoke has a much
higher concentration of cotinine [Milnerowicz et al., 1997], An earlier study found
that this depended on the mother's nicotine consumption and that babies exclusively
breast fed by smoking mothers had urinary cotinine excretion levels in the same
range as those of adult smokers [Schulte-Hobein et al., 1992],
Infant botulism was suggested to be a cause of some SIDS deaths. Although the
toxin responsible for botulism can be passed on to an infant in breast milk [Golding
et al., 1997], breast milk has been found to contain secretory IgA antibodies against
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Clostridium botulinum vegetative cell antigens and breast fed infants compared to
formula fed infants were found to have a slower onset of disease [Arnon, 1984],
1.9 The mechanism ofa SIDS death
A number of hypotheses have been proposed to explain the mechanism of a SIDS
death and are listed in Table 1.2. The most relevant to this project is that some
deaths result from pathophysiological responses, produced against a combination of
microbial products and / or cigarette smoke, occurring during a time of an infant's
development when the endocrine responses are less able to "damp down" the effects
of inflammatory mediators [Blackwell et al., 1995a, b].
The model in Figure 1.4 outlines the steps leading to a SIDS death. The model was
developed for respiratory pathogens but can also be applied to gastrointestinal
pathogens. There are a number of factors which enhance colonisation of an infant by
bacteria: virus infection; maternal smoking; expression of the Lewis3 antigen on
baby's cells.
The Lewis3 antigen can be used as a host cell receptor by bacteria implicated in
SIDS including the respiratory pathogens S. aureus and B. pertussis [Saadi et al.,
1993; 1994; 1996a, b]. During the 2 - 4 month age range, 80-90% of infants express
Lewis3 antigen on their red blood cells, and the antigen is also present on epithelial
cells since it can be adsorbed from secretions. There are differences in efficiency
and maturation of the Lewis and secretor genes during this period of an infant's
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development. The secretor gene matures later than the Lewis gene therefore at this
time, even secretor infants will express high amounts of Lewis3 on their cells
[Blackwell et al., 1992]. The Lewis3 antigen was found in respiratory secretions of
71% of SIDS infants [Blackwell et al., 1992; Saadi et al., 1993],
If an infant is over-wrapped, subject to virus infection or placed in the prone
sleeping position, the temperature at the mucosal surface might rise to between 37
and 40°C allowing production of superantigenic toxins. These toxins induce
production of inflammatory mediators, and if the infant is unable to control
inflammatory responses by 1) antibodies neutralising the toxin or 2) by sufficient
Cortisol responses, this could lead to uncontrolled inflammatory responses similar to
those involved in toxic shock syndrome.












The actual protective mechanism of breast feeding in relation to SIDS is not known.
The aims of this project were to investigate a possible protective effect of breast
feeding at two stages of the model: 1) at the level of colonisation by bacteria; 2) at
the level of induction of inflammatory mediators to bacterial toxins.
The specific objectives were to address the following questions:
1) Do the methods used in most binding studies reflect the interactions at the
mucosal surface?
2) What were the effects of human milk and infant formula on binding of a
respiratory and a gastrointestinal pathogen implicated in SIDS to epithelial
cells?
3) What were the effects of oligosaccharide components on bacterial binding to
epithelial cells?
4) Are there antibodies to the toxins implicated in SIDS present in human milk?
5) Can components in human milk reduce the ability of the staphylococcal toxins
to induce inflammatory mediators?
6) Are the night-time levels of Cortisol sufficient to control inflammatory responses
to staphylococcal toxins?
Although bacterial toxins have been detected in tissues from some SIDS infants and
inflammatory responses observed, there is at present no direct evidence that the
47
toxins have induced the observed inflammatory responses. As part of this project,
the last objective was to develop a reverse transcriptase polymerase chain reaction
(RT-PCR) protocol to provide a method to obtain evidence that toxins in tissues of
SIDS infants have induced the inflammatory responses.
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Chapter Two
General materials and methods
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2.1 Phosphate buffered saline (PBS)
This was prepared by addition of 6.8 g NaCl (Sigma), 1.43 g Na2HP04 (BDH) and
0.43 g KH2P04 (Fisons) to 1 litre of distilled water (pH 7.2).
2.2 Kato III cell culture and collection
Kato III cells were chosen for use in this model system to minimise differences in
expression of H and Lewis antigens noted for individual donors as variation
associated with diet or smoking [Alkout et al., 1997], Kato III, an epithelial cell line
derived from a gastric carcinoma (CB769) was obtained from the European
-5
Collection of Animal Cell Cultures. Cells were cultured in 75 cm tissue culture
flasks (Greiner) at 37°C in 5% C02 in growth medium (GM) which contained RPMI
1640 (Gibco), 20% (v/v) foetal calf serum (FCS) (Gibco), 1% (w/v) L-glutamine
(Gibco), penicillin (100 IU ml"1) and streptomycin (200 pg ml"1) (Gibco).
For binding assays, cells were detached from the flask by gentle scraping using a
cell scraper (Greiner). The cells were washed twice in PBS by centrifugation at 300
x g for 10 min and resuspended in PBS. The cells were counted using a Neubauer
haemocytometer by preparing a 1 in 10 dilution of the cells in 0.5% (w/v) trypan




S. aureus NCTC 10655 which produces TSST-1 was grown on nutrient agar plates
for 24 h at 37°C. C. perfringens NCTC 2661 (kindly provided by Mr R. Brown of
this department) was grown on blood agar plates for 24 h at 37°C under anaerobic
conditions (Oxoid Gas Generating Kit).
2.4 Collection ofmilk specimens andpreparation ofinfantformula
Milk was collected from mothers participating in a longitudinal survey of infants'
nasopharyngeal flora. Ethical permission for the study was obtained. Informed
written consent was given by the mothers at recruitment into the study by the
research nurse and health visitors at the 6 week postnatal medical examination.
Information on socioeconomic background and medical history was obtained by the
research nurse who helped the mother fill in a standardised questionnaire at the first
interview.
Milk specimens were collected from women in various stages of lactation by
manual expression. The specimens were transported within 2 - 4 h to the laboratory
and stored at -20°C until examined. Whole and defatted pools of human milk
containing aliquots of 42 specimens were prepared. To prepare the defatted pool, an
aliquot of the whole pool was centrifuged twice at 2,000 x g for 15 min at 4°C. The
clear middle layer was separated from the upper fatty layer and from cells at the
bottom of the tube. Both pools were stored in aliquots at -20°C.
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Infant formula was prepared with sterile water according to the manufacturers'
instructions. All dilutions ofmilk and infant formula were made in PBS.
2.5 ELISA reagents
Table 2.1 lists the antibodies, horse radish peroxidase (HRP)-labelled antibodies, the
standards and their sources.
2.5. 1 Coating buffer
Coating buffer was prepared by addition of 1.59 g Na2C03 (BDH), 2.93 g NaHC03
(BDH) and 0.20 g NaN3 (Sigma) to 1 litre of distilled water (pH 9.6).
2.5.2 Washing buffer
Washing buffer was prepared by addition of 8.00 g NaCl (Sigma), 0.20 g KH2P04
(Fisons), 1.15 g Na2HP04 (BDH), 0.20 g KC1 (BDH), 1 g bovine serum albumin
(BSA) (Sigma) and 0.5 ml Tween-20 (BDH) to 1 litre of distilled water.
2.5.3 Blocking buffer
Blocking buffer was prepared by addition of 1% (w/v) BSA to sterile PBS.
2.5.4 Phosphate citrate buffer
Phosphate citrate buffer was prepared by addition of 21.00 g citric acid (BDH) and
14.20 g Na2HPQ4 (BDH) to 1 litre of distilled water (pH 5.0).
\ \
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2.5.5 Substrate ofdetection ofHRP-labelled antibodies
The substrate contained 40 mg of ortho-phenylenediamine dihydrochloride (OPD)
(Sigma) in 100 ml of phosphate citrate buffer and was activated immediately prior
to use with 40 pi 30% (v/v) H202 (Sigma).
2.5.6 Stopping solution
Stopping solution was 12.5% (v/v) H2S04 diluted in distilled water.
a fy
2.6 ELISA to detect Lewis and Lewis antigens in human milk, infant formula
and cows' milk
Plates were coated overnight at 4°C with 100 pi of breast milk, infant formula or
cows' milk samples diluted 1 in 10, 1 in 100 or 1 in 1,000 in coating buffer. Positive
controls of saliva samples from a non-secretor (Lewis3) and a secretor (Lewisb)
donor and a negative control of a saliva sample from a Lewis negative donor, were
also included on each plate. The plates were washed 3 times with washing buffer
and 100 pi of blocking buffer were added to each well for 30 min at room
temperature. The plates were washed 3 times and 100 pi ofmouse monoclonal anti-
Lewis3 or anti-Lewisb (SNBTS) both diluted 1 in 50 in blocking buffer were added
to the plates for 2 h at room temperature. The plates were washed 3 times and 100
pi of HRP-anti-mouse IgG (SAPU) diluted 1 in 100 in blocking buffer were added to
the plates for 2 h at room temperature. The OPD substrate (2.5.5) was added to the
wells, incubated at room temperature for 15 - 30 min and the reaction stopped with
the stopping solution (2.5.6). The absorbance at 490 nm (A490) was determined and
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the A490 for the negative control wells subtracted from the test sample A490. The
results for the test samples were compared with those for the non-secretor, secretor
and Lewis negative controls.
2.7 Source ofstaphylococcal and clostridial toxins
Table 2.2 lists the toxins used and their sources.
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Table 2.1 List ofmonoclonal / polyclonal antibodies, recombinant cytokines and
their sources
Antibody /Recombinant Source
Mouse monoclonal anti-human IL-6 R&D*
Recombinant human IL-6 R&D*
Goat polyclonal anti-human IL-6 R&D*
Mouse monoclonal anti-human IL-ip R&D*
Recombinant human IL-ip R&D*
Goat polyclonal anti-human IL-1P R&D*
Mouse monoclonal anti-human TNF-P R&D*
Recombinat human TNF-P R&D*
Goat polyclonal anti-human TNF-P R&D*
HRP anti-sheep/goat IgG SAPU**
HRP anti-mouse IgG SAPU**
HRP goat anti-human IgA Sigma
Standard human IgA derived from colostrum Sigma
FITC-labelled anti-mouse IgG Sigma
HRP anti-horse IgG Sigma
Mouse monoclonal anti-Lewisa SNBTS***
Mouse monoclonal anti-Lewisb SNBTS***
HRP sheep anti-TSST-1 Toxin Technology
HRP sheep anti-SEC Toxin Technology
C. perfringens anti-toxin MrR. Brown, Dept. ofMedical Microbiology
Anti-H type 2 Serotec
HRP sheep anti-bovine IgA Bethyl Laboratories, Universal Biologicals Limited
HRP sheep anti-bovine IgGi Bethyl Laboratories, Universal Biologicals Limited
Bovine immunoglobulin reference serum Bethyl Laboratories, Universal Biologicals Limited
* R & D Systems Europe Ltd., 4-10 The Quadrant, Barton Lane, Abingdon, Oxon, 0X14 3YS, UK.
** Scottish Antibody Production Unit, Law Hospital, Carluke, Lanarkshire, ML8 5ES, Scotland.
*** Scottish National Blood Transfusion Service, Ellen's Glen Road, Edinburgh, EH17 7QT.
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Table 2.2 List of toxins and their sources
Toxin Source
Toxic shock syndrome toxin (TSST-1) Toxin Technology
Staphylococcal enterotoxin C (SEC) Toxin Technology
C. perfringens enterotoxin A (CEA)
(number 8237)
Dr D. Williamson, The Defence Microbiology Division
(CBDE), Porton Down
Chapter Three
The effect of human milk and infant formula
preparations on binding of toxigenic
Staphylococcus aureus to epithelial cells
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3.1 Introduction
Many of the risk factors for respiratory tract infections are also associated with
SIDS. Breast feeding reduces susceptibility to respiratory tract infections [Pisacane
et al., 1994] and oligosaccharide components in human milk have been
demonstrated to inhibit binding of the bacterial respiratory pathogens Streptococcus
pneumoniae and Haemophilus influenzae to human pharyngeal or buccal epithelial
cells [Andersson et al., 1986],
Prior to death, many SIDS victims had mild symptoms of respiratory tract
infections. Compared to healthy infants in the same age range, toxigenic bacteria
such as S. aureus and Streptococcus species are more likely to be identified among
SIDS infants [Telford et al., 1989], In a longitudinal survey of healthy infants in the
age range at greatest risk of SIDS, 56% were colonised by S. aureus but these
bacteria were identified in 86% of 39 local SIDS infants examined during the same
period [Blackwell et al., 1999],
The Lewis3 antigen is expressed by 80-90% of infants during the 2-4 month age
range in which most deaths occur. Lewis3 is a receptor for S. aureus [Saadi et al.,
1993] and an adhesin has been isolated from these bacteria by affinity purification
with synthetic Lewis3 [Saadi et al., 1994], Epidemiological studies have found the
peak in isolation of S. aureus from infants in the 2 - 4 month age range parallels
expression of the antigen [Aniansson et al., 1992, Blackwell et al., 1999, Harrison et
al., 1999a], Work by other groups has suggested that oligosaccharides and
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glycoconjugates present in human milk can act as analogues of epithelial cell
receptors that bind bacterial adhesins, thereby reducing the ability of bacteria to
colonise epithelial surfaces [Andersson et al., 1986, Goldman, 1993],
The first objective of this study was to compare the ability of human milk and infant
formula for their effect on binding of S. aureus to epithelial cells. The second
objective was to assess the effect of the synthetic Lewis3 and Lewisb antigens on
bacterial binding. Two different methods were used in this study. The first was an in
vivo method in which bacteria, cells and the milk or formula were added together
and binding allowed to occur. The second was the conventional experimental or in
vitro approach in which bacteria were initially incubated with the milk or formula,
washed and the treated bacteria added to the cells. Previous studies have used the in
vitro approach [Saadi et al., 1993], but the in vivo approach was assessed to try to
simulate more closely competitive interactions that occur on mucosal surfaces.
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3.2 Material andMethods
3.2.1 Preparation and labelling ofS. aureus
3.2.1.1 Collection and numeration ofbacteria
S. aureus were grown as described in 2.2 and harvested in PBS using sterile swabs
(Greiner). The bacteria were washed twice by centrifugation (2,000 x g for 20 min)
and resuspended in PBS. The number of bacteria mf' were determined using the
standard curve (Figure 3.1).
3.2.1.2 F1TC labelling ofbacteria
The washed bacteria were labelled with 2 ml of 0.02% (w/v) fluorescein
isothiocyanate (FITC) (Sigma) dissolved in F1TC buffer (0.05M sodium carbonate
and 0.1M sodium chloride dissolved in distilled water, pH 9.2). After 30 min
incubation in the dark at room temperature, the bacteria were washed 3 times with
PBS at 2,000 x g for 20 min.
3.2.2 Bacterial binding assays
3.2.2.1 In vitro protocol
For the in vitro protocol, FITC-labelled bacteria (200 pi) were incubated for 1 h at
37°C in an orbital incubator (100 rpm) with breast milk, infant formula or the
synthetic Lewis antigens, washed twice and added to an equal volume of Kato III
cells at various ratios of bacteria per cell. After incubation for 1 h at 37°C, the cells
were washed twice by centrifugation at 300 x g for 10 min with PBS and fixed with
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1% (v/v) buffered paraformaldehyde. The results were analysed with an EPICS XL
flow cytometer (Coulter) as described in 3.2.7.
3.2.2.2 In vivo protocol
For the in vivo approach, breast milk, infant formula preparations, synthetic Lewis'1
or Lewis1' antigens (Dextra) were mixed with cells and bacteria and the experiment
carried out as in 3.2.2.1.
3.2.3 Preparation ofthe synthetic Lewis antigens
The synthetic Lewis3 and Lewis1' antigens (Dextra) were prepared in sterile PBS and
kept at 4°C with 0.05% sodium azide.
3.2.4 Detection ofLewis", Lewish and H type 2 antigen expression on the surface of
bacteria andKato III cells
8 1 5 1Bacteria (2x10 bacteria ml") or Kato III cells (5 x 10 cells ml") were incubated
with 1 in 5, 1 in 10 or 1 in 20 dilutions of murine monoclonal anti-Lewis3, anti-
Lewis1' (SNBTS) or anti-H type 2 (Serotec) in PBS. Incubation was carried out for 30
min at 37°C in an orbital incubator (100 rpm) and the bacteria or cells were washed
twice with PBS. FITC-labelled anti-mouse IgM (200 p.1) (Sigma) diluted 1 in 20 in
PBS was added to all tubes and incubated as above. The bacteria or cells were
washed twice and fixed in 1% (v/v) buffered paraformaldehyde. Negative controls
of bacteria or cells incubated with PBS alone and bacteria or cells incubated with
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FITC-labelled anti-mouse IgM only were included. The results were read by flow
cytometry.
3.2.5 Inhibition of bacterial binding by pre-treatment of Kato III cells with
anti-Lewisa or anti-Lewis1
Kato III cells (5x 1CP cells ml"1) (200 pi) were incubated with 200 pi of anti-Lewis3
or anti-Lewisb diluted 1 in 5, 1 in 10 or 1 in 100 in PBS for 60 min at 37°C in an
orbital incubator (100 rpm). Cells were washed twice and incubated with 200 pi of
FITC-labelled bacteria (400 per cell) for 60 min at 37°C in an orbital incubator (100
rpm). Cells were washed twice and fixed in 1% (v/v) buffered paraformaldehyde.
Negative controls of cells incubated with PBS alone or cells incubated with
anti-Lewis3 or anti-Lewisb were included. The results were read by flow cytometry.
3.2.6 Binding ofbiotinylated bloodgroup antigens to whole bacteria
Bacteria were washed twice and half of the suspension heated to 100°C for 60 min
to inactivate bacterial peroxidases. After washing, both heat-treated and control
bacteria were resuspended in coating buffer at dilutions of 1 x 107, 1 x 108 and 1 x
10; bacteria ml"1 and 96-well flat-bottomed microtitre plates were coated with 100
pi of the suspensions overnight at 4°C. The plates were washed 3 times with
washing buffer and 100 pi of the biotinylated antigens Lewis3, Lewis5, H type 2, A
or B (diluted to 10 pg ml"1 in blocking buffer) (Syntesome) were added and
incubated at 37°C for 60 min. The antigens were removed and the plates washed 3
times. Streptavidin-HRP (100 pi, diluted to 1.3 pg ml"1 in blocking buffer) (Sigma)
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were added to the plates and incubated at 37°C for 60 min. The OPD substrate was
added and the colour change stopped after approximately 10 min. The A490 was
recorded using an ELISA plate reader (Dynatech). Controls of heat-treated and
control Helicobacter pylori 11637 (3.2 x 108 bacteria ml"1) which has adhesins that
bind Lewis3, Lewis'1 and H type 2 and antibodies against the different blood group
antigens were included as positive controls. Negative controls were bacteria to
which no synthetic antigens were added but to which the streptavidin-HRP and
substrate were added.
3.2.7 EPICSXL flow cytometer
The binding study results were analysed with an EPICS XL flow cytometer
(Coulter). Cells were selected from a display of forward angle light scatter versus
90° light scatter by means of a bitmap. The percentage of cells with fluorescence
channel values greater than the controls (cells alone) were obtained from a
one-parameter histogram measuring fluorescence on a logarithmic scale. The mean
fluorescence channel values for positive cells were also obtained from a
one-parameter histogram measuring fluorescence on a logarithmic scale. The results
were expressed as the binding index (BI) of each sample calculated by multiplying
the percentage of fluorescent cells by the mean fluorescence channel value.
3.2.8 Statistical methods
For comparison of inhibition of binding of bacteria by blocking cell receptors with
antibodies to Lewis3 or Lewis'1 or blocking the bacterial adhesin with the synthetic
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Lewis3 or Lewis'1 antigens, the BI of cells in each sample was compared with the
control by the formula: % inhibition = 100 - [(BI of the sample / BI of the control) x
100], The results were assessed by Student's t-test. For the effect of whole and
defatted breast milk or infant formula on bacterial binding to epithelial cells, the
control of cells with bacteria and PBS was given a value of 100% and all other
values were expressed as a percentage of the control. Those results with a
percentage value below 100 demonstrated inhibition of binding whilst those values
greater than 100 demonstrated enhanced binding. The results were compared
between dilutions: 1 in 10 and 1 in 100; 1 in 100 and 1 in 1,000; 1 in 1,000 and 1 in
10,000. The results for the in vivo and in vitro methods were compared for each
dilution by Student's t-test for paired samples.
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3.3 Results
3.3.1 Standard curvesfor total bacterial count
The standard curve of optical density in relation to the total number of bacteria ml 1
for S. aureus (Figure 3.1) was used in all subsequent binding studies.
3.3.2 Effect ofFITC-labelling on bacterial binding
Bacteria were washed and half the preparation was labelled with FITC and half were
unlabelled. Both labelled and unlabelled bacteria were diluted to ratios of 100 and
200 bacteria per cell and 200 pi of the appropriate bacterial suspension were added
to 200 pi of Kato III cells (5 x 10^ cells ml"1). Binding was allowed to occur for 1 h
at 37°C in an orbital incubator (100 rpm). The cells were washed twice in PBS at
300 x g for 10 min and fixed in 1% (v/v) buffered paraformaldehyde.
A smear of each suspension was made on a microscope slide and Gram stained to
detect bound bacteria which were counted by light microscopy (100 x). A control of
cells alone was included. For each ratio of bacteria : cell, the numbers of bacteria
per cell were counted for 20 cells and the mean of 2 individual slides are shown
in Figure 3.2. As with previous studies comparing binding of FITC-labelled and
unlabelled bacteria (S. aureus, H. pylori, pneumococci), the results indicate that
FITC-labelling does not significantly enhance or reduce binding of S. aureus to the
epithelial cell line used.
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Figure 3.1 OD (540 nm) in relation to the total number ofbacteria ml"1 determined
by microscopy
Figure 3.2 The effect ofFITC-labelling on binding ofS. aureus to Kato III cells
unlabeiled 100 unlabelled 200 labelled 100 labelled 200
condition
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3.3.3 Optimisation ofincubation time and ratio ofbacteria to Kato III cells
FITC-labelled S. aureus was incubated for 15, 30, 60 and 120 min at five different
ratios of bacteria per cell: 85, 170, 340, 680 and 1360. The results are presented in
Figures 3.3a and 3.3b. The binding index (BI) did not appear to increase
significantly with increasing incubation after 15 min. For binding assays, an
incubation time of 60 min was chosen and a ratio near the mid-point of the linear
curve was chosen (400 bacteria per cell) to detect differences due to treatment with
different reagents.
3.3.4 Detection ofLewis", Lewisb andH type 2 antigen expression on the surface of
Kato III cells and S. aureus
Binding ofmonoclonal antibodies was assessed to determine ifKato III cells express
these antigens on their surface. Binding of the antibodies to S. aureus was also
assessed as many species have surface components cross-reactive with blood group
antigens. The results are shown in Table 3.1 and represent the mean binding indices
from three experiments.
The Kato III cells bound high levels of anti-Lewis3 and anti-Lewisb but lower levels
of anti-H type 2. Both Lewis3 and Lewish can be used as receptors for S. aureus. The
bacteria also bound the monoclonal antibodies with anti-Lewisb exhibiting the
highest binding index and anti-H type 2 the lowest.
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Table 3.1 Mean binding indices obtained with monoclonal antibodies to Lewis3,
Lewis5 or H type 2 binding to a) Kato III cells and b) S. aureus (3 experiments)
a) Kato III cells
Monoclonal Cells Cells plus FITC Anti- Anti- Anti-
Antibody Alone anti-mouse IgM Lewis3 Lewis5 14 type 2
Dilution
1 in 5 491 873 41,615 33,710 9,139
1 in 10 491 873 36,849 30,950 3,685















1 in 5 238 593 35,223 39,495 8,830
1 in 10 238 593 22,746 35,128 4,712
1 in 20 238 593 13,383 28,804 3,349
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3.3.5 Inhibition of bacterial binding by pre-treatmenl of Kato III cells with
anti-Lewis" or anti-Lewisb
Both anti-Lewis3 and anti-Lewisb inhibited binding of S. aureus (Table 3.2). This
indicates that S. aureus can use both Lewis3 and Lewish antigens expressed on the
surface of Kato III cells as receptors. Although anti-Lewisb appeared to bind in
greater levels to the bacteria, similar inhibition was obtained by pre-treatment of the
Kato III cells with the two antibodies.
3.3.6 Binding ofbiolinylated blood group antigens to whole bacteria
It was found that heat-treated bacteria provided more reliable results than untreated
bacteria which exhibited colour changes with substrate alone. This can be explained
by the presence of peroxidases which react with the substrate. Heating at 100°C
denatures these enzymes but not the adhesins that bind Lewis antigens [Alkout et
al., 1997],
Adhesins that bind Lewis3 have been isolated by affinity purification from outer
membrane preparations of S. aureus and H. pylori [Saadi et al., 1994; Alkout et al.,
1997], The results for binding of biotinylated blood group antigens are shown in
Table 3.3a (for S. aureus) and 3.3b (for H. pylori). This experiment provided direct
evidence that there are adhesins on S. aureus that bind the Lewis3 and Lewis5
antigens. There are also components that can bind H, A and B blood group antigens.
Table 3.2 Mean percentage inhibition of binding of S. aureus following












cells alone plus PBS 388 " 388 "
cells plus anti-Lewis 590 " 436 -
cells plus S. aureus 18,092 " 18,092 "
monoclonal antibody
dilution 1 in 5
9,515 47.4 8,672 52.1
monoclonal antibody
dilution 1 in 10
9,101 49.7 10,743 40.6
monoclonal antibody
dilution 1 in 20
12,172 32.7 10,832 40.1
Table 3.3 a) Binding of biotinylated blood group antigens to S. aureus (mean of 6
experiments)
Blood group 1 x 107 bacteria ml"1 1 x 108 bacteria ml"1 1 x 10y bacteria ml"1
antigen (A490) (A490) (A490)
Lewis3 0.070 0.088 0.138
Lewis'1 0.061 0.128 0.120
H 0.113 0.104 0.115
A 0.125 0.162 0.178
B 0.062 0.077 0.106
Bacteria alone 0.024 0.042 0.065
Table 3.3 b) Binding of biotinylated blood group antigens to H. pylori (mean of 6
experiments expressed as A490)









3.3.7 Detection ofLewisa and Lewish in human milk, cows' milk and infant formula
preparations
At a dilution of 1 in 100, the 32 human milk samples bound monoclonal antibodies
to Lewis3 and Lewis'1 antigens (Figure 3.4). The levels detected varied among donors
depending on secretor status; women who were non-secretors (samples 9, 11, 12, 13,
14, 16, 19, 20, 29) had very low readings for Lewisb. In contrast to the human milk
samples, there were very low levels of binding of monoclonal anti-Lewis3 and anti-
bLewis for whole, semi-skimmed, skimmed or organic cows' milk (samples 33 to
36) at the 1 in 100 dilution. Low readings were also obtained with the infant
formulas samples 37 to 41 at the 1 in 100 dilution.
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Figure 3.4 Binding of monoclonal anti-Lewisa (•) or anti-Lewisb (O) to individual
milk samples (1 to 32), whole, semi-skimmed, skimmed and organic cows' milk (33
to 36) and formula preparations (37 to 41) (each diluted 1 in 100)
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3.3.8 Effect of whole and defatted human milk on binding of S. aureus to Kato III
cells
Dilutions ofmilk ranging from 1 in 10 to 1 in 10,000 were tested for their effect on
bacterial binding. No significant differences in binding were observed between the 1
in 10,000 dilution and the control of bacteria, cells and PBS; therefore, these
dilutions were omitted from the analyses.
In 6 experiments, whole and defatted human milk caused enhancement of bacterial
binding with both methods (Tables 3.4a and 3.4b, Figure 3.5). Greater enhancement
of binding was observed for the in vitro method compared with the in vivo method,
and this enhancement effect was reduced with increasing dilutions of human milk.
Significant enhancement of binding was observed for the in vivo method with whole
milk at the 1 in 100 dilution (p=0.016) and for the in vitro method with both whole
milk (p=0.011) and defatted milk (p=0.015) at the 1 in 10 dilution.
Paired sample t-tests were carried out to test for significant differences between
different dilutions ofwhole or defatted milk within the two methods. For the in vivo
method, significant differences were found for whole milk between dilutions 1 in
100 and 1 in 1,000 (p=0.008) and dilutions 1 in 1,000 and 1 in 10,000 (p=0.034).
For defatted milk, significant differences were only found between dilutions 1 in 10
and 1 in 100 (p=0.006). For the in vitro method, significant differences were found
for whole milk between dilutions 1 in 10 and 1 in 100 (p=0.041) and for defatted
milk between dilutions 1 in 100 and 1 in 1,000 (p=0.010).
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Paired sample t-tests were carried out to test for significant differences between the
methods for the same dilution. For whole milk, the increase in binding was
significantly higher with the in vivo method for the 1 in 100 dilution (p=0.003) and
the 1 in 1,000 dilution (p=0.004), but for defatted milk no significant differences
between the two methods were observed for any dilution tested. Bacteria incubated
with whole milk showed significantly higher binding than those incubated with
defatted milk with the in vivo method at the 1 in 100 dilution (p=0.011) and the 1 in
1,000 dilution (p=0.024) but none were observed for the in vitro method.
Table 3.4 Effect of whole
to Kato 111 cells using a)
expressed as a percentage
100%)
a) in vivo
Dilution % Se 95% CI P
1 in 10 W 127.6 31.4 47.0-208.3 0.418
1 in 100W 176.7 21.3 121.9-231.5 0.016*
1 in 1,000 W 124.3 15.1 85.5- 163.1 0.168
1 in 10 D 172.9 36.4 79.2-266.6 0.102
1 in 100 D 90.7 14.9 52.3- 129.0 0.560
1 in 1,000 D 67.4 13.1 33.8-101.1 0.055
b) in vitro
Dilution % Se 95% CI P
1 in 10 W 409.5 77.8 209.4-609.6 0.011*
1 in 100 W 154.1 25.8 87.7-220.5 0.090
1 in 1,000 W 108.4 26.4 40.4- 176.4 0.765
1 in 10 D 258.3 43.4 146.8-369.9 0.015*
1 in 100 D 192.0 41.5 85.4-298.6 0.077
1 in 1,000 D 110.7 22.6 52.7- 168.7 0.656
(W) and defatted (D) breast milk on binding of S. aureus
in vivo and b) in vitro methods (mean of 6 experiments
of control bacteria treated with PBS and given a value of
* significant differences from control treated with PBS only
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Figure 3.5 Comparison of the in vivo (method A) and in vitro (method B) methods












° defatted method B
A whole method B
+ defatted method A
O whole method A
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3.3.9 Effects of infant formula preparations on binding ofS. aureus to Kato III cells
Three different infant formula preparations were investigated for their effect on
binding of S. aureus to Kato III cells with both methods. There was no significant
variation associated with formula type with either method; therefore, the results
obtained for each method and for each dilution have been grouped together (Tables
3.5a and 3.5b, Figure 3.6). In contrast to whole and defatted human milk, the results
obtained differed considerably. For the in vivo method, infant formula inhibited
bacterial binding to Kato III cells and this inhibition of binding was reduced with
increasing dilutions of the formula. In contrast, with the in vitro method, infant
formula caused enhanced bacterial binding to the cells and this enhancement was
also reduced with increasing dilutions of the formula.
A significant reduction of binding was observed for the in vivo method at the 1 in 10
(p=D.000) and 1 in 100 (p=0.000) dilutions. A significant enhancement of binding
was observed for the in vitro method with all three dilutions: 1 in 10, p=0.004; 1 in
100, p=0.001; 1 in 1,000, p=0.000. Significant differences between the in vivo and
in vitro methods for the same dilution were found for the 1 in 10 dilution (p=0.024)
and the 1 in 100 dilution (p=0.005). Significant differences between dilutions were
found for the in vivo method between dilutions 1 in 100 and 1 in 1,000 (p=0.003)
and for the in vitro method between dilutions 1 in 1,000 and 1 in 10,000 (p=0.000).
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Table 3.5 Effect of infant formula preparations on binding of S. aureus to Kato III
cells using a) in vivo and b) in vitro method (mean of 13 and 12 experiments
respectively) expressed as a percentage of results for control bacteria treated with
PBS and given a value of 100%)
a) in vivo
Dilution % Se 95% CI P
1 in 10 44.2 5.9 31.2-57.1 0.000*
1 in 100 55.2 4.9 44.6-65.8 0.000*
1 in 1,000 90.5 6.3 76.6- 104.3 0.160
b) in vitro
Dilution % Se 95% CI P
1 in 10 288.8 51.0 176.5-401.1 0.004*
1 in 100 255.6 34.5 179.7-331.4 0.001*
1 in 1,000 325.6 37.8 242.4-408.8 0.000*
* significant differences from controls treated with PBS only
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Figure 3.6 Comparison of the in vivo (method A) and in vitro (method B) methods












3.3.10 Investigation ofenhancement ofS. aureus binding
To investigate the enhancement effect, flow cytometry and microscopy studies were
carried out and the results from the former are shown in Figure 3.7. The observed
enhancement was found to be due to formation of bacterial aggregates by
pre-incubation of the bacteria with milk or infant formula.
3.3.11 Inhibition ofbinding ofS. aureus by synthetic Lewisa or Lewish antigens
Dose response experiments with synthetic Lewis3 or Lewisb antigens were carried
out with both methods. The dose response curves from 3 experiments are shown as
the mean percentage inhibition of binding (Figures 3.8a and 3.8b) and the error bars
represent the standard error of the mean (SEM).
Different results were obtained with the two methods for inhibition of binding by
the synthetic antigens. Higher levels of inhibition were obtained for Lewis'1 with the
in vivo method whilst higher levels of inhibition were obtained for Lewis3 with the
in vitro method. Significant inhibition of binding was observed with lower
concentrations of Lewisb compared to Lewis3. With the in vivo method, consistently
significant inhibition of binding was observed for Lewis3 between 20 and 40 pg ml"1
36.5 % (95% CI 5.6 - 67.3, p=0.037) and 33.6 % (95% CI 10.6 - 56.5, p=0.024)
respectively with a plateau of inhibition reached at 20 pg ml"1. For Lewisb,
significant inhibition of binding was observed between 4 and 5 pg ml"1 43.8% (95%
CI 36.9 - 50.8, p=0.008) and 44.4 % (95% CI 34.9 - 54.0, p=0.011) respectively
with a plateau of inhibition reached at 20 pg ml"1 53.3% (95% CI 45.1 - 61.6,
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p=0.008). With the in vitro method, consistent and significant inhibition of binding
was observed for Lewis3 between 8 and 10 pg mf1 47.3% (95% CI 15.5- 79.1,
p=0.034) and 56.2% (95% CI 29.7 - 82.7, p=0.012) respectively with a plateau of
inhibition reached at 10 pg ml"1. For Lewisb, consistent and significant inhibition of
binding was observed between 4 and 6 pg ml"1 42.0% (95% CI 7.1 - 76.8, p=0.035)
and 54.7% (95% CI 21.0 - 88.4, p=0.020) respectively, with a plateau reached at 6
pg ml"1.
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Figure 3.7 Aggregation of S. aureus by pooled whole human milk and infant formula
detected by flow cytometry
Bacteria alone
Bacteria plus whole milk Bacteria plus infant formula
(1 in 10 dilution) (1 in 10 dilution)
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Figure 3.8 Inhibition of binding of S. aureus by the synthetic Lewis3 (diamond) and
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3.3.12 Addition ofsynthetic Lewisa or Lewisb antigens to infantformula
Synthetic Lewis3 or Lewis1' antigens were added to two different dilutions of infant
formula (1 in 10 and 1 in 100) to give a final concentration of 20 gtg ml"'. This
concentration was chosen since maximum inhibition of binding was observed with
this concentration for the in vivo method using the synthetic Lewis antigens (3.3.11).
These preparations were used in the in vivo system to investigate the potential for
improving the inhibitory activity of infant formula against S. aureus binding to
epithelial cells. Positive controls included in these experiments consisted of cells,
bacteria and PBS; cells, bacteria and Lewis antigen; cells, bacteria and the
appropriate dilution of formula. The test samples contained cells, bacteria, the
appropriate dilution of formula with Lewis3 or Lewish antigens.
The mean percentage inhibition of binding for 4 experiments are shown in Table
3.6. Although the addition of Lewis3 or Lewisb to infant formula increased the
observed inhibition of binding compared to infant formula alone, significant
differences between the control (cells, bacteria and infant formula) and test samples
(cells, bacteria, infant formula and the Lewis antigen) were found only for the 1 in
100 dilution of formula with synthetic Lewis3 added (p=0.036).
Table 3.6 Inhibition of bacterial binding (in vivo) method by infant formula and
infant formula containing 20 pg ml"1 of synthetic Lewis3 or Lewisb The p value
represents the difference between the equivalent dilutions of infant formula and
infant formula with Lewis antigen added (mean of 4 experiments).
Condition Mean % inhibition of binding
Formula diluted 1 in 10 54.7
Formula diluted 1 in 10 plus Lewis3 61.0 (p = 0.255)
Formula diluted 1 in 10 plus Lewis11 60.8 (p = 0.452)
Formula diluted 1 in 100 55.8
Formula diluted 1 in 100 plus Lewis3 63.0 (p = 0.036)
Formula diluted 1 in 100 plus Lewisb 59.3 (p = 0.741)
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3.4 Discussion
Staphylococcal toxins have been identified in tissues of SIDS infants [Newbould et
al., 1989; Malam et al., 1992; Zorgani et al., 1999] and a significantly higher
isolation rate for S. aureus among SIDS infants 3 months of age or younger
compared with healthy infants has been reported [Blackwell et al., 1999; Harrison et
al., 1999a], The longitudinal epidemiological studies on nasopharyngeal flora of
infants found no association between frequency of isolation of S. aureus with
socioeconomic circumstances of the family or method of feeding [Harrison, 1998;
Blackwell et al., 1999]; however, higher density of colonisation by S. aureus was
connected with exposure of the infant to cigarette smoke [Harrison, 1998], The
objectives of the present study were to determine if human milk was better able to
reduce the density of colonisation of epithelial cells by S. aureus compared with
infant formula and to determine if oligosaccharides which act as receptors for S.
aureus could inhibit bacterial binding.
3.4.1 Methodology
The epithelial cell line, Kato III, was chosen for use in the model system to
minimise differences in expression of H and Lewis antigens noted for individual
donors in other studies [Alkout et al., 1997], Most studies on inhibition of bacterial
binding are carried out by the in vitro protocol in which the bacteria or the cells are
treated with the inhibitory substance, the excess washed away and the binding
assays carried out. This study found that there were significant differences in results
obtained by the two protocols. The in vivo method is thought to reflect more closely
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the interactions between mucosal cells, bacteria and the human or formula milk.
The in vitro method was more useful for identifying components involved in
binding.
3.4.2 Effects ofhuman milk andformula on bacterial binding
The effects of whole and defatted human milk on bacterial binding were similar
with both methods. Enhancement of binding rather than inhibition was observed and
flow cytometry studies suggest that enhanced binding occurs due to the formation of
bacterial aggregates. Greater enhancement of binding was observed using the in
vitro method in which there was more time for bacteria to aggregate before addition
to the cells.
Host protection by secretory IgA has been found to occur through agglutination of
bacteria and inhibition of their attachment. Studies by Wold et al. [cited in Rudloff
et al., 1997] found that an interaction could occur between bacterial mannose lectins
and IgA receptor oligosaccharides and this interaction could inhibit bacterial
binding to colonic epithelial cells.
For infant formula, significantly different results were obtained with the two
methods. The in vivo method showed consistent inhibition of binding regardless of
formula type whilst the in vitro method showed enhancement of binding due to
bacterial aggregation.
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From the results obtained in this part of the study, breast milk can be suggested to
have a protective effect due to aggregation of the bacteria. The factors responsible
for aggregation were present in both whole and defatted milk. Bacterial aggregates
are more readily engulfed by phagocytes than single bacteria which would result in
greater bacterial clearance. If the in vivo method reflects conditions on the mucosal
surface, formula preparations might reduce the numbers of bacteria attaching to the
epithelium.
3.4.3 Components contributing to reduction ofbacterial binding
There is increasing evidence that oligosaccharides and glycoconjugates present in
human milk can reduce the ability of bacteria to colonise epithelial surfaces by
acting as receptor analogues and binding to bacterial adhesins [Goldman, 1993], The
bacteria bound the biotinylated Lewis antigens (3.3.6), and a dose response effect
was observed for inhibition of binding of S. aureus by the synthetic Lewis3 and
Lewis'1 antigens (Figures 3.8a and 3.8b). Fligher levels of the Lewis antigens were
required to cause maximum inhibition of binding using the in vivo method
compared to the in vitro method. With the in vivo method, the bacteria can either
bind to the Lewis antigen expressed on the cell surface or the Lewis antigen in
solution; however, with the in vitro method, direct blocking of the bacterial adhesin
occurs before addition to the cells. Although a dose response effect was observed for
inhibition with the synthetic Lewis antigens, there was no correlation between the
levels of these antigens in individual human milk samples with their inhibitory
effect [Saadi et al., 1999], Other workers have shown that free oligosaccharides
purified from low molecular weight fractions of human milk can inhibit the ability
91
ofStreptococcus pneumoniae and H. influenzae to bind human pharyngeal or buccal
epithelial cells [Andersson et al., 1986],
Breast milk was found to contain much higher levels of Lewis antigens compared to
infant formula or cows' milk. Work has been carried out by another group to
compare human milk, bovine milk and infant formula based on bovine milk for their
oligosaccharide content. This work found that whilst human milk had a high content
(6 g/1) of neutral oligosaccharides and their fucosylated or sialylated derivatives,
bovine milk and infant formula contained very low levels [Rudloff et al., 1997],
Based on these results and the inhibition of binding studies involving the Lewis
antigens, the following hypothesis was tested: the inhibitory activity of infant
formula in the in vivo system might be increased by the addition of Lewis antigens
to the formula preparation. Significant differences in binding between the effect of
formula alone and the effect of formula plus Lewis antigen were observed only for
the 1 in 100 dilution with Lewis3 added. It might be that higher concentrations of the
Lewis antigens would need to be added before a significant difference in binding is
observed.
3.4.4 Conclusions
In contrast to our original hypothesis, human milk did not reduce bacterial binding
in experiments carried out by either the in vivo or in vitro methods. This suggests
that aggregation of bacteria might play a major role in the protection afforded by
breast feeding. Infant formula was found to have inhibitory activity in the in vivo
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experiments but enhanced bacterial binding in the in vitro ones. These studies
indicate that the method used for binding studies needs to be considered in planning
experiments. The in vitro method is used most widely and is valuable for assessment
of individual components for inhibitory activity. The in vivo method was developed
to assess the complex interactions at mucosal surfaces.
Density of colonisation is an important factor in development of bacterial diseases
due to invasion or toxin production [Beachey et al., 1981] and these results suggest
that both human milk and infant formula have oligosaccharide components that
might reduce binding ofS. aureus to epithelial cells. The potential for improving the
inhibitory activity of infant formula by addition of Lewis antigens is an area for
further investigation.
Chapter Four
The effect of human milk and infant formula
preparations on binding of Clostridium
perfringens to epithelial cells
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4.1 Introduction
Breast feeding is associated with protection against enteric infections [Buescher,
1994], Many SIDS infants have symptoms of gastrointestinal infections prior to
death and compared to healthy infants in the same age range, toxigenic strains of
Clostridium perfringens are more likely to be identified in SIDS infants [Lindsay el
a!., 1994], A number of studies have found significantly higher levels of C.
perfringens and their toxins in SIDS cases compared to non-SIDS cases [Lindsay et
al., 1993; Murrell et al., 1993], and one study found C. perfringens in faeces from
45.4% of SIDS infants compared to 19.6% of healthy babies [Murrell et al., 1993],
This study also found that formula fed SIDS infants had a significantly higher
incidence of C. perfringens and its enterotoxin in their faeces than breast fed infants
[Murrell et al., 1993], C. perfringens enterotoxin A has been identified in body
fluids of SIDS infants [Murrell et al., 1987], and because of its superantigenic
nature, has been suggested to have a significant role in some SIDS deaths [Lindsay
et al., 1994, Lindsay et al., 1996],
Adherence to the intestinal mucosa allows bacteria to resist expulsion by peristaltic
clearing mechanisms and is the first stage in development of a gastrointestinal
infection. Human milk is unique in its content of free oligosaccharides,
glycoproteins and glycolipids. There is evidence that free oligosaccharides and
glycoconjugates can act as soluble receptor analogues of intestinal cell surface
carbohydrates. These interfere with either bacterial binding, thereby preventing
colonisation, or with binding of toxins to their receptors [Goldman, 1993;
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Ashkenazi, 1996], The Lewis antigens are oligosaccharide components of both
breast milk and infant formula [Chapter 3],
Breast fed compared to formula fed infants have a very different faecal flora. In
breast fed babies, the predominant organisms are bifidobacteria, lactobacilli and
staphylococci. In contrast in formula fed infants, the predominant organisms are
enterococci, coliforms and bacteroides [Wharton el al., 1994], Breast fed infants
receive protection against gastrointestinal infections and this might be because
lactose and oligosaccharides present in breast milk have been found to facilitate
growth of the bifidus flora in the gut [Emmett et al., 1997],
The previous chapter summarised investigations on the effect of human milk, infant
formula and synthetic Lewis antigens on binding of the respiratory pathogen S.
aureus which expresses an adhesin that binds the Lewis antigens [Saadi el al.,
1994], The results in Chapter 3 found the method used significantly influenced the
results obtained with human milk compared with infant formula. The objective of
this chapter was to determine if similar effects were obtained with a gastrointestinal
organism implicated in S1DS.
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4.2Materials and methods
4.2.1 Preparation and labelling ofC. perfringens
4.2.1.1 Collection and numeration ofbacteria
C. perfringens were grown as described in 2.2 and prepared as described in 3.2.1.1.
4.2.1.2 FITC labelling ofbacteria
C. perfringens was labelled with FITC as described in 3.2.1.2.
4.2.2 Bacterial binding assays
Bacterial binding assays with C. perfringens were carried out as described in 3.2.2.
4.2.3 Preparation ofthe synthetic Lewis antigens
The Lewis antigens were prepared and stored as described in 3.2.3.
4.2.4 Detection ofLewis", Lewish andH type 2 antigen expression on the surface of
C. perfringens
Expression of Lewis3, Lewisb and H type 2 antigens on the surface of C. perfringens
was assessed as described in 3.2.4.
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4.2.5 Inhibition of C. perfringens binding by pre-treatment of Kato III cells with
anti-Lewis" or anti-Lewisb
Inhibition of C. perfringens binding after pre-treatment of Kato III cells with
monoclonal anti-Lewis3 or anti-Lewisb was assessed as described in 3.2.5.
4.2.6 Binding ofbiotinylated bloodgroup antigens to whole bacteria
The binding of biotinylated blood group antigens to C. perfringens was assessed as
described in 3.2.6.
4.2.7 EPICSXL flow cytometer
The binding study results were analysed with an EPICS XL flow cytometer
(Coulter) as described in 3.2.7.
4.2.8 Statistical methods




4.3.1 Standard curve for total C. perfringens count
The standard curve of optical density in relation to the total number of bacteria mf1
for C. perfringens was used in all subsequent binding studies (Figure 4.1).
4.3.2 Effect ofFITC-labelling on bacterial binding
A binding assay was carried out using FITC-Iabelled and unlabelled C. perfringens
at ratios of 100 and 200 bacteria per cell to determine if FITC altered binding using
the method described in 3.3.2. For each ratio of bacteria : cell, the numbers of
bacteria per cell were counted for 20 cells and the mean results of 2 slides are
shown in Figure 4.2. As with previous studies of other bacteria using these methods
(,S. aureus, H. pylori, pneumococci), the results indicate that FITC-labelling does not
significantly enhance or reduce binding of C. perfringens to the epithelial cell line
used.
4.3.3 Optimisation ofincubation time and ratio of bacteria to Kato III cells
FITC-labelled C. perfringens was incubated for 15, 30, 60 and 120 min at five
different ratios of bacteria per cell: 85, 170, 340, 680 and 1360. The results are
presented in Figures 4.3a and 4.3b. The binding index (BI) increased with increasing
time. For binding assays, an incubation time of 60 min was chosen and a ratio near
the mid-point of the linear part of the curve was chosen (400 bacteria per cell) to
detect differences due to treatment with different reagents.
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Figure 4.1 OD (540 nm) in relation to the total number of bacteria ml"1 determined
by microscopy
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Figure 4.2 The effect ofFITC-labelling on binding of C. perfringens to Kato III cells
(mean of 2 experiments)
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4.3.4 Detection ofLewis", Lewisb and H type 2 antigen expression on the surface of
C. perfringens
Binding of monoclonal antibodies specific for Lewis2, Lewis'1 or H type 2 to C.
perfringens was assessed since many species also have surface components
cross-reactive with blood group antigens. The results are shown in Table 4.1 and
represent the mean binding index obtained for three experiments. C. perfringens had
a high binding index for anti-Lewis3 and low binding indices for anti-H type 2 and
anti-Lewisb.
4.3.5 Inhibition of C. perfringens binding by pre-treatment of Kato III cells with
anti-Lewisa or anti-Lewis'
The percentage inhibition in the binding of C. perfringens observed following
pre-treatment of Kato 111 cells with monoclonal antibodies to the Lewis antigens are
summarised in Table 4.2. Although inhibition of binding of C. perfringens to the
antibody coated cells was observed, it did not reflect the differences in binding of
the antibodies to the bacteria. The BI for anti-Lewis3 was much higher than that for
bLewis , but there was little difference in the inhibition studies.
4.3.6 Binding ofbiotinylated bloodgroup antigens to whole bacteria
The results are shown in Table 4.3 and provide direct evidence that there are
adhesins on C. perfringens that bind the Lewis3 and Lewis'1 antigens as well as the
other blood group antigens H, A and B.
Table 4.1 Mean binding indices obtained with monoclonal antibodies to Lewis3,














1 in 5 465 1,031 27,796 3,924 8,760
1 in 10 465 1,031 26,721 3,295 3,807
1 in 100 465 1,031 25,533 2,049 3,006
Table 4.2 Mean percentage inhibition of binding of C. perfringens following pre¬












cells alone plus PBS 388 - 388 -
cells plus anti-Lewis 590 - 436 -
cells plus C. perfringens 35,270 - 35,270 -
monoclonal antibody 31,402 11.0 28,020 20.5
dilution 1 in 5
monoclonal antibody 30,089 14.7 29,789 15.5
dilution 1 in 10
monoclonal antibody 33,032 6.3 30,575 13.3
dilution 1 in 20
Table 4.3 Binding of biotinylated blood group antigens to C. perfringens (mean of 6
experiments)
Blood group 1 x 107 bacteria ml"1 1 x 108 bacteria ml"1 1 x 109 bacteria ml"1
antigen (A490) (A490) (A490)
Lewis3 0.093 0.106 0.112
Lewisb 0.091 0.098 0.111
H 0.109 0.106 0.175
A 0.198 0.184 0.216
B 0.114 0.077 0.122
Bacteria alone 0.048 0.040 0.064
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4.3.7 Effect ofwhole and defatted human milk on binding ofC. perfringens to Kato
III cells
Whole and defatted human milk were tested at dilutions of 1 in 10, 1 in 100, 1 in
1,000 and 1 in 10,000. No significant differences in binding were observed between
the 1 in 10,000 dilution and the control of bacteria, cells and PBS. The 1 in 10,000
dilution was not used in further analyses.
In 6 experiments, for both methods with whole or defatted human milk, there was a
general pattern of enhancement of bacterial binding (Tables 4.4a and 4.4b and
Figure 4.4) but the enhancement was not significant compared with the untreated
controls. Greater levels of binding were observed with the in vitro method, and this
was reduced with increasing dilutions of human milk. A small but significant
reduction in binding was observed for the defatted milk at higher dilutions.
Paired sample t-tests were carried out to test for significant differences between
dilutions of whole or defatted milk within each method. For the in vivo method,
significant differences were found for whole milk between the 1 in 1,000 and 1 in
10,000 dilutions (p=0.044) but no significant differences between dilutions were
found for defatted milk. For the in vitro method, significant differences between
dilutions were found for whole milk between the 1 in 10 and 1 in 100 dilutions
(p=0.009) and for defatted milk between the 1 in 10 and 1 in 100 dilutions
(p=0.042).
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Paired sample t-tests were carried out to test for significant differences between the
two methods for the same dilution. With the in vitro method, significantly greater
binding was observed for whole milk at the 1 in 100 dilution (p=0.000) and the 1 in
1,000 dilution (p=0.000) and for defatted milk at each of the three dilutions: 1 in 10
dilution p=0.001; 1 in 100 dilution p=0.000; 1 in 1,000 dilution p=0.001. Paired
sample t-tests were also carried out to test for significant differences between whole
and defatted milk. Enhancement of binding was significantly higher for whole milk
than defatted milk with the in vivo method at the 1 in 1,000 dilution (p=0.045). With
the in vitro method, enhancement of binding with whole milk was significantly
greater than that for defatted milk at the 1 in 10 dilution (p=0.026).
Table 4.4 Effect of whole (W) and defatted (D) breast milk on binding of C.
perfringens to Kato III cells using a) in vivo and b) in vitro methods for the mean of
6 experiments expressed as a percentage of control bacteria treated with PBS
(100%)
a) in vivo
Dilution % Se 95% CI P
1 in 10 W 117.0 29.1 42.1 - 191.9 0.584
1 in 100 W 171.5 34.3 83.2-259.8 0.092
1 in 1,000 W 130.7 12.3 99.0- 162.4 0.055
1 in 10 D 160.3 26.0 93.5-227.1 0.068
1 in 100 D 135.3 15.8 94.6- 176.1 0.076
1 in 1,000 D 88.7 3.4 79.9-97.5 0.022*
b) in vitro
Dilution % Se 95% CI P
1 in 10 W 512.3 233.1 86.8-1111.4 0.137
1 in 100 W 232.1 78.5 30.2-433.9 0.153
1 in 1,000 W 167.6 55.9 23.9-311.4 0.281
1 in 10 D 245.3 74.2 54.6-436.1 0.108
1 in 100 D 147.8 31.2 67.5-228.1 0.186
1 in 1,000 D 120.3 30.9 40.9- 199.7 0.540
* significant differencesfrom controls treated with PBS only
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Figure 4.4 Comparison of the in vivo (method A) and in vitro (method B) methods
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4.3.8 Effects of infant formula preparations on binding ofC. perfringens to Kato III
cells
Three different infant formula preparations were investigated for their effect on
binding of C. perfringens to Kato III cells using the two methods. When the results
from the three different formulas were analysed, it was found that within the
methods, there was no significant variation associated with formula type; therefore,
the results obtained for each method and for each dilution have been grouped
together (Tables 4.5a and 4.5b and Figure 4.5). In contrast to whole and defatted
human milk, the results obtained for the in vivo and in vitro methods differed. With
the in vivo method, infant formula reduced bacterial binding to Kato III cells at the
first two dilutions and this effect was reduced with increasing dilution of the
formula. In contrast, with the in vitro method, infant formula caused enhanced
bacterial binding to the cells and this enhancement was reduced with increasing
dilutions of the formula.
A significant reduction in binding was observed for the in vivo method for the 1 in
100 (p=0.023) dilution and a small but significant increase in binding for the 1 in
1,000 (p=0.009) dilution. Significant enhancement of binding was observed for the
in vitro method for each of the three dilutions: 1 in 10, p=0.005; 1 in 100, p=0.002;
1 in 1,000, p=0.005.
Paired sample t-tests were carried out to test for significant differences between
dilutions within each method. Significant differences were found for the in vivo
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method between dilutions 1 in 100 and 1 in 1,000 (p=0.004) and for the in vitro
method between dilutions 1 in 100 and 1 in 1,000 (p=0.000) and dilutions 1 in 1,000
and 1 in 10,000 0=0.000).
Paired sample t-tests were carried out to test for significant differences between the
two methods for the same dilutions of infant formula. Significant differences
between the two methods for the same dilution were found for C. perfringens for all
three dilutions: 1 in 10, p=0.020; 1 in 100, p=0.000; 1 in 1,000, p=0.000.
Table 4.5 Effect of infant formula preparations on binding of C. perfringens to Kato
III cells using a) in vivo and b) in vitro methods for the mean of 13 and 12
experiments respectively expressed as a percentage of results for control bacteria
treated with PBS (100%)
a) in vivo
Dilution % Se 95% CI P
1 in 10 85.7 9.5 64.9- 106.4 0.159
1 in 100 86.6 5.1 75.5-97.8 0.023*
1 in 1,000 106.3 2.0 101.9-110.8 0.009*
b) in vitro
Dilution % Se 95% CI P
1 in 10 559.0 132.2 268.0-849.9 0.005*
1 in 100 456.3 90.2 257.7-654.8 0.002*
1 in 1,000 241.7 40.2 153.3-330.1 0.005*
* significant differences from controls treated with PBS only
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Figure 4.5 Comparison of the in vivo (method A) and in vitro (method B) methods














4.3.9 Investigation ofenhancement ofC. perfringens binding
To investigate the enhancement of binding effect, flow cytometry and microscopy
studies were carried out and the results of the former are shown in Figure 4.6. The
enhancement of binding observed following pre-incubation of the bacteria with
either human milk or formula was found to be due to the formation of bacterial
aggregates.
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Figure 4.6 Aggregation of C. perfringens by pooled whole human milk and infant
formula detected by flow cytometry
Bacteria alone
I ! M III 1—I I I I I III
13 100
3S LOG
Bacteria plus whole milk
(1 in 10 dilution)
Bacteria plus infant formula
(1 in 10 dilution)
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4.3.10 Inhibition ofbinding ofC. perfringens by synthetic Lewisa or Lewish antigens
Dose response experiments with synthetic Lewis3 and Lewisb antigens were carried
out with both methods. Results of 3 experiments are shown as the mean percentage
inhibition of binding in Figures 4.7a and 4.7b and the error bars represent the
standard error of the mean. For C. perfringens, similar results for inhibition of
binding by Lewis3 and Lewisb antigens were obtained with both methods. For the in
vivo method, significant inhibition of binding was observed for Lewis3 from 2 jug
ml"1 18.8% (95% CI 10.2 - 27.4, p=0.011) with a plateau of inhibition at 20 jug ml"1
52.2% (95% CI 36.7 - 67.6, p=0.005). For Lewisb, significant inhibition of binding
was also observed from 2 jug ml"1 15.3% (95% CI 13.8 - 16.8, p=0.001) with a
plateau of inhibition at 20 jug ml"1 51.9% (95% CI 32.4 - 71.4, p=0.008). For the in
vitro method, significant inhibition of binding was observed for Lewis3 from 4 jug
ml"1 40.0% (95% CI 29.0 - 51.0, p=0.004) with a plateau at 10 pg ml"1 47.2% (95%
CI 5.8 - 88.5, p=0.039). For Lewis1', significant inhibition of binding was observed
from 2 pg ml"1 24.1% (95% CI 8.0 - 40.2, p=0.023) with a plateau at 5 pg ml"1
55.5% (95% CI 35.8 - 75.2, p=0.007).
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Figure 4.7 Inhibition of binding of C. perfringens by the synthetic Lewis" (diamond)






4.3.11 Addition ofsynthetic Lewisa or Lewisb antigens to infant formula
Synthetic Lewis3 or Lewisb antigens were added to two different dilutions of infant
formula (1 in 10 and 1 in 100) to give a final concentration of 20 pg ml"1. This
concentration was chosen since maximum inhibition of binding was observed with
this concentration for the in vivo methods using the synthetic Lewis antigens
(4.3.10). These preparations were used in the in vivo system to investigate the
potential for improving the inhibitory activity of infant formula against C.
perfringens binding to epithelial cells. Positive controls included in these
experiments consisted of cells, bacteria and PBS; cells, bacteria and Lewis antigen;
cells, bacteria and the appropriate dilution of formula. The test samples contained
cells, bacteria, the appropriate dilution of formula and Lewis3 or Lewish antigens.
The mean percentage inhibition of binding for 4 experiments are shown in Table
4.6. Although the addition of Lewis3 or Lewisb to infant formula increased the
observed inhibition of binding compared to infant formula alone, there was no
significant difference in binding between infant formula alone and infant formula
plus synthetic Lewis3 or Lewisb.
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Table 4.6 Inhibition of bacterial binding (in vivo method) by infant formula and
infant formula containing 20 jag mf1 of synthetic Lewis3 or Lewis'1. The p value
represents the difference between equivalent dilutions of infant formula and infant
formula with Lewis antigen added (mean of4 experiments).
Condition Mean % inhibition of binding
Formula diluted 1 in 10 16.7
Formula diluted 1 in 10 plus Lewis3 23.7 (p = 0.119)
Formula diluted 1 in 10 plus Lewis'1 25.6 (p = 0.061)
Formula diluted 1 in 100 12.9
Formula diluted 1 in 100 plus Lewis3 24.1 (p = 0.053)
Formula diluted 1 in 100 plus Lewisb 24.2 (p = 0.200)
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4.4 Discussion
For C. perfringens, both methods gave similar results for whole and defatted human
milk. Enhancement of binding rather than inhibition of binding was observed and
flow cytometry studies suggest that enhanced binding occurs due to the formation of
bacterial aggregates. Greater enhancement of binding was observed using the in
vitro method because bacterial aggregates are formed when they are incubated with
milk or formula. Significantly different results were obtained with infant formula.
The in vivo method showed inhibition of binding at the lower dilutions regardless of
formula type. The in vitro method showed enhancement of binding. The results with
C. perfringens are similar to those observed with S. aureus.
Oligosaccharides and glycoconjugates present in human milk have been found to
inhibit binding of certain enteric pathogens and their toxins by acting as receptor
analogues [Goldman, 1993], Pre-incubation of epithelial cells with fucose
containing glycopeptides from lactoferrin was found to inhibit adherence ofShigella
flexneri to intestinal cells [Izhar el al., 1982], This suggests fucose containing
components are binding to a receptor on the cell and blocking adherence. Fucosyl
containing oligosaccharides protected against the heat-stable enterotoxin of E. coli
[Cleary et al., 1983], Breast feeding has also been found to be protective against
salmonella. Fluman milk antibodies to Clostridium difficile have been found to
inhibit the binding of toxin A to its intestinal receptor. Bacteria producing soluble
exotoxins have been found in the gastrointestinal tract of some SIDS infants
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[Bettelheim et al., 1989; Bettelheim et al, 1990; Bettiol et al., 1994; Lindsay et al,
1994; Rolfe et al., 1995],
Inhibition of binding of C. perfringens to cells pre-treated with anti-Lewisa (14.7%)
or anti-Lewisb (20.5%) was not as marked as that observed for S. aureus {49.1% for
anti-Lewisa and 52.1% for anti-Lewisb).
In this study, a dose response effect was observed for inhibition of binding of C.
perfringens by the synthetic Lewis3 and Lewisb antigens. These antigens are
components of breast milk and infant formula. Higher levels of the Lewis antigens
are required to cause maximum inhibition of binding using the in vivo protocol in
which the bacteria can bind either to the Lewis antigen on the cell surface or to
antigens in solution. In the in vitro protocol, direct blocking of the bacterial adhesin
occurs before addition to the cells.
Density of colonisation is an important factor in development of bacterial disease
due to invasion or toxin production [Beachey, 1981], This study suggests that the
Lewis antigens in both human milk and infant formula might reduce binding of C.
perfringens to epithelial cells. The results obtained for synthetic Lewis antigens with
the two methods follow the same trends as those observed for S. aureus in the
previous chapter.
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Breast milk contains much higher levels of the Lewis antigens compared to infant
formula or cows' milk [Chapter Three]. Based on these results and the inhibition of
binding studies with the Lewis antigens, the following hypothesis was tested: the
inhibitory activity of infant formula in the in vivo system might be increased by the
addition ofLewis antigens to the formula preparation. Although greater inhibition of
bacterial binding was observed by the addition of Lewis antigens to the formula, no
significant differences in binding were observed between formula alone and formula
plus the synthetic Lewis antigens. It might be that higher concentrations of the Lewis
antigens need to be added before significant differences in binding are observed.
The cost of the antigens limited the numbers of experiments and concentrations
tested.
Significantly higher levels of C. perfringens and their toxins have been identified in
SIDS cases compared to non-SIDS cases [Lindsay et al., 1993; Murrell et a/., 1993]
and formula fed infants had a significantly higher incidence of C. perfringens and its
enterotoxin in their faeces than breast fed infants [Murrell et al., 1993], Compared
with healthy infants, enterotoxigenic strains of S. aureus and their toxins have also
been isolated significantly more often from the gastrointestinal tracts of SIDS
infants. Formula fed SIDS infants had a higher incidence of S. aureus and its
enterotoxin than breast fed babies, but the increase was not significant [Murrell et
al., 1993],
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In conclusion, although the free oligosaccharides Lewis" and Lewisb were shown to
inhibit binding of C. perfrmgens, the major protective effect ofwhole human milk is
likely to be due to aggregation of the bacteria by antibodies and glycoconjugates.
This could result in enhanced clearance by phagocytic cells or other innate
mechanisms such as peristalsis in the gut. Addition of these antigens to formula
preparations might enhance the inhibition noted in the in vivo method; however, the
concentration of Lewis antigens which showed maximum inhibition alone had no
significant effect when mixed with the formula preparation. Higher concentrations
of the antigen need to be tested, but the cost of the synthetic antigens did not permit
further studies. These studies should be extended to other enterotoxigenic bacteria
implicated in SIDS.
Chapter Five
Detection of IgA antibodies in human milk that
bind to bacterial toxins implicated in SIDS
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5.1 Introduction
Bacteria that produce soluble toxins on respiratory or gastrointestinal mucosa have
been implicated in a significant number of cases of SIDS [reviewed by Blackwell et
al., 1994; 1995a, b]. Toxins of S. aureus and C. perfringens have been identified in
tissues and body fluids of some SIDS victims [Murrell et al., 1987; Malam et al.,
1992; Lindsay et al., 1993; Zorgani et al., 1999], These toxins can act as
superantigens and have been suggested to play a role in precipitating the events
leading to some SIDS deaths [Lindsay, 1996], C. perfringens does not invade
healthy cells but produces toxins and C. perfringens enterotoxin interacts with the
cell membrane causing pore formation [Petit et al., 1999],
Breast fed infants are at a lower risk of dying from SIDS compared to formula fed
infants [Ford et al., 1993] and breast feeding has been suggested to enhance
secretory immunity of mucosal surfaces during the early neonatal period [Stephens,
1986] as development of the secretory IgA system does not occur until some time
afterbirth [Goldman, 1993],
Secretory IgA is the predominant immunoglobulin in breast milk [Goldman, 1993]
and plays an important role as a specific defence mechanism for the breast fed baby
by providing local immunological protection at mucosal surfaces against bacterial or
viral infection or by preventing antigens crossing the epithelial barrier [Jatsyk et al.,
1985; Vassilev et al., 1996], Levels of secretory IgA are highest in colostrum, and
concentrations of secretory IgA in milk decrease with time as an infant's own
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immune system begins to provide protection against potential pathogens [Davidson
etal., 1987],
The agglutination of S. aureus and C. perfringens by human milk was observed in
3.3.11 and 4.3.9. Another protective effect of human milk could be the neutralising
activities of secretory antibodies for toxins which are not present in infant formula
preparations. Antibodies to the heat stable enterotoxin of Escherichia coli have been
identified in human milk and these antibodies protected suckling mice from the
lethal effects of the toxin [Cleary et al., 1983], Both non-immunoglobulin and
immunoglobulin components of human milk were found to inhibit binding of
Clostridium difficile toxin A to its receptor [Rolfe et al., 1995],
The aim of this work was to examine individual samples of human milk and
different infant formula preparations to quantitate levels of IgA specific for the
staphylococcal toxins toxic shock syndrome toxin-1 (TSST-1), staphylococcal
enterotoxin C (SEC) and C. perfringens enterotoxin A (CEA). Antibody levels
against TSST-1 and SEC were compared with the isolation of S. aureus from the
mother's nose or throat.
In non-ruminant species, the main immunoglobulin present in external secretions
and involved in mucosal immunity is IgA. In cattle and sheep however, IgG, is the
predominant immunoglobulin in external secretions and is more important than IgA
in the mucosal immune system of ruminants. This is especially evident in the
127
ruminant mammary gland which has the least well developed IgA system of all the
secretory organs. Shortly before parturition, there is selective transfer of IgGi from
blood serum and IgGi is present in high levels in both the ruminant mammary gland
and colostrum. IgG] is crucial for protection of the newborn against various
pathogens and maternally derived IgGi protects young animals against colibacillosis
and rotavirus infections [Lascelles et al., 1986], Infant formula preparations are
made from skimmed cows' milk or skimmed cows' milk powder and were not
expected to contain human IgA antibodies; however, infant formula preparations
might contain bovine IgGj. This was assessed in both infant formula and cows'
milk. Samples of human milk were included as a negative control since these should
not contain any bovine antibodies.
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5.2 Materials andmethods
5.2.1 ELISA for detection of specific human IgA against staphylococcal and
clostridial toxins in human milk and infantformula
The wells of microtitre plates (Greiner) were coated with 50 pi of the individual
toxin (1 pg ml"1) in coating buffer, TSST-1, SEC or CEA. Controls included wells
coated with 50 pi of serial dilutions of a standard human IgA derived from
colostrum (Sigma); concentrations ranged from 9 - 9,200 ng ml"'. The plates were
incubated overnight at 4°C.
The plates were washed with washing buffer and blocked with 50 pi of blocking
buffer for 30 min at room temperature. The plates were washed and 50 pi of
undiluted human milk or infant formula preparations or dilutions of 1 in 5, 1 in 10
or 1 in 100 in blocking buffer were added to the appropriate wells. Blocking buffer
(50 pi) was added to the standard and TSST-1 and SEC control wells. For the CEA
plates, 50 pi of C. perfringens anti-toxin (kindly supplied by Mr R. Brown of this
Department) developed in horse and diluted 1 in 100 in blocking buffer was added.
All plates were incubated for 2 h at room temperature.
After washing, 50 pi of HRP-labelled goat anti-human IgA (Sigma) diluted 1 in 100
in blocking buffer were added to the test and standard wells. To the control wells
which contained toxin but no milk or infant formula sample, for TSST-1 and SEC,
50 pi of HRP-labelled sheep anti-TSST-1 (Toxin Technology) (diluted 1 in 300 in
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blocking buffer) or HRP-labelled sheep anti-SEC (Toxin Technology) (diluted 1 in
600 in blocking buffer) were added respectively. For CEA, 50 pi of HRP-labelled
rabbit anti-horse IgG (diluted 1 in 100 in blocking buffer) (Sigma) were added. All
plates were incubated for 2 h at RT. The plates were washed and the experiment
continued as described in 2.6. The samples were tested in duplicate. The absorbency
at 490 nm (A490) was measured on an ELISA plate reader (Dynatech), the results
analysed and the immunoglobulin concentrations (ng ml"1) were determined by
comparing their absorbency with the linear part of the standard curve run for each
experiment.
5.2.2 ELISA for detection of specific bovine IgG/ against staphylococcal and
clostridial toxins in cows' milk, infantformula and human milk
Plates were coated with the appropriate toxin as described in 5.2.1. Controls
included wells coated with 50 pi of various concentrations of bovine
immunoglobulin reference serum (Bethyl Laboratories, Universal Biologicals
Limited) ranging for IgGj from 2.3 - 45,200 ng ml"1. The plates were incubated
overnight at 4°C.
The plates were washed with washing buffer and blocked with 50 pi of blocking
buffer for 30 min at room temperature. The plates were washed and 50 pi of
undiluted cows' milk, infant formula preparations or human milk were added to the
wells. Dilutions of these (1 in 10; 1 in 100; 1 in 1,000 in blocking buffer) were also
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added to the appropriate wells. The positive control wells were treated as described
in 5.2.1. All plates were incubated for 2 h at room temperature.
After washing, 50 pi of HRP-labelled sheep anti-bovine IgGj (Bethyl Laboratories,
Universal Biologicals Limited) diluted 1 in 100 in blocking buffer was added to the
test and standard wells. The control wells were treated as described in 5.2.1. All
plates were incubated for 2 h at room temperature.
The plates were washed and the experiment continued as described in 2.6. The
samples were tested in duplicate. The absorbency at 490 nm (A490) was measured on
an EL1SA plate reader (Dynatech), the results analysed and the IgGi
immunoglobulin concentrations (ng ml"1) were determined by comparing their
absorbency with the linear part of the standard curve run for each experiment.
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5.3 Results
5.3.1 Detection ofhuman IgA hound to TSST-1, SEC and CEA in human milk and
infant formula by ELISA
Individual breast milk samples were tested for the presence of IgA antibodies that
bind to TSST-1 (n = 33), SEC (n = 32) and CEA (n = 28). Preliminary work with
TSST-1 used whole and defatted pools of human milk (Figure 5.1). The whole milk
pool gave higher results than the defatted pool; therefore, whole milk samples were
used. Individual milk samples were tested without dilution and at dilutions of 1 in 5,
1 in 10 and 1 in 100 to try to dilute out the inhibitory activity of the milk observed at
lower dilutions (Figure 5.1).
The results obtained for IgA binding to TSST-1 are shown in Figure 5.2. The levels
of IgA binding to TSST-1 ranged from 900 - 3,100 ng ml"1 with a mean of 1,788 ng
ml"1 (SD ± 587). The results obtained for IgA binding to SEC are shown in Figure
5.3. The levels of IgA binding to SEC ranged from 1,000 - 3,600 ng ml"1 with a
mean of 2,009 ng ml"1 (SD ± 618). The results obtained for IgA binding to CEA are
shown in Figure 5.4. The levels of IgA binding to CEA ranged from 1,000 - 4,300
ng ml"1 with a mean of 1,718 ng ml"1 (SD ± 636).
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Figure 5.1 IgA antibodies bound to TSST-1 in pooled whole and defatted human
milk (dilution 1 = neat; dilution 2 = 1 in 5; dilution 3 = 1 in 10; dilution 4 = 1 in
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Figure 5.2 IgA antibodies bound to TSST-1 in individual samples ofbreastmilk
( - ) = no S. aureus isolated, ( ♦ ) = S. aureus isolated
sample number
Figure 5.3 IgA antibodies bound to SEC in individual samples of breast milk
( - ) = no S. aureus isolated, ( ♦ ) = S. aureus isolated
sample number
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Figure 5.4 IgA antibodies bound to CEA in individual samples of breast milk
sample number
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There were 28 individual samples with sufficient milk to test for IgA antibodies
against the three toxins. Of these 28 samples, the levels of IgA antibodies that bound
to TSST-1 were highest in five (17.8%) compared with either SEC or CEA. In one
sample (20%), the levels of IgA binding to TSST-1 were highest followed by SEC,
then CEA. In three samples (60%), the levels of IgA binding to TSST-1 were highest
followed by CEA, then SEC. For the remaining sample (20%), the levels of IgA
binding to TSST-1 were highest followed by equal levels of SEC and CEA.
Of the 28 samples, 17 (60.7%) contained higher levels of IgA that bound to SEC
compared with either TSST-1 or CEA. In nine of the 17 samples (52.9%), the levels
of IgA binding to SEC were highest followed by TSST-1, then CEA. In six of the 17
samples (35.3%), the antibody levels against SEC were highest followed by CEA,
then TSST-1 and in two of the 17 samples (11.8%), the levels of IgA binding to SEC
were highest followed by equal levels of TSST-1 and CEA.
There were five of the 28 samples (17.8%) which contained highest levels of IgA
antibodies to CEA compared with either TSST-1 or SEC. In three samples (60%),
the levels of IgA bound to CEA were highest followed by TSST-1, then SEC. In two
samples (40%), the highest levels of IgA were bound to CEA followed by SEC, then
TSST-1.
One of the 28 samples had equal levels of IgA bound to SEC and CEA but lower
levels of IgA bound to TSST-1.
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Five different infant formula preparations were examined as negative controls for
the presence of human IgA against TSST-1, SEC and CEA. No specific IgA was
detected in any of the infant formula preparations tested. This was the expected
result since infant formulas are prepared from skimmed cows' milk or skimmed
cows' milk powder.
5.3.2 Isolation of S. aureus from the mother and detection of human IgA to
staphylococcal toxins
The breast milk samples were collected at either visit one or two during the first 6
months after the infant was born. The IgA levels bound to TSST-1 and SEC were
assessed with reference to the presence or absence of S. aureus in the mother's nose
or throat. Samples 24 and 25, and samples 26 and 27 were taken from the same
mother at different times due to their becoming involved in the study for the second
time after the birth of another child.
For the 33 samples tested for IgA binding to TSST-1, 17 (51.5%) had concentrations
less than the mean of 1,788 ng ml"1 (SD ± 587). Of these, eight (47.1%) had no S.
aureus isolated at either visit and nine (52.9%) had S. aureus isolated at one or more
visits. Of 16 samples with concentrations greater than or equal to 1,788 ng ml"1, five
(31.2%) had no S. aureus isolated at either visit and 11 (68.8%) had S. aureus
isolated at one or more visits. There were five of the 33 samples (15.1%) (numbers
4, 6, 19, 20 and 33) that contained IgA levels greater than the upper limits of the
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standard deviation (2,375 ng ml"1) of IgA bound to TSST-1. S. aureus was not
isolated from two of the mothers (40%) (numbers 19 and 20) at either visit;
however, for the remaining three samples (60%) (numbers 4, 6 and 33), S. aureus
was isolated from the mother at one or more visits. There were five samples (15.1%)
(numbers 15, 16, 24, 27 and 30) that had IgA levels less than the lower limits of the
standard deviation (1,201 ng ml"1). Of these samples, two (40%) of the mothers
(numbers 15 and 30) had no S. aureus isolated at either visit whilst the other three
samples (60%) came from mothers who had S. aureus isolated at one or more visits.
For 32 samples tested for IgA bound to SEC, 19 (59.4%) had concentrations less
than the mean of 2,009 ng ml"1 (SD ± 618). Of these, 10 donors (52.6%) had no S.
aureus isolated at either visit but the remaining nine (47.4%) had S. aureus isolated
from the mother at one or more visits. There were 13 samples (40.6%) with IgA
levels greater than or equal to 2,009 ng ml"1. Of these, three donors (23.1%) had no
S. aureus isolated at either visit and ten of the mothers (76.9%) had S. aureus
isolated at one or more visits. There were five of the 32 samples (15.6%) (numbers
4, 5, 6, 19 and 25) that had IgA levels above the upper limits of the standard
deviation (2,627 ng ml"1). For one sample (number 19), no S. aureus was isolated
from the mother at either visit. The other 4 samples came from mothers who had S.
aureus isolated at one or more visits. There were five samples (15.6%) that had IgA
levels below the lower limits of the standard deviation (1,391 ng ml"1) and all 5
donors were culture negative for S. aureus at both visits (Fisher's exact test p <
0.05).
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5.3.3 Detection ofbovine IgGj bound to TSST-1, SEC and CEA in cows' milk, infant
formula and human milk by ELISA
Bovine IgGj antibodies against TSST-1, SEC or CEA were not detected in any of
the different infant formula preparations (n = 5) or human milk samples (n = 4)
tested. Bovine IgGi antibodies which bound to TSST-1, SEC and CEA, were
detected in whole, semi-skimmed and skimmed cows' milk. Highest levels were
bound to TSST-1, followed by SEC and then CEA. The results for the different
cows' milk samples are shown in Figure 5.5.
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Figure 5.5 IgG, antibodies bound to TSST-1, SEC and CEA in whole, semi-














Secretory IgA has been suggested to act locally in the infant gut as a first line of
defence against foreign antigens. This might occur by binding to gastrointestinal
pathogens and interfering with their attachment to mucosal cells [Davidson et al.,
1987]. Secretory IgA is well adapted to persist in the gastrointestinal tract since it is
resistant to digestive enzymes [Goldman, 1993] as shown by its detection in faeces
[Davidson et al., 1987], Secretory IgA is resistant to digestion because of its stable
molecular arrangement [Lonnerdal, 1996]. No immunoglobulins have been found in
the intestinal tracts of bottle fed infants until they produce their own secretory IgA
[Jatsyk et al., 1985], Breast fed infants have been found to produce their own
intestinal secretory IgA sooner than formula fed infants [Dallas et al., 1998],
Specific IgA antibodies in breast milk have been found against common
microorganisms present in the gastrointestinal or respiratory tracts [Goldman, 1993],
A number of studies have found that breast feeding protects infants against
pathogenic species including Campylobacter, Shigella, E. coli, respiratory syncitial
virus (RSV), Haemophilus influenzae and Helicobacter pylori [van Rosen et al.,
1990, Thomas et al., 1993; Buescher 1994]. IgA is thought to be responsible for this
protection, and an association between the absence of specific immunoglobulin in
human milk and the occurrence of symptomatic infections caused by these bacteria
and viruses has been observed [Buescher, 1994], Evidence has been obtained which
found that mothers' produce "environmentally specific" milk for their infants.
Levels of secretory IgA in breast milk are increased upon maternal exposure to
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specific pathogens and means that infants receive antibodies directed against
specific pathogens. These antibodies provide an infant with protection during a time
when their immune system is not fully developed [Lawrence, 1994],
Studies have also found that by binding to bacterial toxins, secretory IgA can
neutralise their activity [Kim et al., 1984; Rolfe et al., 1995; Dallas et al., 1998],
Secretory IgA has been found to neutralise the effects of Clostridium difficile toxin
A [Kim et al., 1984] and this was suggested to occur through inhibition or
modification of binding of toxin A to its intestinal receptor [Rolfe et al., 1995],
Later work by the same group found that toxin A binds to the secretory component
which acts as a receptor analogue [Dallas et al., 1998], Human milk has also been
found to prevent Vibrio cholerae toxin and heat-stable E. coli enterotoxin causing
pathogenic effects without preventing colonisation by the bacteria in question
[Dallas et al., 1998],
The levels of IgA detected in individual breast milk samples varied among mothers,
and these different levels of protective antibodies might confer different degrees of
protection to an infant against bacterial toxins. In most samples the highest levels of
IgA were detected in the ELISA with SEC; however, the highest IgA level detected
was 4,300 ng ml"1 and was against CEA. It was not possible to test the milk samples
for their ability to neutralise the toxins in a model system using human bufiy coats
because both whole and defatted milk elicited production of strong inflammatory
responses from the cells in the absence of toxin; however, the Lewis3 and Lewisb
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antigens which were found in the milk samples were examined for their effect on
TSST-1 [Chapter Six],
While S. aureus was isolated from about two thirds of women whose milk samples
had levels of IgA to the toxin greater than or equal to the mean, the difference was
not significant compared to isolation rates from women whose milk samples had
levels below the mean. The only exception was found for SEC. Five samples had
IgA levels above the upper limits of the standard deviation and of these, S. aureus
was isolated from 4 of the mothers. Five samples were also found to have IgA levels
below the lower limits of the standard deviation and all five were culture negative
for S. aureus.
Some samples were found to have low levels of specific antibody to TSST-1 and /
or SEC and had been taken when S. aureus was isolated from the mother (Figures
5.2 and 5.3). Two explanations can be suggested: 1) S. aureus isolated from these
mothers did not produce the relevant toxins; 2) the mothers were recently colonised
and had not yet developed IgA to the toxins.
For 20 women in the 20-29 and 30-39 age ranges, the mean levels of serum IgG
bound to TSST-1 were 5,150 ng ml"1 and 4,050 ng ml"1 respectively and for SEC,
4,200 ng ml"1 and 2,850 ng ml"1 respectively [AI Madani, 1999], This indicated that
the majority of women of child-bearing age have encountered the toxins and have
produced a good humoral response. Levels of secretory IgA produced in response to
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an antigen decrease with time if the stimulus is no longer present. The higher
proportion of carriers among women with IgA levels to TSST-1 (68.8%) or SEC
(76.9%) greater than or equal to the mean indicate that carriage of S. aureus by the
mother might have a booster effect on secretory IgA responses. Greater numbers of
women need to be assessed to obtain evidence for this hypothesis.
In comparison to non-ruminant species, cows' milk contains very little IgA
[Wharton et al., 1994]. IgGi is the main immunoglobulin involved in the mucosal
immune system of ruminants and is of particular importance in protecting young
ruminant animals against various pathogens [Lascelles et al., 1986], Pregnant cows
have been immunised with a polyvalent E. coli vaccine in an attempt to increase the
immunoglobulin content of cows' milk; however, although an extra antibody was
produced, it was IgG and not secretory IgA [Wharton et al., 1994], IgGj was
detected in cows' milk but not in any of the infant formula preparations or human
milk samples tested. Thus, formula fed infants will not have any protective
antibodies, either human or bovine, in their intestinal tracts against infectious agents
or their products, until they produce their own secretory IgA.
In conclusion, if bacterial toxins play a role in precipitating a SIDS death, the
presence in breast milk of IgA antibodies which could neutralise bacterial toxins
implicated in SIDS might contribute to the reported protective effect of breast
feeding in relation to these infant deaths.
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Chapter Six
The prevalence of night-time deaths in SIDS:
Development of a system to assess factors that
could control inflammatory responses to toxic
shock syndrome toxin-1 (TSST-1)
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6.1 Introduction
It has been proposed that some SIDS deaths are due to uncontrolled inflammatory
reactions in response to infectious agents and / or cigarette smoke [Blackwell el al.,
1995a], Major candidates for triggering these reactions are pyrogenic toxins of S.
aureus. These toxins have been identified in tissues of over half the SIDS infants
tested and from cases of unexpected deaths in adults and older children [Newbould
et al., 1989; Malam et al., 1992; Bentley et al., 1997; Zorgani et al., 1999], They
have superantigenic activities that can induce shock and death in previously healthy
adults [Schlievert, 1995],
There is evidence for mild infection and associated inflammatory responses in SIDS
infants. As a group, SIDS victims had evidence of increased inflammatory
stimulation in the upper airways and intestinal tract compared with infants who died
of other causes such as violent deaths. Pro-inflammatory cytokines, interleukin-6
(IL-6), interleukin-ip (IL-lp) and tumour necrosis factor-a (TNF-a), have been
detected in body fluids or tissues of SIDS victims. At autopsy, there are often signs
of mild inflammatory reactions and increased levels of some acute phase proteins,
increased production of immunoglobulins in the respiratory tract and gut, and
changes indicating T-cell activation [Forsyth et al., 1999; Vege et al., 1999],
The majority of SIDS deaths occur during the early hours of the morning and it has
been suggested that sleep might be involved in the mechanism of some SIDS deaths
[Schechtman el al., 1995; Cornwell et al., 1998]. Studies on the physiology of sleep
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in infants have produced important clues to relate developmental stage with the
proposed role of inflammation in SIDS.
The 2-4 month age range has been consistently identified as the period in which
the majority of SIDS deaths occur. During this age range, infants develop adult-like
night-time temperature patterns and diurnal variation in hormone levels. In normal
infants, between 7 and 16 weeks, the body temperature falls at night to 36.4°C,
similar to that of sleeping adults; however, this change can occur as late as 22 weeks
among infants of low birthweight or who experienced problems at delivery
[Lodemore et al., 1992]. Infants who remain in the "immature" state share many risk
factors with SIDS infants, and Wailoo and colleagues have suggested that the
"immature state" is a risk factor for SIDS. In contrast, other work by this group
found that Asian infants stay in the "immature" stage significantly longer than white
infants [Petersen et al., 1994], but Asian infants have been found to have a lower
incidence of SIDS [Balarajan et al., 1989],
The findings of Wailoo and colleagues can also be explained by relating them to
other physiological changes that occur in conjunction with the change in body
temperature rhythm. The week following the switch to an adult-like night-time
temperature pattern, there is a dramatic drop in night-time, but not daytime, Cortisol
levels. Before the developmental change, the morning and night-time values for
Cortisol are 0.34 - 22.5 pg df1 and 0.22 - 15.2 pg df1 respectively. After the
developmental switch, there is no significant change in the daytime levels
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0.34 - 23.9 jag df1 but a sharp drop in the night-time levels to 0.1 - 7.25 pg dl~' is
observed.
Cortisol and other glucocorticoids play a key role in suppression of almost all
components of the inflammatory responses. In infants, the adrenal gland decreases
in weight during the first two months after birth. This is associated with a decrease
in plasma Cortisol levels [Wittekind et al., 1993],
Hormone levels associated with circadian rhythm affect inflammatory responses in
adults. Adults are less able to control inflammatory responses such as TNF
responses to endotoxin during the early hours of the morning when there is minimal
secretion of Cortisol since the gland is less responsive after midnight [Pollmacher et
al., 1996], It is during these hours that a significant number of SIDS deaths occur.
Inflammatory responses induced by endotoxin from blood samples of individuals
with obstructive sleep apnoea syndrome were compared with responses induced
from samples obtained from normal individuals. TNF-a, IL-1, IL-6 and IFN-y
responses were measured in samples taken at different times during the day and
night. For normal individuals, the peak of induction of these mediators occurred
during late evening or early morning. For patients with obstructive sleep apnoea
syndrome, the peak occurred during the afternoon or early evening. Production of
high levels of inflammatory mediators corresponded to times of minimal Cortisol
production [Entzian et al., 1996],
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Breast fed infants develop adult-like night-time temperature and circadian rhythm
patterns significantly earlier than formula fed infants [Lodemore et al., 1992], Breast
milk contains IgA antibodies that can bind to the staphylococcal toxins TSST-1 and
SEC [Chapter Five], These antibodies might be able to reduce TSST-1 's ability to
induce pro-inflammatory cytokine production. Depending on secretor status, Lewisa
and Lewisb antigens are found in high levels in breast milk, but in much lower levels
in infant formula [Chapter Three], In other studies, toxins have been demonstrated
to bind to the Lewis antigens expressed on the surface of monocytes. Binding of
pertussis toxin to macrophages was reduced by capping the Lewis3 antigen on cells
with monoclonal antibodies to the antigen [van't Wout et al., 1992], Binding of
some staphylococcal enterotoxins (TSST-1 and SEC) to monocytes can be partially
inhibited by pre-treating monocytes with monoclonal anti-Lewis3 antibodies [Essery
etal., 1994; Essery, 1997],
The objectives of the present study were: 1) to assess in a model system the effects
of breast milk, infant formula and the synthetic Lewis3 and Lewisb antigens on
induction of pro-inflammatory cytokines in response to TSST-1; 2) to investigate the
effect of Cortisol levels in infants found at night and during the day (both before and




6.2.1 Source ofhuman cells
One day old human buffy coats were obtained from the Scottish National Blood
Transfusion Service (SNBTS) (Royal Infirmary of Edinburgh). The buffy coats were
diluted 1 in 4 with sterile pyrogen free PBS and layered onto a Histopaque 1077
gradient (Sigma). After centrifugation at 300 x g for 30 min at room temperature
(RT), the cells in the interface layer were removed and washed twice in Dulbeco's
Modified Eagle's Medium (DMEM) at 250 x g for 10 min. Viable cells were
counted using the trypan blue exclusion method using a Neubauer Haemocytometer
and diluted to 2 x 106 cells ml*1 in DMEM plus 5% (v/v) serum from the individual
donor or 5% (v/v) FCS (Gibco), 1% (w/v) L-glutamine (Gibco), penicillin (100 IU
ml"1) and streptomycin (200 pg ml"1) (Gibco).
6.2.2 Optimisation of toxin concentration and incubation time for induction of
inflammatory mediators
TSST-1 was used in all experiments. Dose response experiments were carried out to
determine the optimal amount of toxin for induction of the pro-inflammatory
cytokines TNF-a, TNF-P, IL-ip, IL-6 and nitric oxide. TSST-1 was tested at
concentrations of 0.1 - 5 pg ml"1. In these initial experiments, 50 pi of medium or
TSST-1 was added to 950 pi of cells (2 x 106 cells ml"1) resuspended in growth
medium containing 5% (v/v) FCS. The samples were incubated for 0, 8, 12, 16, 24,
36, 48 and 72 h at 37°C in 5% C02. The tubes were centrifuged at 250 x g for 20
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min; the supernatant fluids were stored at -20°C and the cells were stored at -70°C.
The supernatants were examined for pro-inflammatory cytokine production.
6.2.3 Pasteurisation ofthe human milkpool and infantformula
The pasteurisation method described by Jay [1996] was adapted for human milk and
infant formula. The pasteurisation process was carried out in a water bath under the
following conditions of temperature and time: 63°C for 30 min; 72°C for 15 sec;
89°C for 10 sec; 100°C for 5 sec. After pasteurisation, a loopful of the human milk
pool or infant formula was streaked on Columbia horse blood agar plates and
incubated at 37°C for 48 h to check for the presence of any contaminating
microorganisms [Wright et a/., 1998],
6.2.4 Preparation ofthe synthetic Lewis antigens
The synthetic Lewisa and Lewisb antigens (Dextra) were prepared by dissolving
them in 1 ml of pyrogen free PBS. They were stored in 200 pi aliquots at -20°C until
use. No sodium azide was added to this preparation.
6.2.5 Effect of pasteurised breast milk and infant formula on induction of
inflammatory mediators
Leukocytes (1 ml), prepared as described in 6.2.1 and diluted to 2 x 106 cells ml"1 in
medium containing 5% FCS, were added to 5 ml sterile culture tubes (Elkay).
Negative controls containing cells with medium alone (1 ml) or cells with breast
milk or infant formula alone (500 pi of the appropriate dilution of milk or formula
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and 500 |ul of medium) were included in each experiment. The positive control
samples contained cells plus 500 pi of medium and 500 pi of toxin at a final
concentration of 0.1 pg ml"1. Test samples contained cells plus 500 pi of toxin and
500 pi of the appropriate milk or formula dilution. The dilutions of milk and
formula used were 1 in 10 and 1 in 100.
6.2.6 Effect ofsynthetic Lewis antigens on induction ofinflammatory mediators
6.2.6.1 Optimisation oftoxin concentration and incubation time
In these initial experiments, 500 pi ofmedium and 500 pi of TSST-1 was added to 1
ml of cells (2 x 106 cells ml"1) resuspended in growth medium containing 5% (v/v)
serum from the individual donor. Concentrations of TSST-1 ranging from 0.1 - 1.0
pg ml"1 were tested and assessment of TNF-a and IL-6 production made at 0, 6 and
24 h. TSST-1 was used in all experiments involving the synthetic Lewis antigens at
a final concentration of 0.5 pg ml"1.
6.2.6.2 Effect ofsynthetic Lewis antigens
Leukocytes (1 ml) were added to 5 ml sterile culture tubes (Elkay). Negative
controls containing cells with medium alone (1 ml) or Lewis antigen alone (500 pi
of the appropriate Lewis antigen concentration and 500 pi of medium) were
included in each experiment. The positive control samples contained cells with 500
pi of toxin and 500 pi of medium at a final concentration of 0.5 pg ml"1. Test
samples contained cells plus 500 pi of toxin and 500 pi of the appropriate Lewis
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antigen concentration. Lewis3 and Lewisb antigens were added to give final
concentrations of 0.5, 5 and 10 jug ml1.
Results for the test samples were expressed as percentage of the positive control
with toxin and cells only (100%).
6.2.7 Effect ofCortisol on induction ofinflammatory mediators
Leukocytes (1 ml) prepared in 6.2.1 were resuspended in growth medium with 5%
(v/v) FCS and added to 5 ml sterile culture tubes (Elkay). Negative controls
containing cells and medium alone (1 ml) or Cortisol alone (500 jul Cortisol and 500
pi medium) were included in each experiment. The positive control samples
contained cells and 500 pi of toxin and 500 pi ofmedium at a final concentration of
0.1 pg ml"1. Test samples contained cells and 500 pi of toxin and 500 pi of the
appropriate Cortisol concentration. Water-soluble hydrocortisone (Sigma) was
freshly prepared in cell growth medium for each experiment to give a range of
concentrations from 0.62 pg df1 to 25 pg dl"1. These concentration ranges were
chosen based on the graph produced by Wailoo and Petersen (Figure 6.1) [from
Blackwell et al., 1995a (permission from Mike Wailoo to use this graph has been
requested)] which showed changes in urinary excretion of Cortisol in the weeks
before and after the appearance of an adult-like temperature pattern. The values
were converted to represent the values of Cortisol present in serum based on
information from Jonetz-Mentzel et al., 1993 (Table 6.1); Cole et al., 1995; Sonntag
et al., 1996 and Orth et al., 1998.
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The samples were incubated for 0, 3, 6, 9, 12, 24, 48 and 72 h and the supernatants
and cells collected and stored as described in 6.2.3. The supernatants were tested for
pro-inflammatory cytokine production and the results for the test samples treated
with Cortisol expressed as a percentage of the control containing toxin alone
(100%).







Figure 6.1 Urinary free Cortisol excretion in relation to circadian rhythm pattern
development [Blackwell et al., 1995a]
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6.2.8 ELISAsfor detection of inflammatory mediators
6.2.8.1 Detection ofIL-6production by ELISA
The wells of microtitre plates (Greiner) were coated with 50 pi of mouse
monoclonal anti-IL-6 (R&D Systems, UK) diluted 1 in 500 to 1 jug ml"' in coating
buffer. After incubation overnight at 4°C, the wells were washed 3 times with
washing buffer. The plates were blocked with 50 pi of blocking buffer at room
temperature for 30 min. The wells were washed 3 times and 50 pi of the test
samples added to duplicate wells. For each plate, dilutions of standard recombinant
human IL-6 (R&D) ranging from 0.19 - 100 ng ml"1 were made in DMEM medium,
added to duplicate wells and incubated for 2 h with continuous shaking in an orbital
incubator at 37°C. The plates were washed 3 times and 50 pi of goat polyclonal
anti-IL-6 antibody (R&D) diluted 1 in 1,000 to 1 pg ml"' in blocking buffer was
added to each well. The plates were incubated at 37°C for 2 h with continuous
shaking, washed 3 times and 50 pi of HRP-conjugated donkey anti-sheep/goat IgG
(SAPU) diluted 1 in 100 in blocking buffer was added to each well. The plates were
incubated at 37°C for 1 h, washed 3 times and the plates were developed as
described in 2.5.6. The absorbency at 490 nm was measured using an ELISA plate
reader (Dynatech). The concentration of IL-6 (ng ml"1) in each sample was obtained
by comparing the absorbency obtained with those of the standard curve obtained
with the recombinant IL-6. The results of duplicate samples were averaged and the
results expressed in ng ml"1.
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6.2.8.2 Detection ofIL-lft and TNF-/3production by ELISA
The ELISA protocol for detection of IL-6 production was used to test for production
of IL-ip and TNF-[3 and the appropriate monoclonal and polyclonal antibodies and
recombinant standards were used as described in Table 2.1.
6.2.9. Bioassayfor detection ofTNF-aproduction
This method was adapted from the technique of Delahooke et at, [1995],
6.2.9.1 L929 cells
The mouse fibroblast cell line L929 obtained from the European Collection of
Animal Cell Cultures was used for TNF-a bioassays. Cells were grown in 75 cm
tissue culture flasks (Greiner) at 37°C with 5% C02 in growth medium (GM)
containing DMEM (Sigma) containing 5% (v/v) FCS (Gibco), 1% (w/v) L-glutamine
(Gibco), penicillin (100 IU ml"1) and streptomycin (200 pg ml"1) (Gibco). Cells were
split once semi-confluent growth was reached.
6.2.9.2 Day one
Growth medium was discarded and the monolayer washed twice with sterile PBS.
To disperse the cells 0.005% (w/v) trypsin - 0.02% (w/v) EDTA (1.5 ml) was added
for 30 sec, discarded and the cells left for 5-10 min to detach. The cells were
resuspended in growth medium and washed twice to remove trypsin. The cells were
counted at a 1 in 10 dilution in trypan blue with a Neubauer counting chamber and
the cell count adjusted to 3 x 103 cells ml"1 in the growth medium. Cells (100 pi)
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were added to 96-well tissue culture plates; 6 wells per plate contained medium only
to act as negative controls. The plates were incubated at 37°C, 5% C02 for 24 h.
6.2.9.3 Day two
The medium was aspirated from all wells and replaced with 100 pi of assay medium
containing RPMI 1640 (Gibco) supplemented with 5% (v/v) FCS (Gibco) and 1%
(w/v) L-glutamine (Gibco) and actinomycin D (2 pg ml"1) (Sigma). The plates were
incubated for 2 h at 37°C with 5% C02. The medium was aspirated and 100 pi of
test supernatant (diluted 1 in 2 or 1 in 4) in assay medium without actinomycin D
added. To control wells with cells alone or wells with medium alone, 100 pi of
assay medium was added. A standard curve was determined for each plate using
standard recombinant human TNF-a (National Institute for Biological Standards and
Control) ranging from 0 to 100 IU ml"1 and the plates were incubated for 20 h at
37°C with 5% C02.
6.2.9.4 Day three
The medium was discarded and the cells stained with 100 pi of filtered 0.5% (w/v)
crystal violet in 20% (v/v) methanol in distilled water. This was left for 2 min and
the plates washed gently with running tap water. The plates were allowed to dry and
the dye dissolved in 100 pi of 20% (v/v) acetic acid in distilled water for 10 min.
The optical density was then read in an EL1SA plate reader (Dynatech) at 570 nm
blanked on the negative controls. The results were expressed as IU ml"1 of human
TNF-a derived from the standard curve.
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6.2.10 Spectrophotometry assayfor detection ofnitric oxide production
This assay detected the level of nitrite, the stable breakdown product of nitric oxide,
in culture supernatants. Greiss reagent 0.3% (w/v) naphthylenediamine
dihydrochloride (Sigma) and 1% (w/v) sulfanilamide (Sigma) in 5% (v/v) H3PO4
were mixed 1 : 1 immediately prior to use. An equal volume of the reagent was
added to 50 pi of culture supernatant and incubated at room temperature for 20 min.
The absorbency was read at 570 nm on an ELISA plate reader (Dynatech) which
was blanked on a control containing medium alone. A standard curve NaN02
diluted in DMEM medium alone was included on each plate.
6.2.11 Statistical analyses
The results were analysed by a Student's t-test for paired samples.
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6.3 Results
6.3.1 Optimisation ofIL-6, IL-(3and TNF-J3ELISAs
The recombinant standards were used to optimise the dilutions of monoclonal and
polyclonal antibodies to their respective cytokines. The average optical density of
two duplicate wells was measured and the results of this experiment for IL-6, 1L-1P
and TNF-(3 are shown in Figures 6.2a, b and c respectively.
The optimum dilutions for the antibodies to each of the three cytokines were found
to be 1 in 500 and 1 in 1,000 for the monoclonal and polyclonal antibodies
respectively.
6.3.2 Optimisation of toxin concentration and incubation time for induction of
inflammatory mediators
Three bufify coats were tested using TSST-1 concentrations of 0.1, 0.5, 1.0 and 5.0
pg ml"1. Consistent production of TNF-a and IL-6 were observed and the results are
shown in Figures 6.3 and 6.4 respectively. There was no consistent production of
TNF-P, II.-1P or nitric oxide over the time periods tested. The optimum
concentration of TSST-1 in the presence of foetal calf serum was 0.1 pg ml"1 and
maximum production of TNF-a was observed between 6 and 9 h whilst maximum
IL-6 production was observed at 16 h (Figures 6.5 and 6.6).
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Figure 6.2 Optimisation of monoclonal and polyclonal dilutions for a) IL-6; b) IL-
1(3; c) TNF-(3 ELlSAs (m = monoclonal, p = polyclonal)
a) 0 = m 1/125, p 1/1000; □ = m 1/125, p 1/2000; A = 1/500, p 1/1000; x = m 1/500,
p 1/2000; + = m 1/1000, p 1/1000; o = m 1/1000, p 1/2000
0.4
IL-6 (ngmf1)
b) 0 = m 1/500, p 1/1000; □ = m 1/500, p 1/2000; A = m 1/1000, p 1/1000; x = m
1/1000, p 1/2000
IL-1B (ngmf1)




Figure 6.3 Production of TNF-a in response to increasing doses of TSST-1 (n - 3)
(0 = cells alone, □ = 5.0 pgrnF1, A= 1.0 pgml"1, x = 0.5 pgml"1, + = 0.1 pgmf1)
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Figure 6.4 Production of IL-6 in response to increasing doses of TSST-1 (n — 3) (0 —
cells alone, □ = 5 pg ml"1, A = 1.0 pg ml"1, + = 0.5 pg ml"1, x = 0.1 pg ml*1)
Time (h)
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Figure 6.5 Time course for production of TNF-a by human buffy coats in response
to 0.1 pg ml"1 TSST-1 (n = 9)
Time (h)
165
Figure 6.6 Time course for production of IL-6 by human buffy coats in response to
0.1 pg ml"1 TSST-1 (n = 7)
Time (h)
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6.3.3 Effect of pasteurised human milk and infant formula on induction of
inflammatory mediators
The effect of two different dilutions (1 in 10 and 1 in 100) of the pasteurised
defatted human milk pool and one infant formula preparation on TNF-a and IL-6
production were investigated. In these experiments, control cells incubated with
human milk or infant formula but no toxin, were found to be non-specifically
stimulated.
To try to overcome this problem, an experiment was carried out with leukocytes
from a group O Rh-negative donor to test three different modifications; 1) no serum
added to the system; 2) 5% serum from the donor added to the system; 3) 5% FCS
added to the system. For the positive controls of toxin alone, TNF-a production was
observed in all conditions tested but IL-6 production was only observed if FCS or
serum from the donor was present. Breast milk stimulated production of both TNF-a
and IL-6 regardless of the presence or absence of serum.
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6.3.4 Effect ofsynthetic Lewis antigens on TNF-a and IL-6 production in response
to TSST-J
6.3.4.1 Optimisation of toxin concentration and incubation time for the Lewis
antigen neutralisation studies
Due to non-specific stimulation of the leukocytes by human milk or infant formula,
further studies on the role of glycoconjugates in milk were not pursued. The Lewis
antigens are also present as free oligosaccharides; therefore, the synthetic antigens
were tested in the model system. To reduce further the possibility of non-specific
stimulation, homogenous sera of the donor was used to replace FCS in the assay
medium. Because of this, the toxin concentrations were re-tested to determine
optimal concentrations.
Three bufify coats were tested using TSST-1 at a final concentration of 0.1, 0.5 and
1.0 jug ml"1 at 0, 6 and 24 h. Consistent TNF-a and IL-6 production was observed
and the results are shown in Figures 6.7 and 6.8 respectively. The optimum
concentration of TSST-1 in the presence of individual donor serum was found to be
0.5 pg ml"1.
6.3.4.2 Effect ofsynthetic Lewis antigens on TNF-a and IL-6production
Cells incubated with Lewis8 or Lewisb alone produced similar levels of both TNF-a
and IL-6 compared to the negative control cells which were incubated with medium
alone (Figures 6.9a and b; Figures 6.10a and b).
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Figure 6.7 TNF-a dose response of human buffy coats (n = 3) to different
concentrations of TSST-1 with 5% of homogenous donor serum as a replacement
for FCS ( 0 = no toxin, □ = 0.1 pg ml"1, A = 0.5 pg ml"1, x = 1.0 pg ml"1)
Time (h)
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Figure 6.8 IL-6 dose response of human bufiy coats (n = 3) to different
concentrations of TSST-1 with 5% homogenous donor serum as a replacement for
FCS ( 0 = no toxin, □ = 0.1 pg ml"1, A = 0.5 pg ml"1, x = 1.0 pg ml"1)
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Figure 6.9 Effect of a) Lewis3 and b) Lewisb on induction of TNF-a (n = 5). ( 0 =
cells alone; □ = cells plus toxin (0.5 pg ml"1); A = cells plus Lewis3 0.5 pg ml"1; + =





Figure 6.10 Effect of a) Lewis3 and b) Lewisb on induction of IL-6 (n = 5) ( 0 = cells
alone; □ = cells plus toxin (0.5 pg ml"1); A = cells plus Lewis3 0.5 pg ml"1; + = cells






6.3.4.3 Effect ofsynthetic Lewis antigens on TNF-a and IL-6production in response
to TSST-1
There was no consistent increase or decrease of TNF-a production in response to
any concentration of synthetic Lewisa or Lewisb antigen tested (Figures 6.1 la and b
respectively) at either 6 or 24 h. The lowest levels of TNF-a were observed for toxin
incubated with 0.5 jag ml"1 of the Lewis antigen and the level of TNF-a appeared to
increase with increasing amounts of the Lewis antigen.
There was a significant decrease in IL-6 production in response to TSST-1 for all
concentrations of synthetic Lewis3 tested at both 6 h (0.5 pg ml"1 p=0.003; 5 pg ml"1
p=0.049; 10 pg ml"1 p=0.024) and 24 h (0.5 pg ml"1 p=0.037; 5 pg ml"1 p=0.046; 10
pg ml"1 p=0.041) (Figure 6.12a). There was a significant decrease in IL-6 production
at 6 h by synthetic Lewisb at a concentration of 5 pg ml"1 (p=0.031); however, a
significant increase in IL-6 production was observed at 24 h (p=0.020) by synthetic
Lewis11 at a concentration of 10 pg ml"1 (Figure 6.12b). As with the results for TNF,
lowest levels of IL-6 were observed for 0.5 pg ml"1 of the antigens.
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Figure 6.11 Effect on TNF-a production in response to TSST-1 in the presence of





















Figure 6.12 Effect on IL-6 production in response to TSST-1 in the presence of the
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6.3.5 Effect ofCortisol on TNF-a and IL-6production in response to TSST-1
6.3.5.1 Effect ofCortisol on TNF-a and IL-6production
Preliminary studies examined the effect of Cortisol concentrations (0.62 - 25 jag df1)
on induction ofTNF-a and IL-6 from buffy coat cells. The results for concentrations
< 5 pg dl"1 and > 5 pg dl"1 are shown in Figures 6.13 (n = 9) and 6.14 (n = 7). Cells
incubated with Cortisol produced levels of both cytokines similar to the negative
control cells which were incubated with medium alone.
6.3.5.2 Effect ofCortisol on TNF-a and IL-6production in response to TSST-1
Concentrations of Cortisol ranging from 0.62 to 25 pg dl"1 were used in these
experiments (n = 9 for TNF-a and n = 7 for IL-6) to assess their effects on leukocyte
responses to 0.1 pg ml"1. The results have been divided in to two groups. The first
group included concentrations of Cortisol less than or equal to 5 pg dl"1 which are
representative of levels present in infants at night after the development of circadian
rhythm. The second group included concentrations of Cortisol greater than 5 pg dl"1
representative of concentrations of Cortisol in infants during the day or at night prior
to the development of the circadian rhythm.
Concentrations of Cortisol less than or equal to 5 pg dl"1 did not consistently increase
or decrease TNF-a production over the time period examined. There was a
significant increase in TNF-a at 20 h which was not affected by any concentration
of Cortisol tested. Concentrations of Cortisol greater than 5 pg df1 significantly
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decreased TNF-a production at 12 h (p = 0.005) (Figure 6.15). Concentrations of
Cortisol less than or equal to 5 pg df' did not significantly increase or decrease IL-6
production; however, concentrations of Cortisol greater than 5 pg dl"' significantly
decreased IL-6 production in response to TSST-1 at 12 h (p = 0.019) and 16 h (p =
0.010) (Figure 6.16). IL-6 levels observed with the higher Cortisol levels were
consistently lower than those obtained with < 5 pg dl"1.
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Figure 6.13 Effect ofCortisol alone on TNF-a production from human buffy coats (n
= 9) (DMEM = ♦, TSST-1 = x, Cortisol (< 5 pg dl"1) = Cortisol (> 5 pg df1) =
Time (h)
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Figure 6.14 Effect of Cortisol alone on IL-6 production from human buffy coats (n =
7) (DMEM = ♦, TSST-1 = x, Cortisol (< 5 pg dl"1) = ■, Cortisol (> 5 pg dl"1) = A)
Time (h)
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Figure 6.15 Effect of Cortisol on TNF-a production from human buffy coats




Figure 6.16 Effect of Cortisol on IL-6 production from human buffy coats stimulated




6.4.1 Lewis antigen studies
Non-specific cytokine stimulation of human leukocytes in response to breast milk or
infant formula in the absence of toxin meant that the model could not be used to test
for neutralisation of the toxin. One problem which might affect the studies involving
breast milk is that breast milk contains 1L-6 and TNF-a [Rudloff el al., 1991, Saito
et al., 1991]; however, no TNF-a or IL-6 were detected at time 0 h which might be
due to the effect of pasteurisation. Concentrations of these cytokines are higher in
colostrum compared to mature milk, and other work has suggested that IL-6 present
in human milk is associated with local IgA production in the breast [Saito et al.,
1991], Another problem which might affect studies with infant formula is that it has
been previously suggested that some infant formulas might stimulate human
immune responses [Lambert et al., 1995],
Since both breast milk and infant formula contain Lewis3 and Lewis'1 antigens, the
model was used to test the effects of these on the ability of TSST-1 to induce TNF-a
and IL-6 production. Studies have shown that toxins can bind to Lewis antigens
expressed on monocytes and pre-treatment of monocytes with monoclonal
anti-Lewis3 antibodies inhibited binding of TSST-1 and SEC [Essery et al., 1994;
Essery, 1997],
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Cleary et al\ [1983] suggested that a carbohydrate molecule present in human milk
could protect suckling mice against the E. coli heat-stable enterotoxin and later
work showed that this molecule was a fucosyl containing oligosaccharide [Newburg
et al., 1990], Oligosaccharides from human milk have also been found to inhibit
binding and activity of the E. coli heat stable enterotoxin to human T84 intestinal
cells [Crane et al., 1994], Oligosaccharide-derivatized dendrimers (a hyper-branched
polymer that radiates from a central core) have also been found to inhibit adherence
of cholera toxin and the heat-labile enterotoxin of E. coli to cell-surface
monoganglioside gal(|31-3)galNAc(pi-4)[sialic acid(a2-3)](gal(pl-4)glc|31-
ceramide (GM1) which is present on intestinal epithelial cells [Thompson et al.,
1998],
The oligosaccharides alone did not induce either TNF-a or IL-6 production. For IL-6
at both 6 and 24 h, a significant decrease in IL-6 production in response to TSST-1
was observed for all three concentrations of Lewisa tested. A significant decrease in
IL-6 production was observed at 6 h for 5 pg ml"1 of Lewisb; however, the
significant increase in IL-6 production at 24 h in response to TSST-1 and Lewisb 10
pg mf! was not expected. Work carried out by other groups using fibroblast cells
has found that there are two different pathways of IL-6 production. One is regulated
by activation of protein kinase C [Sehgal et al., 1987] and the second is controlled
by activation of the cAMP dependent signalling pathway [Zhang et al., 1988], It
might be that the Lewisa and Lewisb antigens act to inhibit two independent
pathways of IL-6 production.
183
The consistent results with Lewis3 might reflect the fact that all but about 3 - 5% of
individuals express this antigen; however, the quantities on cells can vary widely.
Non-secretors usually have high levels of Lewis3 and no Lewisb but secretors can
also express high levels of Lewis3. This depends on the efficacy of the fucosyl
transferase coded for by the secretor gene. It might be that non-secretors produce
inflammatory mediators in response to high concentrations of Lewisb. If the donors
used in the buffy coat experiments were non-secretors, this might explain why there
was increased IL-6 production in response to high concentrations of Lewisb.
There was no consistent effect of either Lewis3 or Lewis1' antigens on TNF-a
production. It might be that TSST-1 induces production of TNF-a and IL-6 by two
different pathways.
To investigate this enhancement of IL-6 production, these experiments could be
repeated in relation to quantitative assessment of the level of Lewis antigens on the
leukocytes. For example leukocytes from non-secretors who express only Lewis3
might be stimulated by the higher concentration of Lewisb whereas a secretor might
not be stimulated by either Lewis3 or Lewis1'. It would also be useful to carry out
these experiments using a slightly modified protocol in which TSST-1 was initially
incubated with the appropriate concentration of Lewis3 or Lewisb antigen for 2 h at
37°C before addition to the cells and TNF-a and IL-6 production at 6 and 24 h
measured. Lower concentrations of the antigen also need to be examined as the
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lower levels of TNF-a and IL-6 were noted for the lowest concentrations of the
Lewis antigens tested.
6.4.2 Night-time occurrence ofSIDS
The night-time prevalence of SIDS deaths prompted studies on the physiological
development of infants to explain the association with sleep and the age range
during which the majority of these deaths occur (2-4 months). These studies
identified significant decreases in night-time Cortisol levels closely following the
switch to lower night-time body temperature associated with development of
circadian rhythm. These observations could be highly relevant to the hypothesis that
inflammatory reactions triggered by infection are involved in the events resulting in
death. The range of night-time Cortisol levels found in infants after the switch to the
adult-like night-time temperature rhythm is 0.1 - 7.25 pg df1. The range of Cortisol
levels tested (0.5 - 5 pg df1) were within this range and were insufficient to control
inflammatory responses induced by TSST-1. Levels as high as 10 pg df' were not
found to have any consistent effect on induction of either IL-6 or TNF-a [A1
Madani, 1999],
In various tissues, glucocorticoids have been found to regulate negatively IL-6 gene
expression through a repressive mechanism of IL-6 promoter activity [Takeshita et
al., 1996], Glucocorticoids have been found to do this by repressing the activity of
the transcriptional enhancer NF-kB by a dual mechanism involving protein-protein
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interactions between NF-kB and the glucocorticoid receptor and induction of IkBoc
which terminates the NF-kB response [Wissink et al., 1998],
6.4.3 Peak incidence ofSIDS in the 2-4 month age range
During the 2 - 4 month age range, decreasing levels of maternal antibodies against
bacteria and viruses result in infants being more reliant on their inflammatory
responses to deal with infection. Significant inflammatory responses might be quite
common among infants; however, if the events occur during a period in which the
ability to control these responses is reduced, the result might be SIDS or a "near
miss" episode. Indirect evidence that younger infants have reduced or better
controlled inflammatory responses to micro-organisms comes from a large study
carried out in conjunction with the change in immunisation schedules in Britain.
One of the unexpected findings associated with the change was the significant
decrease in adverse reactions (fever or local inflammatory reactions) to the
diphtheria, pertussis and tetanus vaccine among infants immunised at 2 months
compared with those immunised at 3 months. This was found for both acellular and
whole cell pertussis vaccines [Miller et al., 1997], If, as the work on night-time
levels of Cortisol suggests, younger infants are better able to deal with inflammatory
mediators because of higher Cortisol levels, the new immunisation schedule is
helping to increase levels of antibodies against bacterial toxins during a period in
which infants are better able to handle inflammatory responses.
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Wailoo and colleagues found that infants who share many of the risk factors
associated with SIDS remain in the "immature" developmental stage longer than
those with few risk factors. They suggested that this prolonged developmental stage
might contribute to susceptibility to SIDS. Alternatively, infants who remain in this
developmental stage are better able to control inflammatory responses and benefit
from the extra time to produce active immunity through vaccination or natural
exposure. An example is the observation that Asian infants remain in the immature
stage longer than white infants [Petersen et al., 1994] although the majority are
breast fed. Poverty is strongly associated with SIDS [Blair et al., 1996; Brooke et
al., 1997], In Britain, studies carried out in Birmingham and across the UK found
that most of the Asian families were classified as socially deprived [Farooqi et al.,
1995; Church, 1996]; however, Asian families had a lower incidence of SIDS and
deaths due to respiratory infections compared to white families [Balarajan et al.,
1989],
6.4.4 Conclus ions
Due to non-specific stimulation, it was not possible to determine whether or not
breast milk or infant formula could reduce pro-inflammatory cytokine production in
response to TSST-1. Serum IgG antibodies to TSST-1 and SEC were found to
reduce induction of inflammatory mediators by these toxins [Al Madani, 1999], The
IgA antibodies found in human milk to the toxins [Chapter 5] would be expected to
neutralise the toxins on mucosal surfaces. Lewis antigens are found in breast milk
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and in these studies Lewis3 (but not Lewisb) significantly and consistently decreased
IL-6 production in response to TSST-1.
The findings of this chapter also indicate that Cortisol levels observed during both
the day and at night prior to development of the circadian rhythm would contribute
to control of pro-inflammatory cytokines; however, levels observed at night after
development of the circadian rhythm pattern might not be sufficient to control
production of TNF-a or IL-6. If this switch to circadian rhythm occurs early when
maternal antibodies are still present or an infant is receiving IgA in breast milk, or
later when immunisation or natural exposure has induced protective antibodies,
inflammatory responses to common infections would be better controlled. If the
switch occurs during the period in which maternal antibodies are very low, an infant
is formula fed or the infant has not produced its own active immunity, uncontrolled
inflammatory responses produced against micro-organisms or their products might
precipitate the series of events leading to a SIDS death.
Chapter Seven
Detection of TNF-a and IL-6 gene expression
by reverse transcriptase - PCR (RT-PCR)
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7.1 Introduction
Bacterial toxins and the inflammatory mediators they induce have been implicated
in the mechanism of a SIDS death. Although toxins have been detected in tissues
taken from some SIDS infants and inflammatory mediators have been observed,
there are no studies which have examined specimens for both the toxins and for
evidence of the inflammatory responses.
Blood samples taken at autopsy often arrive too late for accurate screening for
cytokines. An alternative approach would be to examine tissues for gene expression.
This would need to be correlated to the interval between death and autopsy and the
method of storage.
Human leukocytes consistently produced the pro-inflammatory cytokines TNF-a
and IL-6 [Chapter 6] in response to TSST-1. The cells from these experiments had
been stored at -70°C. The aim of this part of the project was to carry out preliminary
studies with the stored cells to develop a reverse-transcriptase polymerase chain
reaction (RT-PCR) technique to detect messenger RNA (mRNA) for TNF-a and
IL-6. A positive P-actin control was included. This gene is constitutively expressed
and mRNA should be detectable at all times.
For detection of changes of gene expression by RT-PCR, expression must be
controlled at the level of transcription. There is evidence from nuclear run-on
transcription assays that TSST-1 can cause transcriptional activation of TNF-a gene
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expression in human peripheral blood monocytes and the monocytic cell culture
line, THP-1. These studies found that non-stimulated primary human monocytes
have very low levels of TNF-a mRNA but upon addition of TSST-1, there is de
novo gene transcription and a rapid increase in steady state TNF-a mRNA levels
[Trede et al., 1991], Further studies indicated that TNF-a gene expression is tightly
regulated at both the transcriptional and translational levels by MHC-class II
ligands. Upon TSST-1 binding to MHC-class II molecules, there is a fast peak
transient induction of TNF-a mRNA and nuclear run-on assays indicated that there
was a 4-fold increase in the rate of transcription which did not require de novo
protein synthesis. Induction of TNF-a transcripts in monocytes by TSST-1 has been
found to be dose-dependent with a plateau ofTNF-a expression reached at 1 pg ml"1
of TSST-1 [Espel etal., 1996],
TSST-1 has been found to induce rapid activation of the transcriptional enhancer
NF-kB [Trede et al., 1993], One possible method of transcriptional activation of
TNF-a by superantigens was investigated by studies involving THP-1 cells and
SEA. In these experiments, SEA induced NF-kB activation and NF-kB bound
strongly to the TNF-a promoter at the k3 site which is the most proximal of the
three putative NF-kB sites (Figure 7.1). This results in transcriptional activation of
the TNF-a gene [Trede et al., 1995], Induction of TNF-a gene transcription in
monocytes by TSST-1 has also been found to involve activation of protein kinase C
[Trede et al., 1994],
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IL-6 has a central role in the host defence mechanism and requires an "early"
response. In accordance with this, there is evidence that IL-6 is transcriptionally
induced in a variety of tissues in response to a variety of substances which trigger
inflammation. These include bacterial endotoxins, virus infections, tissue damage
inducing agents, inflammation associated cytokines such as IL-ip, TNF-a and
interferons [Faggioli et ai, 1997].
One potential problem with the application of these studies to SIDS infants is that
many tissues taken from these infants at autopsy are stored in formalin which is not
a good fixative for nucleic acids.
The aims of this part of the study were:
1) to develop an RT-PCR technique to detect TNF-a and IL-6 gene expression in
the stored leukocytes which had been stimulated with TSST-1;
2) to determine the effect of freezing and formalin fixation on mRNA detection.
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Figure 7.1 The human TNF-a promoter and the k3 site [Trede et al., 1995],
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7.2 Materials and methods
7.2.1 Extraction ofRNA
Two different RNA extraction protocols were used and are described in 7.2.1.1 and
7.2.1.2. For RNA extraction, all solutions were prepared using Millipore pure water
which had been treated with 0.1% diethyl pyrocarbonate (DEPC) (Sigma). To
prepare the water, 0.1% DEPC was added to the water, incubated overnight at 37°C
and then autoclaved to remove all traces of DEPC. All glassware used was
incubated overnight at 37°C with a 0.1% DEPC solution and then autoclaved. All
chemicals used had been tested for the presence of any RNases, DNases and
proteases and were certified free.
RNA was extracted from leukocytes (2 x 106 ml"1) which had been used in the
model system developed in Chapter 6. These cells had been stored in freezing
medium (100 ml contains: 50 ml FCS; 10 ml dimethylsulphoxide (Sigma); 40 ml
RPMI medium) at -70°C. Before RNA extraction was carried out, the cells were
thawed, washed in DMEM medium (stored at 4°C) by centrifugation at 250 x g for
15 min at 4°C to remove all traces of the freezing medium and the supernatant was
carefully removed without disturbing the cell pellet. The cells were stored on ice.
7.2.1.1 RNA extraction by guanidinium thiocyante phenol-chloroform extraction
The method of Chomczynski et ah, [1987] was adapted for these experiments. All
solutions were stored on ice before use.
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Denaturing solution D (200 jul) containing 4M guanidine-thiocyanate (Sigma), 25
mM sodium citrate (pH 7), 0.5% (w/v) sarcosyl and 0.1 M 2-mercaptoethanol
(Sigma) was added to the cells. The cells were resuspended and transferred to 2.0 ml
Eppendorf tubes (Greiner). Sodium acetate (2M, pH 4) (20 pi) (Sigma) and
phenol-chloroform (200 pi) (Sigma) were added and the contents mixed by
inversion after each addition. The tubes were shaken vigorously for 10 sec and
stored on ice for 15 min. The tubes were centrifuged at 10,000 x g for 20 min at 4°C
and the upper aqueous layer containing the RNA was transferred to a clean
Eppendorf tube. This step was then repeated. Isopropanol (200 pi) was added and
the tube stored at -20°C for 1 h. The RNA was precipitated by centrifugation at
10,000 x g for 20 min at 4°C. The pellet was resuspended in 60 pi of solution D and
60 pi of isopropanol and stored at -20°C for 1 h. After centrifugation at 10,000 x g
for 20 min at 4°C, the pellet was washed with 200 pi of 75% ethanol and
centrifuged as described. Excess ethanol was removed and the pellet was allowed to
dry. The pellet was resuspended in 50 pi of DEPC-treated water and stored at -70°C
until use.
7.2.1.2 Extraction ofRNA by the Qiagen RNeasy Mini Kit
The RNeasy mini protocol for the isolation of total RNA from animal cells was
used. All steps were carried out at room temperature. All solutions and RNase free
water used were contained in this kit and the method was carried out as follows.
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The cells were prepared as described and the cell pellet loosened by flicking the
tube. To disrupt the cells, Buffer RLT (350 pi) containing (3-mercaptoethanol
(Sigma) (10 pi per 1 ml of Buffer RLT) were added and the mixture pipetted until
no cell clumps were visible. To homogenise the samples, the lysate was added to a
QIAshredder column (Qiagen) and centrifuged for 2 min at 8,000 x g. One volume
(350 pi) of 70% ethanol was added to the homogenised lysate and mixed by
pipetting. The lysate (700 pi) was added to an RNeasy spin column sitting in a 2.0
ml collection tube and centrifuged for 15 sec at 8,000 x g. The flow-through was
discarded. Buffer RW1 (700 pi) was added to the RNeasy column for 5 min and
then the tube centrifuged for 15 sec at 8,000 x g. The flow-through and collection
tube were discarded. The RNeasy spin column was transferred to a clean 2.0 ml
collection tube and 500 pi of Buffer RPE was added to the RNeasy column. After
centrifugation for 15 sec at 8,000 x g, the flow-through was discarded and a further
500 pi of Buffer RPE was added to the column. To completely dry the membrane,
the column was centrifuged for 2 min at 8,000 x g. The column was transferred to a
new 1.5 ml collection tube and 30 pi of RNase-free water added to the membrane.
To elute the RNA, the column was centrifuged for 1 min at 8,000 x g. The RNA
preparation was stored at -70°C until use.
7.2.3 Quantitation ofRNA
This was carried out by UV spectrophotometry. The spectrophotometer was set at
260 nm and blanked using a water alone control. 5 pi of the RNA preparation was
added to 995 pi of distilled water and the A26o determined. The concentration of
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RNA in the preparation was calculated using the standard value that RNA at a
concentration of 40 pg ml"' has an OD of 1 [Sambrook et al., 1989],
7.2.4 DNase digestion ofRNA preparations andRNA cleanup
7.2.4.1 DNase digestion ofRNA preparations
The DNase, DNase reaction buffer (supplied as a 10 times concentrate) and stopping
solution were obtained from Promega. The reaction mixture consisted of the
following: 22.5 pi of the RNA preparation; 1.5 pi of RNase inhibitor; 3 pi of 10 x
DNase reaction buffer; 3 pi of DNase (final volume of 30 pi). After mixing, the
reaction mixture was overlaid with 50 pi of mineral oil and incubated for 30 min at
37°C; 3 pi of stopping solution was added and the mixture incubated at 65°C for 10
min.
7.2.4.2 RNA cleanup protocol
The RNeasy Mini Kit (Qiagen) was used to purify the RNA from the components of
the DNase digestion. All solutions and RNase free water used were contained in this
kit and the method was carried out as follows.
RNase free water (70 pi) was added to the DNase digested preparation. Buffer RLT
(350 pi plus 10 pi of P-mercaptoethanol per 1 ml of Buffer RLT) was added and the
samples mixed thoroughly. Ethanol (70% v/v) (250 pi) was added and the mixture
mixed well by pipetting. The samples (700 pi) were applied to the RNeasy spin
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column and the column centrifuged for 15 sec in a bench top centrifuge at 8,000 x g.
The flow through and collection tube were discarded and the column added to a new
collection tube. Buffer RPE (500 pi) was added and the column centrifuged for 15
sec at 8,000 x g. The flow through was discarded and 500 pi of buffer RPE added.
The column was centrifuged for 2 min at 8,000 x g. The RNA was eluted by
addition of 30 pi RNase free water and the column centrifuged at 8,000 x g for 1
min. The digested RNA was stored at -70°C.
7.2.5 RT-PCRfor TNF-a, IL-6 and [Pactin
The RT-PCR core kit (Perkin-Elmer) was used according to the provided
instructions. After thawing, all components were vortexed and stored on ice until
use. A positive control of (3-actin and negative controls in which no RNA or no
reverse transcriptase had been added, were included.
For reverse transcription (RT), a master mix was prepared and contained the
following in each reaction: 4 pi of 25 mM MgCl2 solution; 2 pi of 10 x PCR buffer
II (supplied at 10 times the working concentration); 1 pi of DEPC-treated water; 2
pi dGTP (10 mM); 2 pi dATP (10 mM); 2 pi dTTP (10 mM); 2 pi dCTP (10 mM);
1 pi of oligo d(T)16 (50 pM); 1 pi of RNase inhibitor (20 U pf1); 1 pi of Murine
Leukemia Virus Reverse Transcriptase (MuLV RT) (50 U pf1). The master mix (18
pi) was aliquoted into individual thin-walled PCR tubes (Greiner) and 2 pi of the
RNA extract was added to give a final reaction volume of 20 pi. The addition of
DEPC water could be omitted if 3 pi of the RNA extract was to be added. The
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reaction was overlaid with 50 jlx! ofmineral oil (Sigma) and the RT conditions used
were: 42°C for 15 min; 99°C for 5 min; 15°C for 5 min. The PCR machine used was
a THC-2 model (Tecan).
For PCR, a master mix was prepared which contained per reaction: 4 pi of 25 mM
MgCl2 solution; 8 pi of 10 x PCR buffer H; 65.5 pi of sterile Millipore pure water;
0.5 pi of AmpliTaq DNA polymerase (5 U pf1). This mixture (78 pi) was aliquoted
into individual thin-walled tubes and 2 pi of the appropriate specific primer added.
The RT (20 pi) reaction was added to give a final volume of 100 pi. After mixing,
the reaction was overlaid with 50 pi of mineral oil and the PCR conditions used
were: 94°C for 5 min; 60°C for 5 min. These were followed by 25 cycles for IL-6
and P-actin and 35 cycles for TNF-a of 72°C for 1 min 30 sec, 94°C for 45 sec and




















































TNF-a, IL-6 and P-actin primers were all obtained from (Stratagene). The primers
were reconstituted in 100 pi of 5 mM Tris.HCl and 0.1 mM EDTA solution and
stored in 20 pi aliquots at -20°C. The sequences are shown in Table 7.1. The
primers have been designed to span an intron-exon boundary and this should ensure
that an mRNA derived PCR product is obtained.
7.2.7 Detection ofRT-PCRproducts
7.2.7.1 Preparation ofsamples
RT-PCR samples (20 pi) were added to 4 pi of gel loading buffer (Sigma) (supplied
as a 6 times concentrate). Molecular weight (MW) markers 0X174 Hae III (Sigma)
(1.5 pi) were added to 2 pi of gel loading buffer (supplied at 6 times the working
concentration) and 10 pi Millipore pure water. The molecular weight markers had
band sizes of 72, 118, 194, 234, 271,281,310, 603,872, 1078 and 1353 base pairs.
7.2.7.2 Electrophoresis ofsamples
The RT-PCR products were run out on a 2% agarose gel (Pharmacia) containing 0.5
x TBE buffer (Gibco-BRL) (supplied at 10 times the working concentration: TOM
Tris, 0.9M Boric Acid, 0.01M EDTA). A Jencon HU13 Midi Horizontal
Electrophoresis Unit was used and the electrophoresis buffer was 1 x TBE. The gel
was run at 150 V for 1 h 15 min and then stained for 10 - 15 min in an ethidium
bromide solution containing 150 pi of a 1 mg ml"1 stock in 300 ml of distilled water.
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7.3.1 DNase digestion ofRNA preparations
This was done to remove all traces of contaminating DNA. DNA contamination was
detected in the P-actin RT-PCR reactions when the samples were not DNase
digested and no reverse transcriptase was added. DNA contamination could not be
detected in either the TNF-a or IL-6 RT-PCR experiments regardless of whether or
not the RNA preparations had been DNase treated since a band was only detected in
tubes where reverse transcriptase had been added but not in its absence.
One problem which was encountered was that when the RNA preps were DNase
digested and then purified, although RNA could be detected by spectrophotometry,
the TNF-a and P-actin bands appeared very faint on the gel even with 3 pi of the
appropriate RNA preparation added to the reaction mixture. In future studies, a
greater number of cells could be stimulated to increase the starting concentration of
RNA. This would result in a greater yield of RNA following DNase digestion and
sample cleanup.
7.3.2 Optimisation ofRT-PCR conditions
Various concentrations of RNA and cycle numbers were tested to try to reduce
smearing of the bands in the gel. Tubes were set up for TNF-a, IL-6 and P-actin
with different concentrations of RNA (2 pi) and PCR was carried out for 25 or 35
cycles. The optimal number of cycles was 25 for P-actin with an RNA concentration
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of 75 ng added to the RT reaction. For IL-6, an RNA concentration of 176 ng added
to the RT reaction and 25 cycles was optimal. For TNF-a an RNA concentration of
80 ng added to the RT reaction and 35 cycles was optimal.
To also reduce band smearing, a higher magnesium concentration was tried for both
RT and PCR (5 pi of MgCL solution added instead of 4 pi); however, the
concentration recommended by the RT-PCR kit (Perkin-Elmer) with the appropriate
concentration ofRNA and cycle number was found to be the most successful.
7.3.3 Time course ofexpression for TNF-a and IL-6
RNA extractions were carried out on cells to which no toxin had been added
(negative controls) and on cells to which toxin was added. The cells were collected
and frozen at -70°C at the following times: 0, 3, 6, 9, 12, 16, 20 and 24 h. The
presence of both TNF-a and IL-6 mRNA was detected at 3 and 6 h only. The results
are shown in Figures 7.2a and b and 7.3a and b. Gene expression was detected
before maximum cytokine production in the supernatant was observed (6-9 h for
TNF-a and 16 h for IL-6) and this was expected since peaks in gene expression are
observed before peaks in production.
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7.3.4 Non-specific stimulation ofRNA production
There was some expression of TNF-a and IL-6 mRNA in cells which had not been
incubated with toxin. This was more evident when foetal calf serum had been used
in the assay system but could be reduced when homologous serum from the cell
donor (Figure 7.4) or medium alone was used. When medium alone was used in the
model system TNF-a but no IL-6 could be detected in the supernatant. At the level
of gene expression, TNF-a but no IL-6 mRNA could be detected.
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Figure 7.2
a) Time course of TNF-a mRNA production. Lane 1) MW markers 0X174 Hae III; 2) time 0 h no
TSST-1; 3) time 0 h plus TSST-1; 4) time 3 h no TSST-1; 5) time 3 h plus TSST-1; 6) time 6 h no
TSST-1; 7) time 6 h plus TSST-1; 8) time 9 h no TSST-1; 9) time 9 h plus TSST-1; 10) time 12 h no
TSST-1; 11) time 12 h plus TSST-1; 12) time 24 h no TSST-1; 13) time 24 h plus TSST-1; 14) 0-
actin positive control; 15) negative control; 16) MW markers 0X174 Hae III
b) Time course ofTNF-a detection in cell supernatant
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Figure 7.3
a) Time course of IL-6 mRNA production. Lane 1) MW markers 0X174 Hae III; 2) time 0 h no
TSST-1; 3) time 0 h plus TSST-1; 4) time 3 h no TSST-1; 5) time 3 h plus TSST-1; 6) time 6 h no
TSST-1; 7) time 6 h plus TSST-1; 8) time 9 h no TSST-1; 9) time 9 h plus TSST-1; 10) time 12 h no
TSST-1; 11) time 12 h plus TSST-1; 12) time 24 h no TSST-1; 13) time 24 h plus TSST-1; 14) (3-
actin positive control; 15) negative control; 16) MW markers 0X174 Hae III
b) Time course of IL-6 detection in cell supernatant
Time (h)
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Figure 7.4 RT-PCR on cells using donor serum Lane 1) MW markers 0X174 Hae
III; 2) time 0 h, TNF-a plus RT; 3) time 0 h, TNF-a minus RT; 4) time 0 h, P-actin;
5) time 6 h no TSST-1, TNF-a plus RT; 6) time 6 h no TSST-1, TNF-a minus RT;
7) time 6 h no TSST-1, P-actin; 8) time 6 h plus TSST-1, TNF-a plus RT; 9) time 6
h plus TSST-1, TNF-a minus RT; 10) time 6 h, plus TSST-1 P-actin; 11) MW
markers 0X174 Hae III
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7.3.5 Effect offreezing andformalinfixation on detection ofTNF-o and IL-6 mRNA
7.3.5.1 Effect offreezing on mRNA detection
RNA extraction was carried out on cells which had been stored at -70°C for one
year and two months and on cells which had been stored for 4 months. To overcome
the problem of faint band detection after DNase digestion and clean up, and to
ensure that any TNF-a band being detected was due to the presence of mRNA and
not contaminating DNA, three different RT-PCR reactions were carried out for each
sample: TNF-a primers plus reverse transcriptase added to the RT mixture; TNF-a
primers minus reverse transcriptase added to the RT mixture; P-actin primers plus
reverse transcriptase added to the mixture. To the TNF-a tubes, 3 pi of the
appropriate RNA preparation were added whilst to the P-actin reactions, 2 pi of
RNA and 1 pi of DEPC-treated water were added. Bands were detected for TNF-a
in the tubes where RT had been added for both sets of cells but not in the tubes
where no RT had been added. This indicates that the band was produced due to the
presence of TNF-a mRNA and not due to any contaminating DNA. For P-actin,
bands were detected for both sets of cells. The results are shown in Figure 7.5.
7.3.5.2 Effect offormalin on mRNA detection
Cells which had been stimulated with TSST-1 and incubated for 3 or for 6 h were
pelleted by centrifugation, the freezing medium removed and 500 pi of 0.1% or 4%
buffered formalin (pH 6.7-7.33 (BDF1) prepared in sterile PBS (pH 7.2)) added. Half
the samples were left at room temperature whilst the other half were stored at 4°C.
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Cells were stored under these conditions for 2 or 4 weeks after which RNA
extraction was carried out.
Cells which had been stored for 2 weeks in 0.1% and 4% formalin at room
temperature and at 4°C were used for RT-PCR. For each cell sample, three different
RT-PCR reactions were carried out as described in 7.3.4.1. No TNF-a or (3-actin
bands were detected for any condition tested. The results are shown in Figure 7.5.
Upon RNA quantitation by UV spectrophotometry, either no RNA or very low
levels (less than one quarter of that detected in the frozen samples) could be
detected.
From these results, it was concluded that using the developed method, gene
expression could only be detected in frozen cells but not in cells which had been
stored in formalin.
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Figure 7.5 The effect of freezing and formalin on mRNA detection. Lane 1) MW
markers 0X174 Hae III; lanes 2-4, cells stored in 0.1% formalin at 4°C, TNF-a
plus reverse transcriptase, TNF-a minus reverse transcriptase and P-actin
respectively; lanes 5-7, cells stored in 0.1% formalin at room temperature, TNF-a
plus reverse transcriptase, TNF-a minus reverse transcriptase and P-actin
respectively; lanes 8-10, cells stored in 4.0% formalin at 4°C, TNF-a plus reverse
transcriptase, TNF-a minus reverse transcriptase and P-actin respectively; lanes 11 —
13, cells stored in 4.0% formalin at room temperature, TNF-a plus reverse
transcriptase, TNF-a minus reverse transcriptase and P-actin respectively; lanes 14 —
16, cells stored at -70°C for 4 months, TNF-a plus reverse transcriptase, TNF-a
minus reverse transcriptase and P-actin respectively; lanes 17 - 19, cells stored at -
70°C for one year and 2 months, TNF-a plus reverse transcriptase, TNF-a minus
reverse transcriptase and P-actin respectively; 20) MW markers 0X174 Hae III
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7.4 Discussion
The experiments carried out for this part of the project were preliminary studies to
try to develop a method for detection of gene expression in the tissues of SIDS
infants.
Initial experiments involved determining the optimum cycle number and
concentrations ofRNA to use. The RT-PCR method was found to be more sensitive
for detection of TNF-a mRNA than for IL-6 mRNA. A time course of TNF-a and
IL-6 gene expression was then carried out. Expression of mRNA for both cytokines
was detected at 3 and 6 h.
A higher number of cells should be used in future experiments. This would increase
the initial RNA yield and allow the preparation to be DNase digested to remove any
contaminating DNA. This would remove the problem of a (3-actin band being
observed when the RNA preparations were not DNase digested and no RT was
added to the RT reaction mixture. This problem was not observed for either TNF-a
or IL-6. To overcome the problem of DNA contamination observed for (3-actin, in
the preliminary studies, tubes were set up for TNF-a in the presence and absence of
reverse transcriptase so that if a band was detected in the plus RT tube but not in the
minus RT tube, it was due to the presence ofmRNA for the TNF-a gene and not due
to the presence of any contaminating DNA.
212
Foetal calf serum gave much higher levels of background stimulation ofmRNA for
both cytokines than either donor serum or medium alone. From Chapter 6, TNF-a
but not IL-6 production was detected in supernatants from cells in which the assay
medium was medium alone. RNA extraction was carried out on these cells and only
TNF-a expression could be detected. For future in vitro studies, donor serum should
be used in the assay system if both TNF-a and IL-6 gene expression are to be
detected and this should help to keep non-specific background to a minimum.
TNF-a RNA could still be detected in cells which had been stored at -70°C for more
than one year. No RNA was detected in cells which had been stored in either 0.1 %
or 4% formalin at room temperature or at 4°C.
In conclusion, these preliminary studies have developed a RT-PCR system to detect
TNF-a and IL-6 gene expression. A number of problems were encountered and have
been described. These would have to be taken in to consideration if this work was to
be extended to tissue samples. RNA could still be detected in cells stored at -70°C
but not in cells stored in formalin. In relation to tissues from SIDS infants, it can be
suggested that either fresh or frozen tissue would need to be used to assess the
presence of any cytokine mRNA. The detection of gene expression even in these
tissues might depend on the interval between death and autopsy and the amount of
tissue available for extraction. The studies were carried out with leukocytes in






8.1 Results ofthe study in relation to the original objectives
The role of breast feeding in protecting infants against SIDS has been suggested to
be related to nutritional requirements for brain development [Williams, 1994;
Schulze et al., 1995], In this study, breast feeding was examined in relation to the
hypothesis that some SIDS deaths are due to uncontrolled inflammatory responses in
response to infectious agents and / or cigarette smoke during a time in which infants
are less able to control their inflammatory responses [Blackwell et al., 1995a],
The specific objectives of the study were to address the following questions:
1) Do the methods used in most binding studies reflect the interactions at the
mucosal surface?
2) What were the effects of human milk and infant formula on binding of a
respiratory and gastrointestinal pathogen implicated in SIDS to epithelial cells?
3) What were the effects of oligosaccharide components on bacterial binding to
epithelial cells?
4) Are there antibodies to the toxins implicated in SIDS present in human milk?
5) Can components in human milk reduce the ability of the staphylococcal toxins
to induce inflammatory mediators?
6) Are the night-time levels of Cortisol sufficient to control inflammatory responses
to staphylococcal toxins?
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8.1.1 Effect ofexperimental method on bacterial binding studies
The hypothesis proposed in this section was that breast milk, compared to infant
formula, is better able to reduce the density of colonisation of epithelial cells by S.
aureus and C. perfringens. This section had two aims: 1) to compare the ability of
human milk and infant formula for their effect on binding of S. aureus and C.
perfringens to epithelial cells; 2) to assess the effects of synthetic Lewis3 or Lewish
antigens on bacterial binding.
Two different methods were used in the bacterial binding studies. Most binding
studies employ the conventional experimental or in vitro approach in which the
bacteria are treated with the potential inhibitor before they are added to target cells.
The in vitro method is more useful for identifying components involved in binding
and inhibition of binding. The in vivo approach was developed to try to simulate
more closely the competitive interactions between cells, bacteria, human milk,
infant formula or Lewis antigens that occur on mucosal surfaces.
For studies involving breast milk and infant formula, significantly different results
between the two methods were obtained for both S. aureus and C. perfringens. With
the in vivo method, breast milk enhanced bacterial binding to cells whilst infant
formula inhibited binding. In contrast with the in vitro method, both breast milk and
infant formula caused enhanced bacterial binding to cells. Enhancement of binding
was found to be due to bacterial aggregation and greater enhancement of binding
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was observed for the in vitro method because the bacteria had longer to aggregate
before addition to the epithelial cells.
8.1.2 The effects of human milk and infant formula preparations on bacterial
binding
The results obtained for the binding studies involving human milk and infant
formula were the opposite of the original hypothesis. For both S. aureus and C.
perfringens, regardless of method, breast milk caused bacterial aggregation and
enhanced binding. Based on these results, it can be suggested that protection
associated with breast feeding in relation to SIDS could be due partly to enhanced
clearance of bacterial aggregates. Bacterial aggregates would be more readily
engulfed by phagocytes than single bacteria resulting in greater bacterial clearance.
A second mechanism for protection might be inhibition of binding by free
oligosaccharides. The presence of higher quantities of Lewis antigens in breast milk
compared to infant formula might also act to reduce binding. This was examined in
the next set of experiments.
8.1.3 The effects ofoligosaccharides in human milk on bacterial binding
The Lewis3 antigen has been found to be a receptor for S. aureus and expression of
the antigen parallels the peak in isolation of S. aureus from infants in the 2 - 4
month age range. Human milk has a unique content of free oligosaccharides and
glycoconjugates that act as analogues of epithelial cell receptors. These can bind
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bacterial toxins or adhesins and reduce the ability of bacteria to colonise epithelial
surfaces [Andersson et al., 1986; Goldman, 1993],
The synthetic Lewis3 and Lewis'1 antigens inhibited binding of both S. aureus and C.
perfringens in a dose dependent manner. This was observed with both the in vivo
and in vitro methods. Lower antigen concentrations were required to cause
maximum inhibition of binding using the in vitro method. This is because in the in
vitro method there is direct blocking of the bacterial adhesins whilst with the in vivo
method, the bacteria can either bind to the Lewis antigens on the cell's surface or to
the Lewis antigens in solution.
Breast milk contains much higher levels of Lewis antigens compared to infant
formula or cows' milk. The next set of studies investigated the hypothesis that the
inhibitory activity of infant formula observed with the in vivo method might be
increased by addition of Lewis antigens to formula. Although inhibition of binding
was increased upon addition of Lewis antigens to formula, the decrease in binding
was not significant. It might be that higher concentrations of Lewis antigens would
need to be added to infant formula before a significant difference in inhibition of
binding was observed.
8.1.4 The presence ofantibodies in human milk, infant formula and cows' milk
Bacterial toxins produced on mucosal surfaces have been proposed to precipitate the
series of events leading to a SIDS death. A second protective mechanism of breast
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feeding might be the presence in breast milk, but not in infant formula, of antibodies
against bacterial toxins implicated in SIDS.
Human IgA antibodies against the staphylococcal toxins TSST-1 and SEC and C.
perfringens enterotoxin A were detected in breast milk but not in infant formula.
Different human milk samples contained different antibody levels. These different
levels of protective antibodies might confer different degrees of protection to an
infant against bacterial toxins.
Antibody levels against TSST-1 and SEC were compared with information
regarding isolation of S. aureus from the mother's nose or throat. S. aureus was
isolated from around two thirds of the women whose milk samples had levels of IgA
against TSST-1 or SEC greater than or equal to the mean; however, this difference
was not significant compared to the isolation rate from women whose milk samples
were below the mean. Some samples were found to have low levels of specific
antibody to TSST-1 and / or SEC and had been taken when S. aureus was isolated
from the mother. Possible explanations for this observation are that S. aureus
isolated from these mothers did not produce the relevant toxins or that the mothers
were recently colonised and had not yet developed IgA to the toxins.
IgGi is the main immunoglobulin involved in the mucosal immune system of
ruminants [Lascelles et al., 1986], and IgGj that bound TSST-1, SEC and CEA was
detected in cows' milk but not in any of the infant formula preparations, or human
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milk samples tested (the negative controls). This implies that formula fed infants
receive no protective mucosal antibodies either human or bovine until they produce
their own secretory IgA or they are given fresh cows' milk.
8.1.5 Neutralisation of TSST-1 's activities by human milk or the synthetic Lewis
antigens
Studies with breast milk or infant formula could not be carried out due to non¬
specific stimulation of cells treated with breast milk or formula in the absence of
toxin. Some of the staphylococcal toxins bind to Lewis antigens on monocytes
[Essery et a/., 1994; Essery, 1997], Since Lewis3 and Lewisb antigens are present in
both human milk and infant formula, the model was used to test their effects on
TNF-a and IL-6 production in response to TSST-1. No consistent effect on TNF-a
production in response to TSST-1 was found for any concentration of Lewis3 or
Lewis'1 antigen tested. For IL-6, at both 6 and 24 h, a significant decrease in IL-6
production in response to TSST-1 was observed for all concentrations of Lewis3
tested. A significant decrease in IL-6 production was observed for Lewis11 (5 pg mF1)
but at 24 h, a significantly increased response to TSST-1 and Lewis'1 (10 pg ml"1)
was observed. This was not expected. The consistent results obtained with Lewis3
but not with Lewisb might reflect the fact that all but about 3 - 5% of individuals
express this antigen. Non-secretors usually have high levels of Lewis3 but secretors
can also express high levels of Lewis3. It might be that TSST-1 induces production
of TNF-a and IL-6 by different pathways and this might explain the effect of Lewis3
on IL-6 production but not on TNF-a production. Further evidence for this
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alternative pathway is provided by the fact that IL-6 production in response to
TSST-1 can only be detected in the presence of serum (either FCS or donor). A
recent study found that microbial superantigens stimulate T cells by cross-linking
the MHC II molecule on accessory cells with the V|3 region of the T cell receptor;
however, some superantigens including TSST-1 have been found to stimulate T
cells by a cytokine pathway. The study found that production of IL-1 and IL-6 were
induced in monocytes by all superantigens whereas TNF-a was induced in T cells
and by some superantigens, also in monocytes [Rink el al., 1997],
8.1.6 Night-time prevalence ofSIDS and Cortisol levels
Most SIDS deaths occur during the early hours of the morning and there is a
significant decrease in night-time Cortisol levels the week following the switch to an
adult-like night-time temperature pattern. These observations are highly relevant to
the hypothesis that inflammatory responses triggered by infection are involved in
events which lead to a SIDS death since lower levels of the anti-inflammatory agent
Cortisol means that infants are less able to control their inflammatory responses.
In the model system, concentrations ofCortisol (0.5 - 5 pg df1) which were intended
to represent those observed in infants at night after the development of circadian
rhythm were insufficient to control inflammatory responses (TNF-a and IL-6)
induced by TSST-1. Concentrations of Cortisol greater then 5 pg dF1 which were
intended to represent concentrations observed in infants during the day and at night
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prior to the change significantly decreased TNF-a and IL-6 production at 12 h and at
12 and 16 h respectively.
8.1.7 RT-PCR to detect gene expression
These were preliminary studies to try to devise methods to detect gene expression in
the tissues of SIDS infants. Samples often arrive too late to detect cytokine
production in the blood, especially if the cytokine is unstable. For example, IL-6 is
stable and could be detected whilst TNF-a is often very difficult to detect.
Messenger RNA transcripts for TNF-a and IL-6 were detected at 3 and 6 h only. The
RT-PCR methods were much more sensitive for detection of TNF-a mRNA
compared with IL-6. To improve the method, the numbers of cells used could be
increased. This would increase the final yield of RNA. Bands could be detected in
the P-actin control wells even when no reverse transcriptase had been added. To
overcome this problem, all RNA preps should be DNase digested prior to use. An
increased RNA concentration would allow DNase digestion and clean up using the
Qiagen RNA isolation kit to be carried out and leave sufficient quantities of RNA
for use in RT-PCR. Foetal calf serum was found to give high background
stimulation of mRNA in the absence of toxin. This was reduced in cells where
homologous donor serum or medium alone had been used in the assay although the
presence ofmedium alone was only suitable for detecting TNF-a gene expression.
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This section also investigated the effects of freezing (stored at -70°C) and formalin
fixation (0.1% and 4%) on mRNA detection since tissues from most SIDS infants
have been stored in formalin. Cells were stored in 0.1% and 4% buffered formalin
for 2 and 4 weeks at 4°C and at room temperature and then an RNA extraction
carried out. No TNF-a or P-actin bands were detected using the 2 week RNA
preparations. Both TNF-a and P-actin bands were observed with cells stored for a
short or longer period of time at -70°C. The method might be applied to
examination of frozen tissues from SIDS infants and comparison groups. While
staphylococcal toxins have been detected in both frozen and formalin fixed tissues
[Zorgani et al., 1999], only frozen tissues would be appropriate for studies for
detection of both toxins and mRNA of inflammatory mediators.
8.2 Results in relation to other studies
8.2.1 Hypotheses proposed to explain the mechanism ofa SIDS death
A number of different hypotheses have been proposed to explain the mechanism of
a SIDS death (Table 1.2). There is an increasing body of evidence to support the
hypothesis that SIDS has an underlying infectious cause which can result in a SIDS
death due to uncontrolled inflammatory responses. The common bacterial toxin
hypothesis was proposed by Morris et al\ [1987] and both toxigenic bacteria and
their toxins have been isolated from SIDS infants. Virus infection has been
implicated in SIDS [Howatson, 1992] and this might increase an infant's
temperature to the levels required for induction of superantigenic toxin production
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[Molony et al., 1999], Hypoglycaemia has also been proposed as a hypothesis for
S1DS. Such metabolic problems would be exacerbated during times of stress such as
minor infections [Burchell et al., 1992], Prolonged sleep apnoea has been proposed
as another mechanism of a SIDS death. Infections might result in increased
production of IL-1 and it has been suggested that IL-1 can cause prolonged sleep
apnoea [Guntheroth, 1989], TNF production in response to toxins can induce a
hyperthermic response which might contribute to very high temperatures observed
in some SIDS deaths [Sunderland et al., 1981], TNF can cause cardiac arythmias
and reduce both myocardial contractility and vascular smooth muscle tone [Stevens
etal., 1993],
A number of hypotheses that have now been disproved. These include anaphylaxis
in response to cows' milk since no IgE response was detected in SIDS infants. There
is not much evidence to support a role for common drugs, poisons, carbon monoxide
or lead. It has also been found that vaccination, rather than increasing the risk of
SIDS as originally thought, decreases the risk.
8.2.2 Epidemiology
A number of epidemiological and case-control studies have been carried out to
investigate the relationship between breast feeding, bottle feeding and SIDS [Ford et
al., 1993; Gilbert et al., 1995], A major problem with these studies is that
contradictory results have been obtained. In general, the studies have found that
although breast fed infants still die from SIDS, breast feeding reduces an infant's
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risk whilst bottle feeding increases an infant's risk of dying from S1DS [Bernshaw,
1991], Different levels of IgA to the three toxins examined might reflect variability
of these antibodies in human milk. The levels needed to afford complete or partial
protection need to be addressed.
8.2.3 Problems associated with studies ofinfantfeeding
A number of fundamental problems are associated with investigations of infant
feeding [Gilbert et al., 1995], The first problem relates to defining the method of
feeding. Should a breast fed infant be described as one who is exclusively breast fed
or should it include infants who are partly breast and partly bottle fed? [Cunningham
et al., 1991], Non-exclusive methods of feeding will reduce any actual differences
between breast and bottle feeding. In the UK, exclusively breast fed infants are rare
and it has been found that 45% of babies received bottles of formula or water during
their first week of life. It is also unethical to assign infants randomly to formula fed
or breast fed groups [Bauchner et al., 1986],
A second problem which is evident in infant feeding studies is the variability of both
nutritional and immunological factors among breast milks from different mothers
[Williams, 1994],
Confounding or associated variables are a third problem encountered by studies of
feeding method. Feeding method correlates with socioeconomic factors and
socioeconomic factors must be taken into account when analysing data obtained
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from epidemiological studies. Breast fed infants are more likely to come from
middle or upper class homes and have non-smoking parents. Women in higher
social classes were also found to breast feed for longer. In contrast, formula fed
infants are more likely to come from deprived areas and have parents who smoke
[Cunningham et al., 1991; Williams, 1994; Harrison, 1998, Blackwell et al., 1999],
These factors make it difficult to distinguish between the possibilities that the
protective effect of breast feeding in relation to SIDS is due to actual factors present
in breast milk or due to a reduction of other risk factors which are associated with
lower socioeconomic groups. Some studies have found that when the results are
adjusted for maternal smoking, pre-term gestation and parental unemployment, the
association between the risk of SIDS and bottle feeding is greatly reduced [Gilbert et
al., 1995],
8.2.4 Infection, breast feeding, formulafeeding and SIDS
Infections have been suggested to play a role in the mechanism of a SIDS death.
Breast fed infants have increased protection against gastrointestinal and lower
respiratory disease [Buescher, 1994; Pisacane et al., 1994]; therefore, breast feeding
might reduce the risk of SIDS by providing protection against infection. These
effects hold even when confounding variables have been taken in to consideration,
and they are particularly obvious in countries such as Brazil where formula fed
infants have been found to be 14.2 times more likely to die from diarrhoeal disease
compared to breast fed infants. In contrast, in industrialised countries such as the
UK where infant formulas are hygenically prepared and nutritionally complete, the
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health benefits of breast feeding compared to formula feeding have been questioned
[Williams, 1994],
Maternal IgG antibody is responsible for the major protection of an infant against
bacteria and viruses. IgG specific for toxins would be important defences for
neutralisation of the toxins implicated in SIDS. Levels of maternal IgG fall to about
one quarter of their original levels in infants about three months after birth and the
infant is more vulnerable at this time to a challenge by infectious agents.
It is possible that breast fed infants receive protection by secretory IgA in breast
milk [Bernshaw, 1991], No immunoglobulins are present in the intestinal tracts of
bottle fed infants until they produce their own secretory IgA [Davidson et al., 1987]
and these appear later than breast fed infants [Dallas et al., 1998], Secretory IgA is a
specific defence mechanism for the breast fed baby and provides local
immunological protection at mucosal surfaces against bacterial or viral infection or
by preventing antigens crossing the epithelial barrier. It can be suggested that IgA
antibodies in breast milk which can bind to and neutralise toxin activity [Rolfe et
al., 1995, Dallas et al., 1998] might neutralise the effects of bacterial toxins on
mucosal surfaces reducing the possibility of systemic effects. Premature infants are
at a greater risk of dying from SIDS and they have lower levels of IgG in their first
months of life compared to full-term infants [Morris et al., 1987], It is especially
important that these premature infants are breast fed and receive IgA.
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8.2.5 Virus infection, bacterial toxins, method offeeding and SIDS
Respiratory infections have been implicated in some SIDS deaths, and an infant's
chance of developing such disease is increased by synergistic interactions between
smoking and bottle feeding. In a longitudinal study of mothers and infants, smoking
and formula feeding were found to be significantly higher among lower
socioeconomic groups [Blackwell et al., 1999],
Several respiratory viruses including respiratory syncitial virus (RSV), parainfluenza
virus, rhinovirus, adenovirus and influenza A virus have been identified in SIDS
infants. RSV infection is associated with minimal breast feeding [Ruuskanen et al.,
1993], Experimental studies indicate that viral infections increase the susceptibility
of the respiratory tract to bacterial colonisation by toxigenic bacteria implicated in
SIDS and other respiratory pathogens [Raza et al., 1993; Saadi el al., 1993; Saadi el
al., 1996; El Ahmer et al., 1999],
Evidence for a synergistic interaction between virus infection and bacterial toxins
has been found in several studies. The effects of staphylococcal (a and y) and
diphtheria toxins could be enhanced in 5 day old ferrets infected with influenza
virus. Since there was no effect on viral replication, it was concluded that it was the
virus which was having an effect on the infection [Jakeman et al., 1991], Induction
of an auto-amplification of cytokine production might be one possible interaction
between virus infections and toxins. The permeability of cells can be enhanced by
influenza virus infection and this might allow more or rapid uptake of the toxin. The
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increased permeability will also allow increased release of inflammatory mediators
[Jakeman et al., 1991], Subclinical infections with lymphocytic choriomeningitis
virus was found to prime mice expressing the SEB VP receptor and resulted in
induction of rapid fatal shock with sublethal concentrations of SEB [Sarawar et al.,
1994],
Antibodies and other components of human milk have neutralising effects on many
respiratory viruses. In addition the anti-viral activity of human milk could be
important for reducing the risk of SIDS.
8.2.6 Breast feeding and control of inflammatory responses
During the 2-4 month age range, infants become more reliant on their
inflammatory responses since maternal antibody levels against bacteria and viruses
are decreasing. Immunisation studies have shown that younger infants are better
able to control their inflammatory responses compared to older infants.
Breast fed infants develop circadian rhythm patterns significantly earlier than
formula fed infants. Breast fed infants will be able to neutralise a challenge from
bacteria or their toxins due to the presence ofmaternally derived IgA in breast milk.
Infants (e.g. Asian) who develop adult-like night-time temperature patterns and
circadian rhythm patterns of Cortisol levels later compared with normal infants, will
also be able to control an inflammatory response to bacteria or their toxins since
these infants will have begun to produce their own antibodies and will have
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benefited from the extra time to produce active immunity through vaccination and
natural exposure. Since a greater number of Asian infants are breast fed at least
during the first 4 months of life [Lawson, 1998], they would appear to have two
advantages in relation to protection against SIDS.
If the switch to the circadian rhythm pattern occurs in infants when maternal
antibodies are low, the infant is formula fed or they have not yet begun to produce
their own antibodies, the infant is at an increased risk of SIDS due to lower




8.3.1 Effects ofthe synthetic Lewis antigens on bacterial binding and toxin activity
The effect of adding higher concentrations ofLewis antigens to infant formula needs
to be examined as these naturally occurring substances might improve protection of
mucosal surfaces against some bacterial pathogens (H. pylori, S. aureus, B. pertussis
and C. perfringens) that use these antigens as mucosal receptors.
To investigate the effects of Lewis antigens on IL-6 production, the experiments
could be repeated in relation to a quantitative assessment of the level of Lewis
antigens on the leukocytes. These experiments also need to be repeated using a
slightly modified protocol in which TSST-1 is initially incubated with the
appropriate concentration of Lewis antigen for 2 h at 37°C before addition to the
cells. The effects of lower levels of both antigens need to be tested in these studies.
8.3.2 Cortisol levels
The studies by Wailoo and colleagues need to be extended to determine when an
infant's night-time Cortisol levels rise above 5 pg df1 into a range that could control
the inflammatory responses. The development of these physiological changes in
ethnic groups (e.g. Native Americans, Australian Aborigines) in which there is a
high incidence of SIDS also need to be examined.
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8.3.3 Method offeeding and smoking
In populations in which breast feeding is not strongly associated with socioeconomic
group, it has been found to be protective against the risk of SIDS and against enteric
and respiratory tract infections. Bottle feeding is largely determined by social and
cultural factors and is strongly associated with maternal smoking [Gilbert et al.,
1995], To overcome some of these problems associated with investigation of SIDS
in relation to method of feeding, studies need to be carried out in countries such as
New Zealand where breast feeding is not associated with socioeconomic status to
determine the effects ofmaternal smoking on density of colonisation by normal and
pathogenic micro-organisms. It would also be important to investigate the effects of
bottle and breast feeding on density of colonisation of infants ofmothers who smoke
and mothers who do not smoke.
8.3.4 Method offeeding and response to infection
Studies carried out by other groups on physiological responses to immunisation
(temperature, night-time Cortisol levels) [Westaway et al., 1993] need to be assessed
in relation to method of feeding to determine if inflammatory responses
(temperature) are better controlled in breast fed infants.
8.3.5 Genetic control of inflammatory responses to bacterial toxins
Studies indicate that there are significant genetic factors associated with control of
both pro-and anti-inflammatory responses to endotoxin [Westendorp et al., 1995],
Fatal outcome of meningococcal infection was related to low levels of TNF
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responses and / or high levels of IL-10 responses obtained with in vitro studies of
first degree relatives of the patients [Westendorp et al., 1997],
Future work on SIDS will compare the inflammatory responses to common bacterial
toxins between parents who have had a SIDS death and the responses of parents
who have not. The studies will also include comparison of inflammatory responses
of parents from various ethnic groups to determine if some of the differences in the
incidence of SIDS, particularly those of Asian infants, are due to genetic differences
in their inflammatory responses or differences in their development noted by
Petersen and Wailoo [Petersen et al., 1994],
8.4 Conclusions
There is a growing body of evidence relevant to risk factors for SIDS that indicates
microorganisms might precipitate the series of events leading to death of the infant.
This study investigated the protective effect of breast feeding in relation to SIDS at
two stages of the bacterial toxin model: 1) at the level of colonisation by toxigenic
bacteria; 2) control of inflammatory mediators produced in response to bacterial
toxins.
In bacterial binding studies using the in vivo method, breast milk enhanced bacterial
binding to cells and this was found to be due to bacterial aggregation. In contrast,
infant formula inhibited bacterial binding to cells and it has been suggested that one
protective effect of breast feeding in relation to SIDS might be that in breast fed
infants, aggregate formation leads to enhanced clearance of bacteria by
phagocytosis, ciliary action or peristalsis. The results obtained for the binding
studies disproved the original hypothesis proposed, that breast milk might be better
than infant formula at inhibiting bacterial binding to epithelial cells; however, the
results could be explained to suggest a protective effect of breast feeding in relation
to SIDS. Reduction in bacterial binding observed with infant formula in the in vivo
method could afford some protection by reducing colonisation by potentially
pathogenic bacteria; however, if damage to the host is mediated by toxins, the
formula preparations lack antibodies to the toxins and have very low levels of the
Lewis antigens.
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As expected, breast milk but not infant formula contained human IgA antibodies to
the toxins TSST-1, SEC and CEA. These antibodies might also protect a breast fed
infant by neutralising bacterial toxins on mucosal surfaces and preventing them
entering the bloodstream or by binding to adhesins on pathogens and interfering
with their attachment. This protection would be particularly important during the
period when Cortisol levels drop at night-time following development of circadian
rhythm. IgGi antibodies against TSST-1, SEC and CEA were detected in cows' milk
but not in infant formula preparations. This implies formula fed infants receive no
protective antibodies either human or bovine until they begin to produce their own
secretory IgA or they are fed fresh cows' milk.
If the switch to the circadian rhythm pattern occurs early when maternal antibodies
are present, the infant is receiving IgA in breast milk or later when immunisation or
natural exposure has induced protective antibodies, the infant might be able to
reduce the effects of a challenge with bacterial toxins or infectious agents. If the
switch occurs in an infant when maternal antibodies are low, the infant is formula
fed or the infant has not produced its own active immunity, lower night-time Cortisol
levels might be insufficient to control inflammatory responses induced by bacterial
toxins alone or in combination with other infections. These uncontrolled
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